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DNA POLYMERASE θ (POLQ) AND THE CELLULAR DEFENSE AGAINST DNA
DAMAGE
Matthew James Yousefzadeh, Ph.D. Candidate
Supervisory Professor: Richard D. Wood, Ph.D.

In mammalian cells, DNA polymerase θ (POLQ) is an unusual specialized DNA
polymerase whose in vivo function is under active investigation. The protein is comprised of
an N-terminal helicase-like domain, a C-terminal DNA polymerase domain, and a large
central domain that spans between the two. This arrangement is also found in the
Drosophila Mus308 protein, which helps confer resistance to DNA interstrand crosslinking
agents. Homologs of POLQ and Mus308 are found in eukaryotes, including plants, but a
comparison of phenotypes suggests that not all of these genes are functional orthologs.
Flies with defective Mus308 are sensitive to DNA interstrand crosslinking agents, while
mammalian cells with defective POLQ are primarily sensitive to DNA double-strand breaking
agents. Cells from Polq-null mice are hypersensitive to radiation and the peripheral blood
cells of these mice display increased spontaneous and ionizing radiation-induced levels of
micronuclei (a hallmark of gross chromosomal aberrations), though the mice apparently
develop normally.
Although a defect in the DNA polymerase POLQ leads to ionizing radiation sensitivity
in mammalian cells, the relevant enzymatic pathway has not been identified. Here we define
the specific mechanism by which POLQ restricts harmful DNA instability. Our experiments
show that Polq-null murine cells are selectively hypersensitive to DNA strand-breaking
agents, and that damage resistance requires the DNA polymerase activity of POLQ. Using a
DNA break end joining assay in cells, the repair of DNA ends with long 3′ single-stranded
overhangs was monitored. End joining events that retained much of the overhang were
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dependent on POLQ, and independent of Ku70. To analyze this repair function in more
detail, immunoglobulin class switch joining between DNA segments in antibody genes was
examined. POLQ participates in the end joining of a DNA break during immunoglobulin
class-switching, producing insertions of base pairs at the joins with homology to IgH switchregion sequences. Biochemical experiments with purified human POLQ protein revealed the
mechanism generating the insertions during DNA end joining, relying on the unique ability of
POLQ to extend DNA from minimally paired primers.
DNA breaks at the IgH locus can sometimes join with breaks in Myc, creating a
chromosome translocation. A marked increase in Myc/IgH translocations was observed in
Polq-defective mice, showing that POLQ suppresses genomic instability and genome
rearrangements originating at DNA double-strand breaks. This work clearly defines a role
and mechanism for mammalian POLQ in an alternative end joining pathway (termed
synthesis-dependent end joining) that suppresses the formation of chromosomal
translocations. Our findings depart from the prevailing view that alternative end joining
processes are generically translocation-prone.
Class switch and junction analysis was also performed in mice lacking POLN,
another DNA polymerase related to POLQ. I observed that POLN does not operate in the
same alternative end joining pathway as does POLQ. Loss of Poln does not enhance the
DNA damage hypersensitivity seen in cells lacking Polq. These findings suggest that while
these two polymerases are structurally related they appear to have distinct functions in the
cell. Analysis of the Poln phenotype is still ongoing. Further analysis of POLN and POLQ is
required to clarify the mechanism by which they function in the cell.
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Chapter 1: DNA polymerase POLQ and cellular defense against DNA damage
Note this chapter is based on: Yousefzadeh, M.J., and Wood, R.D. (2013). DNA polymerase
POLQ and cellular defense against DNA damage. DNA Repair 12, 1-9. With permission
from the copyright holder.

1.1 Introduction
The functions of the 16 known mammalian DNA polymerases are currently being
explored (Garcia-Gomez et al., 2013; Hubscher et al., 2002; Lange et al., 2011). DNA
polymerases (pols) play pivotal roles not only in DNA replication (pols α, δ, ε), but also in
base excision repair (pol β), mitochondrial replication and repair (pol γ), non-homologous
end-joining and immunological diversity (pols λ, µ, and terminal-deoxynucleotidyl
transferase), and DNA damage tolerance including translesion synthesis (η, κ, ζ, Rev1).
Some DNA polymerases have roles in more than one pathway of DNA processing.
Identification of mammalian POLQ initially arose from interest in the Mus308 gene
product of the fruit fly Drosophila melanogaster. Mus308 mutants are hypersensitive to
agents that cause DNA interstrand cross-links (ICL), with only modest sensitivity to
monofunctional alkylating agents (Aguirrezabalaga et al., 1995; Harris et al., 1996). This
suggested that Mus308 might play a specific role in repair of ICLs in DNA. Characterization
of the Mus308 gene showed that it encodes an unusual domain configuration, with the Cterminal part of the protein encoding a DNA polymerase, and the N-terminal part of the
protein encoding a DNA helicase (Harris et al., 1996) (Figure 1).
A cDNA encoding the DNA polymerase domain of a homologous enzyme,
designated DNA polymerase θ (POLQ), was identified by Sharief et al. (Sharief et al., 1999).
The predicted protein of 1762 amino acids did not include a helicase-like domain, and is
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now recognized to correspond to the C-terminal portion of full-length POLQ. Independently,
Abbas and Linn assembled a larger 9.1 kb cDNA encoding both polymerase and helicase
domains and predicted it to encode a protein of 2724 amino acids (Abbas, 2000). Seki et al.
independently isolated the first complete and functional POLQ cDNA, showing that it
encodes a 2590 amino acid protein with both a DNA polymerase and helicase-like domain
(Seki et al., 2003). An orthologous mouse POLQ of 2544 amino acids was predicted from
the genomic sequence by Shima et al. (Shima et al., 2003).

Figure 1. Structural comparison and related grouping of POLQ gene family members.
The boundaries of the conserved domains and core catalytic domains of the helicase-like
(yellow/orange) and polymerase (purple/blue) domains are noted in color and determined
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through the Conserved Domain Database (Marchler-Bauer et al., 2011). Numbers above the
proteins indicate amino acid positions. Percentages indicating the individual % similarity
between the helicase-like and polymerase domains of POLQ were generated in MacVector.

The polymerase domains of POLQ and Mus308 belong to the “A” family of DNA
polymerases, showing sequence similarity to E. coli DNA polymerase I (Harris et al., 1996;
Marini et al., 2003). As described in more detail below, however, the polymerase domain of
POLQ contains three unique “insert” regions within the DNA polymerase sequence (Figure
2A and B), which determine some of its biochemical properties (Seki et al., 2004). While
much is known about the enzymatic properties of POLQ in vitro, further study is needed to
better determine its functions in cells. Below I review data on the published literature
regarding the function of POLQ and role in DNA repair.

POLQ gene family distribution in nature
Genes with similarity to POLQ and Mus308 are present in protists, plants, as well as
eukaryotes (Figure 1), but not in yeast or other fungi. It remains to be determined whether
all POLQ-like genes are true orthologs, as it appears that there are functional differences
between species. Mutations in the polq-1 gene of C. elegans confer sensitivity to ICLinducing agents (Muzzini et al., 2008). TEBICHI, a POLQ-like protein found in Arabidopsis,
is important for normal plant development and contributes to alleviating DNA replication
stress and perhaps recombination. Tebichi mutant plants are sensitive to both the ICLinducing agent mitomycin C (MMC) and to the monofunctional alkylating agent methyl
methane sulfonate (MMS) (Inagaki et al., 2009; Inagaki et al., 2006).
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The availability of numerous high quality protein sequences allows direct comparison
by primary alignment, revealing several evolutionary patterns in the POLQ family. The length
between the core polymerase and helicase-like domains of POLQ is about 1500–1600
amino acids in vertebrates, but only about 800 residues in plant homologs and 800–1000
amino acids in invertebrate animals (Table 1A). Further, the positions of the polymerase
domain “inserts” are conserved within the entire POLQ family, but the inserts are much
shorter in the non-vertebrate family members (Table 1B). Expansion of the size of the
central domain and the inserts apparently arose contemporaneously in a common
vertebrate ancestor. The variations in the central domain and polymerase domain insert
lengths may account for some of the differences in damage sensitivities associated with
defects in POLQ family genes in different organisms (Table 1A and B, Figure 2C).
Recently, a report found three RAD51 interaction sites within the central domain of POLQ
and the authors suggest that POLQ interacts with RAD51 to suppress homologous
recombination (Ceccaldi et al., 2015). This serves as the first suggestion that the central
domain may have an important role in the function of POLQ.
Two other genes in multicellular eukaryotes show significant and intriguing
relationships with POLQ. HELQ (formerly HEL308) is a DNA repair helicase with amino acid
sequence similarity to the helicase-like domain of POLQ. HELQ homologs are found in both
animals (Marini and Wood, 2002) and archaea (Woodman and Bolt, 2009), but not in fungi
or bacteria. POLN is a 900 amino acid protein in human cells, harboring an A-family DNA
polymerase domain related to that of Mus308 and POLQ (Marini et al., 2003; Takata et al.,
2010; Takata et al., 2006). In contrast with POLQ, the phylogenetic distribution of POLN
appears to be limited to the deuterostome lineage of eukaryotes, including vertebrates.
Phylogenetic analysis suggests that POLN is no more related to POLQ than it is to the
bacterial pol I polymerases (Figure 2C).

4

A

5

B

6

7

Figure 2. Map and alignment of POLQ polymerase domain. (A) The C-terminal portion of
POLQ (amino acids 1792-2590) necessary for polymerase activity is displayed. The core
polymerase domain of POLQ is displayed in blue. Conserved A-family DNA polymerase
motifs are noted in black. The unique sequence inserts found in POLQ are shown in yellow.
An inactive DnaQ-like 3'→5' exonuclease domain (including insertion loops shaded in
orange), Chaos1 mutation (Ser1932 in mouse/Ser1977 in human), and the 5'-dRP lyase
activity of POLQ mapped to the polymerase domain are noted. An asterisk notes the
tyrosine residue 2337 in motif 4 of the polymerase domain that facilitates ddNTP
incorporation. The location of the serine to proline mutation found in the Chaos1 mutant
mouse is noted in the central domain. (B) Sequence alignment of POLQ family members
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constructed in MacVector. Amino acid numbers for each species in the alignment are
notated in brackets. (C). The dendogram illustrating evolutionary relatedness of POLQ gene
family members was created using SeaView. POLQ, POLN, and bacterial pol I homologs
are shown in orange, cyan, and magenta outlined groups, respectively.

MycoPolI: Mycobacterium tuberculosis pol I; EcPolI: Escherichia coli pol I; TaqPolI: Thermus
aquaticus pol I; TEBICHI: Arabidopsis thaliana TEBICHI; Rice: Oryza sativa pol I;
Soybean: Glycine max POLQ-like; CePolq-1: Caenorhabditis elegans Polq-1;
Mosquito: Aedes aegypti POLQ; Mus308: Drosophlia melanogaster Mus308; Anole: Anolis
carolinensis POLQ-like; Tilapia: Oreochromis niloticus POLQ; Zebrafish: Danio rerio POLQ;
Xenopus: Xenopus tropicalis POLQ; Chicken: Gallus gallus POLQ; Finch: Taeniopygia
guttata POLQ; Dog: Canis lupus POLQ; Rabbit: Oryctolagus cuniculus; Horse: Equus
caballus POLQ; Cow: Bos taurus POLQ; Rat: Rattus norvegicus POLQ; Mouse: Mus
musculus POLQ; Rhesus: Macaca mulatta POLQ; Chimp: Pan troglodytes POLQ;
Human: Homo sapiens POLQ; HsPOLN: Homo sapiens POLN; PtPOLN: Pan
troglodytes POLN; MmPOLN: Mus musculus POLN; DrPOLN: Danio rerio POLN.

The scale bar indicates a distance of 0.1 amino acid substitution per site.
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A

Distance between
core catalyt
ytic domains
Length (aa)
Species
Human
1565
Chimp
1596
Mouse
1552
Cow
1593
Horse
1599
Chicken
1610
Finch
1581
Xenopus
1557
Zebrafish
1457
Tilapia
1271
Anole
1364
Pea Aphid
905
1018
Western Mite
1042
Fruit Fly
801
Mosquito
888
C. elegans
806
Arabidopsis
817
Soybean

B

Vertebrates

Invertebrates

Length of POLQ polymerase domain inserts (aa)
Species
Insert 1
Insert 2
Insert 3
Human
22
52
33
Chimp
22
52
33
Mouse
22
52
33
Chicken
22
52
33
Vertebrates
Dog
22
52
33
Xenopus
22
48
28
Zebrafish
19
51
24
Tilapia
19
42
25
Fruit Fly
4
9
9
Mosquito
0
10
7
Invertebrates
C. elegans
3
9
0
Soybean
5
18
13
Rice
5
0
16
Plants
Arabidopsis
5
17
13

Plants

Table 1. Conservation of POLQ functional interdomain distance and polymerase
domain inserts in evolution. Length of (A) the amino acid separation between the core
catalytic domains of the helicase-like and polymerase domains and (B) polymerase domain
inserts in POLQ gene family members. All lengths are in amino acids.

Low fidelity and translesion synthesis activities of POLQ
Human POLQ has been purified as a recombinant protein from a baculovirusinfected insect cell expression system (Seki et al., 2003; Seki et al., 2004). The protein is
active on substrates including oligonucleotide primer-templates, hairpin primer-templates,
activated calf thymus DNA and poly (dA)-oligo (dT) (Seki et al., 2003; Seki et al., 2004). The
activity of recombinant POLQ is relatively resistant to aphidicolin, a potent inhibitor of
eukaryotic replicative DNA polymerases (pols α,δ,ε) (Cheng and Kuchta, 1993; Dresler et
al., 1988; Seki et al., 2003; Sheaff et al., 1991). POLQ is sensitive to dideoxynucleoside
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triphosphate (ddNTP), consistent with the presence of a tyrosine residue in motif 4 of familyA DNA polymerases that facilitates ddNTP incorporation (Figure 2B) (Doublié et al., 1998;
Seki et al., 2003). Sequence alignment shows that POLQ contains an inactive DnaQ-like
3'→5' exonuclease that lacks conservation in the key HxAxxD ExoIIIε metal binding motif.
Purified POLQ lacks a 3'→5' exonuclease activity, which is a common feature of low fidelity
DNA polymerases (Figure 2A). Primer extension assays to measure DNA polymerase
fidelity, found that purified POLQ frequently misincorporated a G or T across from a T in the
template (Seki et al., 2003; Seki et al., 2004). In a gap-filling assay to measure mutation
frequency, human POLQ generated single base errors at a 10 to 100-fold higher rate than
the other A family DNA polymerase members (γ, ν) (Arana et al., 2008). POLQ adds single
nucleotides to homopolymeric runs at particularly high rates during gap filling, exceeding 1%
in certain sequence contexts. The enzyme generates single base substitutions at an
average rate of 2.4 × 10−3, comparable in rate to the inaccurate family Y human pol κ (5.8 ×
10−3). This is unusual, as the most studied low fidelity polymerases belong to the Y family (η,
ι, κ, Rev1) rather than the A family of polymerases (Goodman, 2002).
Maga et al. purified an activity, thought to be from POLQ, from HeLa cell nuclear
extracts that could efficiently utilize abasic site-containing DNA as a template. The purified
preparation contained several polypeptides of about 100 kDa, one of which was recognized
by an antibody raised against a fragment of recombinant POLQ (Maga et al., 2002). The
active fraction exhibited relatively high fidelity of DNA polymerization, and a 3' → 5'
exonuclease activity, but no ATPase or helicase activities (Maga et al., 2002). It seems likely
that this preparation may have contained an active fragment of POLQ, co-purifying with a 3'
→ 5' nuclease activity. The identity of this exonuclease is unknown but it may be
physiologically relevant to POLQ activity.
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POLQ has the ability to catalyze DNA synthesis across specific forms of endogenous
and exogenous DNA damage in a process called translesion DNA synthesis (TLS). A
notable POLQ enzymatic trait is its ability to incorporate an A residue opposite abasic (AP)
sites and extend from the incorporated nucleotide. Although many DNA polymerases tend to
insert an A opposite an AP site (known as the “A” rule (Avkin et al., 2002; Strauss et al.,
1982; Strauss, 2002), the highly efficient extension from the A opposite an AP site is unique
to POLQ (Seki et al., 2004). For example, POLH (η) can insert a base opposite an AP site
but cannot efficiently extend from the lesion, a property common to human Y family
polymerases (Johnson et al., 2000; Lawrence, 2002; Masutani et al., 2000; Seki et al., 2004;
Vaisman et al., 2002; Zhang et al., 2001). About 18,000 AP sites arise in each diploid
mammalian cell per day by hydrolytic depurination, but insertion of an A opposite such a site
would be mutagenic (Friedberg et al., 2006). Abasic sites are also generated frequently as
intermediates in the base excision repair of uracil following the accidental incorporation of
dUTP during genomic DNA replication (Guillet and Boiteux, 2003; Lindahl, 1993; Nakamura
et al., 1998). If a DNA replication fork encounters such an AP site before it is repaired,
introduction of an A would reconstitute the original undamaged template and be
physiologically useful. It remains to be determined whether this AP site bypass activity is a
function of POLQ in vivo.
POLQ cannot insert a base opposite the common UV-radiation induced cyclobutane
pyrimidine dimers or 6-4 photoproducts (6-4PP). However, if pol ι (Vaisman et al., 2004) is
used to incorporate bases opposite a 6-4PP, POLQ can extend the poorly matched primerterminus (Seki et al., 2004; Seki and Wood, 2008). POLQ was also able to efficiently extend
mismatched A:G, A:T, and A:C termini (Seki and Wood, 2008). The ability of POLQ to
catalyze extension from minimally primed or mispaired DNA ends is quite important for its
function in cells and is discussed in Chapter 2 of this thesis (Yousefzadeh et al., 2014).
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Thymine glycol (Tg) is a common product of reactive oxygen species-mediated
damage to DNA. POLQ and POLN can efficiently bypass both enantiomers (5R,5S) of a Tg
adduct, whereas pol η extends efficiently only from the 5R-Tg (Kusumoto et al., 2002; Seki
et al., 2004; Takata et al., 2006). Translesion synthesis bypass of a Tg residing on a shuttle
vector was reduced in human MRC5 cell lines with diminished levels of POLQ (Yoon et al.,
2014). This finding was clouded, in my opinion, by knowledge that siRNA suppression of
POLQ can be variable and knockdown was measured by semiquantitative RT-PCR, rather
than other detection methods that are more sensitive and quantitative. Furthermore,
immunoblotting for POLQ was carried out using an unvalidated rabbit polyclonal antibody.
The Abcam ab80906 rabbit polyclonal antibody against POLQ used by the authors is
reported by the manufacturer to recognize a band between 144 and 168 kDa when blotted
against placenta lysate. Notably, POLQ has a predicted molecular weight of 290 kDa.
Further, the authors did not show full immunoblots thus leaving open the question of
whether they actually detected the proper band for POLQ or whether it was some other nonspecific band. The authors presented similar controversial immunoblotting results with a
rabbit polyclonal antibody against POLN (Abnova POLN A01 H000353497-A01), thus calling
additional experimental conclusions into doubt regarding the knockdown efficiency of either
POLN or POLQ by siRNA. If the findings do hold true, it suggests that POLQ bypasses Tg
adducts in vivo, through an error prone TLS process. However if POLQ cannot bypass Tg in
vivo then in vitro evidence of POLQ’s ability to bypass Tg could be explained by the
enzyme’s unique ability to utilize minimally or misprimed ends to catalyze extension (Seki
and Wood, 2008; Yousefzadeh et al., 2014). Lesion bypass by POLQ could be useful in
catalyzing the extension of 3’ single-stranded DNA ends (See Chapter 2 of this thesis),
which can be easily damaged through for example methylation, deamination, and
oxidization.
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The ability of POLQ to extend from mismatched, poorly matched or unmatched
termini is unusual and will be understood better after high-resolution structural features of
the active site are determined. The three “inserts” in the catalytic domain are unique to
POLQ (Figure 2A and B), and some specific deletions of these inserts have been analyzed
with respect to activity. Insert 1 comprises 22 amino acids between the first and second
conserved motifs in the “thumb” subdomain, and its sequence is highly conserved
throughout vertebrates (Seki et al., 2004). In other A-family DNA polymerases, the thumb
region influences DNA binding and frameshift fidelity. Deletions in the thumb region of E.
coli Pol I can cause errors in processivity and an increased use of misaligned
primer/template complexes (Cannistraro and Taylor, 2004; Doublié et al., 1998; Minnick et
al., 1996). Insert 2 is 52 amino acids long and falls between the second and third motif and
has the least sequence conservation among the inserts while insert 3 is 33 amino acids that
lies between the fifth and sixth motif (Figure 2A and B). A fragment of POLQ (residues
1792–2590) containing the pol domain and a portion of the central domain (Figure 2A), is
active as a DNA polymerase when produced as a recombinant protein in E. coli. Shorter
fragments are much less active, or inactive (Hogg et al., 2011; Prasad et al., 2009)
indicating that this region of the central domain is required for efficient polymerase activity.
The active fragment is able to bypass AP sites and Tg adducts, showing that these bypass
activities are independent of the N-terminal helicase-like domain. Elimination of Insert 1 of
this POLQ fragment reduced processivity of the enzyme but had little, if any, bearing on the
translesion synthesis properties of the enzyme. However, removal of either inserts 2 or 3
reduced activity on undamaged DNA and eliminated the ability of POLQ to bypass AP sites
or Tg adducts (Hogg et al., 2011).
The helicase-like domain of POLQ has 7 conserved motifs of the superfamily II DNA
and RNA helicase family (Seki et al., 2003). The POLQ helicase-like domain exhibits some
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single-stranded DNA-dependent ATPase activity, though lower in comparison to that of
HELQ. No overt helicase activity of POLQ has been reported (Seki et al., 2003). It is
possible that POLQ will only display helicase activity with an as yet untested substrate or
alternatively, requires additional accessory factors. Another possibility is that the helicaselike domain of POLQ could function as a protein-displacement motor, in lieu of unwinding
DNA. Several cellular functions have been suggested for POLQ. These are summarized in
the next sections.

Hematopoiesis and immunological diversity
Some investigations have explored the possibility of a specialized immunological
function for POLQ, either in somatic hypermutation (SHM) or in class switch recombination
(CSR) of immunoglobulin genes. POLQ is expressed in hematopoietic cells, including
germinal center B cells (Kawamura et al., 2004). SHM acts to introduce point mutations in
the variable (V) region of antibodies to alter their affinities while CSR changes the
immunoglobulin constant region. Both processes are set in motion by the AID enzyme which
can deaminate cytosine to uracil in DNA (Honjo et al., 2004). Mutations may then arise from
low-fidelity repair synthesis or nucleotide misincorporation opposite an AP site (Neuberger
et al., 2005; Seki et al., 2005).
With respect to SHM, Polq−/− mice were previously reported to have decreased
mutations of C:G sequences at SHM hotspots, whereas mutations at A:T sequences were
unaffected (Masuda et al., 2005). POLH is important for A:T mutagenesis in SHM
and Polh−/− Polq−/− mice do not exhibit a decrease in A:T mutations when compared
to Polh−/− mice (Masuda et al., 2007; Ukai et al., 2006). POLQ extends beyond mispairs with
A or T and can extend weakly from mispaired termini generated by POLH, suggesting that
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POLQ and POLH might cooperate during A:T mutagenesis (Masuda et al., 2007). In an
independent set of experiments, mice carrying a gene disruption that completely eliminates
the POLQ enzyme had a frequency of SHM that was reduced by 60–80% (Zan et al., 2005).
There was no overall change in the proportion of events at A:T and C:G positions. Finally,
Martomo et al. found similar mutation frequencies of V genes in Peyer's patches
of Polh−/− Polq+/+ and Polh−/− Polq−/− mutant mice, suggesting that POLQ has only a minor
role, if any, in SHM point mutagenesis (Martomo et al., 2008).
The role of POLQ in immunoglobulin (Ig) gene conversion, a functionally analogous
process to SHM in avian species, but biochemically quite distinct, as it relies on homologous
recombination rather than point mutagenesis, was investigated. The Polq gene was
disrupted in the DT40 chicken B cell line by Yoshimura et al. using gene targeting (Kohzaki
et al., 2010; Yoshimura et al., 2006). Strikingly, a Poln Polq double mutant showed a fivefold decrease in Ig gene conversion, the primary method of V region diversity in avian
species. Further, a triple Polh Poln Polq mutant failed to exhibit any Ig gene conversion
(Kohzaki et al., 2010).
The absence of POLQ does not seem to impair CSR in mammals as the mouse
CH12F3 B-cell line (defective for Polq) can efficiently switch from IgM to IgA after
appropriate stimulation (Li et al., 2011). In vivo CSR frequency was not impaired in mice
lacking Polq, Polh, or both (Martomo et al., 2008). Nevertheless, my research uncovered a
role for POLQ in a subset of CSR events as described in Chapter 2 of this thesis
(Yousefzadeh et al., 2014).
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1.2 POLQ and DNA Repair
Base excision repair
POLQ might serve as a backup DNA polymerase for base excision repair (BER). In
mammalian cells, single-nucleotide BER is performed by POLB (pol β) (Prasad et al., 2009;
Yoshimura et al., 2006). A fragment of human POLQ was shown to display 5'-deoxyribosephosphate lyase (dRp-lyase) activity, an activity necessary for single-nucleotide BER
(Prasad et al., 2009). This dRp-lyase activity is present within a 24 kDa region of the POLQ
polymerase domain (Figure 2). This is in contrast to the much stronger dRp-lyase activity of
pol β, which is present in a distinct domain separate from the polymerase domain. 5'-dRp
lyase activity was still present in a catalytically inactive 98 kDa polymerase fragment of
POLQ (Prasad et al., 2009).
In chicken DT40 cells, Polq and Polq Polb double mutants were examined in regard
to BER (Yoshimura et al., 2006). The Polq single mutant is sensitive to hydrogen peroxide
(which can cause oxidative damage to bases) but not to MMS, although both agents cause
damage that is repaired by BER (Table 2A). The Polq Polb double mutant was more
sensitive to MMS than either of the Polq or Polb single mutants. Extracts from
the Polq mutant DT40 cell line appear to have a reduced capacity for both single-nucleotide
and long patch BER (Yoshimura et al., 2006).
Mouse bone marrow stromal cells lacking Polq do not show increased sensitivity to
either hydrogen peroxide or paraquat in comparison to controls (Goff et al., 2009). Human
SQ20B head and neck cancer cells depleted for POLQ with siRNA are not sensitive to
treatment with temozolomide, an alkylating agent that is related to MMS (Table 2B) (Higgins
et al., 2010b). CH12 mouse B lymphoma cells containing a deletion in an exon required for
POLQ catalytic activity are somewhat more sensitive to MMS in the presence or absence of
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methoxyamine, which reacts with AP sites and prevents single-nucleotide BER by pol β
(Ukai et al., 2006). Taken together, it appears that POLQ is not a major contributor to BER.
POLQ may be a backup enzyme for BER in the nematode C. elegans, which lacks pol β,
although at least one additional DNA polymerase also appears to function in BER in this
organism (Asagoshi et al., 2012).

Interstrand crosslink repair
Mus308, the Drosophila ortholog of POLQ, is implicated in an alternative form of end
joining that may contribute to ICL repair (Chan et al., 2010). Drosophila mus308, C. elegans
polq-1, and Arabidopsis TEBICHI are all sensitive to the ICL-inducing agent MMC (Table
2C) (Aguirrezabalaga et al., 1995; Inagaki et al., 2006; Muzzini et al., 2008). In vertebrate
cells, there are conflicting reports concerning the sensitivity of POLQ to ICL-inducing agents.
DT40 cells lacking POLQ are not hypersensitive to cisplatin, a clinically used ICL agent
(Kohzaki et al., 2010; Yoshimura et al., 2006). However, deletion of Polq slightly sensitized
murine CH12B-lymphoma cells to cisplatin and MMC (Li et al., 2011). The chaos1 mutant
mice and cells derived from them exhibited no hypersensitivity to MMC, suggesting that
POLQ does not play a major role in the repair of ICLs in mammalian cells (Shima et al.,
2004). The investigation of a role for POLQ in the repair of ICL-induced DNA damage is
further explored in Chapter 2 (Yousefzadeh et al., 2014).
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A
Agent
IR
Bleomycin
Etoposide
Peroxide
Paraquat
MMS
MMC
Cisplatin
UVC

Chaos1
+
ND
ND
ND
ND
ND
ND
ND

Vertebrate POLQ knockouts and mutants
BMSC
CH12 Pol
CH12 TKO
++
+
+
++
ND
ND
ND
+
+
ND
ND
ND
ND
ND
ND
ND
ND
ND
+/+/+
+
ND

siPOC
ND

POLQ-depleted human cells
siMRC5
SiQ20B
+
ND
-

DT40
ND
ND
+
ND
-

B
Agent
IR
Temozolomide

siHeLa
++
ND

C
POLQ knockouts in Drosophila, C. elegans, and Arabidopsis
Agent
Mus308
polq-1
TEBICHI
IR
+/ND
MMS
+
+
MMC
+
ND
+
Cisplatin
+
+
ND
HN2
+
+
ND
UVC
ND
ND

Table 2. Sensitivity of POLQ-deficient cells to DNA damaging agents. This table
summarizes the sensitivity of POLQ (A) vertebrate knockouts and mutants, (B) siRNAdepleted cell lines, and (C) non-vertebrate animal and plants knockouts to various DNA
damaging agents when I initiated my project. Sensitivity of cells to damaging agents were
described as (+) hypersensitive, (−) no sensitivity, or (ND) not described.
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Tolerance of DNA double strand breaks and alternative end joining (altEJ) of breaks
While evidence for multiple POLQ functions has been discovered, the strongest
evidence to date, supports a role for POLQ in the defense against radiation-mediated
genomic instability. The chaos1 (chromosome aberration occurring spontaneously 1) mouse
was produced in a phenotype-driven screen (Shima et al., 2003). Male mice were
periodically dosed with N-ethyl-N-nitrosourea (ENU) to induce germline mutations before
mating. Generation 1 male offspring were backcrossed with generation 2 females to create
generation 3 offspring that were potentially homozygous. The frequency of micronuclei (MN)
was measured in male generation 3 mice. MN arise from acentric chromosome fragments
arising from chromosome breakage or from whole chromosomes that was not properly
segregated or packaged into the nucleus at the time of cell division (Nusse et al., 1996).
DNA damaging agents induce MN, and those that form shortly before the nucleus is ejected
can be assayed in peripheral blood reticulocytes by flow cytometry (Dertinger et al., 1996).
The chaos1 mice show increased spontaneous MN in blood samples, and the level is further
elevated by ionizing radiation (IR) and MMC (Shima et al., 2003). The chaos1 recessive
mutation was mapped to a region of chromosome 16 that included the Polq gene, and was
determined to be a T to C point mutation in exon 19 of mouse Polq. This missense mutation
converts Ser to Pro at amino acid 1932, located near the C-terminal end of the central
domain, adjacent to the polymerase domain of POLQ (Figure 2A). Expression of wildtype Polq from a bacterial artificial chromosome was able to suppress
the chaos1 phenotype, suggesting that chaos1 mice possess a mutant allele of Polq (Shima
et al., 2003).
A Polq−/− knockout mouse was then generated by Naoko Shima in John Schimenti’s
laboratory, introducing a point mutation in exon 1 to create a premature stop codon and
replacing exons 2–5 with a neomycin resistance cassette (Shima et al., 2004). A lack of
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complementation was observed between the chaos1 and Polq-null alleles demonstrating
that chaos1 is a mutant allele of Polq. The authors also noted a marked developmental
disadvantage for Atm−/− Polq−/−double mutant mice. The few mice that did survive displayed
signs of severe DNA damage stress, including increased chromosomal instability,
decreased body weight and a delayed onset of thymic lymphomas in comparison
to Atm−/− mice (Shima et al., 2004). Goff et al. found that Polq−/− mice have increased levels
of IR-induced MN and confirmed that the levels of spontaneous MN formation were nearly
identical to those reported for chaos1 mice (Goff et al., 2009; Shima et al., 2004). Further
Goff et al. found that bone marrow stromal cells from the Polq−/− mice were hypersensitive to
gamma irradiation and to bleomycin, a drug that causes DNA double-strand breaks (Table
2A) (Goff et al., 2009). Inhibition of ATM activation with the drug KU55933 increased
radiosensitivity in wild-type but not in Polq−/− cells. Li et al. constructed a Polq-null mutant in
mouse CH12F3 B cells. These cells are more sensitive than normal cells to gammairradiation and etoposide (Li et al., 2011). POLQ was also uncovered in a siRNA screen of
genes that affect the IR sensitivity of human cells. Depletion of POLQ in SQ20B and HeLa
cancer cell lines caused an increase in IR-induced γH2AX foci and sensitized the cells to
gamma-irradiation (Table 2B) (Higgins et al., 2010b). These observations indicate that
POLQ has a role in either the tolerance or repair of DNA double-strand breaks.
The mechanism by which POLQ aids in the defense against IR-mediated genomic
instability is under investigation. Studies of Drosophila Mus308 function point towards a role
of this gene in an alternative form of end joining which relies upon annealing of
microhomologies in order for DNA end joining to occur. Yu et al. investigated the inaccurate
repair of DSBs mediated by the I-SceI nuclease in Mus308 mutants and found a decrease in
a process termed synthesis-dependent microhomology-mediated end joining (SD-MMEJ)
(Yu and McVey, 2010). This repair pathway is independent of Ku70, Lig4, and Rad51 and
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distinct from “canonical” non-homologous end-joining (cNHEJ) of DNA breaks. SD-MMEJ is
related to, or identical to, pathways defined in other biological systems as alternative end
joining (altEJ), or micro-homology-mediated end-joining (MMEJ). Analysis
of mus308 mutants showed a decrease in the use of long microhomologies at the junction
site and abrogation of complex T-nucleotide insertion events. Further analysis suggested
that this altEJ pathway is occurring in parallel to LIG4-mediated canonical end-joining (Chan
et al., 2010). Mus308 is also necessary for the incorporation of additional nucleotides (via an
altEJ pathway) that allows for retrohoming of group II introns in flies (White and Lambowitz,
2012). Worms lacking the functional POLQ homolog also show a defect in this altEJ repair
pathway and exhibit enhanced genomic instability (Koole et al., 2014; Roerink et al., 2014).
One would hypothesize that if cells lacking or with reduced POLQ levels were
hypersensitive to a particular DNA damaging agent, then POLQ may play a role in the repair
of that specific type of DNA damage. However, although such sensitivity assays have been
performed in a number of species (Table 2) there is no unified evolutionarily consensus of
what genotoxic agents that POLQ mutants are hypersensitive to and what DNA repair
pathways it may participate in. In Drosophila, Mus308 does not appear to participate in
homology-directed repair. Mus308 mutant larvae are not more sensitive to IR than wild-type,
but they are synergistically sensitized to radiation by addition of spn-A (Rad51) mutation,
indicating that Mus308-dependent repair is independent of homologous recombination in
Drosophila (Chan et al., 2010). This is in contrast to the Polq mutant in chicken DT40 cells,
which are only hypersensitive to peroxide and showed decreased levels of HR repair of ISceI-mediated DNA DSBs (Kohzaki et al., 2010; Yoshimura et al., 2006). Recently, a mutant
of POLQ (Z16) in the green algae C. reinhardtii was shown to be hypersensitive to the DSBinducing agent zeocin (Plecenikova et al., 2014). Human and mouse POLQ mutants are
radiosensitive, suggesting some divergence of POLQ and Mus308 functions. To understand
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a role for POLQ in mammalian cells, hypersensitivity to a broad spectrum of DNA damaging
agents needs to be tested in a better controlled manner (See Chapter 2) (Yousefzadeh et
al., 2014).
Functions in replication and at the replication fork
There are some suggestions that POLQ might work at the DNA replication fork or in
close connection with DNA replication proteins. As described below, POLQ gene expression
correlates with expression of genes involved in cell cycle control and DNA replication
(Pillaire et al., 2009). MRC5VA human lung fibroblast cells were engineered to stably
express recombinant POLQ, and this resulted in an increase in γH2AX foci, an increase in
chromosomal abnormalities and defective DNA replication fork progression (Lemée et al.,
2010). These data show that it is imperative for cells to keep levels of POLQ tightly
controlled to avoid detrimental effects on the cell. A recent report provided evidence that
POLQ interacts with replication origin factors ORC2 and ORC4 and reduced POLQ levels
alter replication timing (Fernandez-Vidal et al., 2014). In the same screen that identified
the chaos1 allele of POLQ, a second mutant termed chaos3 showed a similar phenotype of
increased micronuclei. Chaos3 has been identified as a hypomorphic allele of Mcm4, a
component of the helicase operating during semiconservative replication (Shima et al.,
2007). In Arabidopsis, TEBICHI gene mutants show striking defects in G2/M checkpoints
that could be due to abnormal DNA replication (Inagaki et al., 2006).

POLQ expression in normal and cancerous tissue
The POLQ gene is ubiquitously expressed in human and mouse tissues and cell
lines, as measured by northern blot analysis, reverse transcriptase polymerase chain
reaction (RT-PCR), and microarrays. Levels of expression appear to be highest in the testis,
human placental tissue and hematopoietic cells (Kawamura et al., 2004; Seki et al., 2003;
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Shima et al., 2003), but POLQ transcripts can be found throughout the body (Table 3).
POLQ is a member of a cluster of genes in which higher levels of expression correlate with
lower patient survival for several cancers. This cluster includes genes involved in DNA
replication, repair, recombination and cell cycle control. Higher expression of POLQ mRNA
was observed in some tumor samples from stomach, lung, and particularly colon cancers
compared to matched control non-tumor tissue (Kawamura et al., 2004). Stratification of
colon cancers based on POLQ expression alone indicated that the “POLQ high” group had
poorer survival than the “POLQ low” group by an average of ~24 months. Another study of
colorectal cancer patients indicated that tumors with higher expression of a group of 47 DNA
replication-related genes (including POLQ) were significantly correlated with poorer patient
survival (Pillaire et al., 2009). POLQ expression levels alone were correlated with poor
patient survival (Pillaire et al., 2009). In an analysis focusing on the expression of DNA
polymerases in human breast cancers, Lemée et al. found that of all 14 nuclear DNA
polymerases, only POLQ expression was significantly higher in cancer samples than in
normal tissue samples. Stratification, according to expression, showed that higher levels
of POLQ expression were correlated with poorer survival outcomes (Lemée et al., 2010).
Another study of POLQ expression in early breast cancer indicated that samples with the
highest POLQ expression level were in ER negative and high-grade tumors. Further, higher
POLQ expression was correlated with poor relapse-free survival (Higgins et al., 2010a).
Considering that radiation therapy is a frontline treatment for breast cancer and that human
cancer cells depleted for POLQ are sensitive to ionizing radiation, POLQ is a molecule of
interest in the study of breast cancers and is a potentially druggable target.
In some non-tumor cells, reduced POLQ levels resulting from siRNA treatment had
little effect on radiation sensitivity (Higgins et al., 2010b). It would be clinically beneficial if
tumor cells but not normal cells could be sensitized by POLQ suppression or inhibition, but it
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remains to be seen whether this is generally the case. As described above, genetic ablation
of POLQ from normal mouse cell lines leads to radiation hypersensitivity. Despite this
radiation sensitivity, the hematopoietic system of Polq−/− mice seems resilient. Mice
irradiated with a sub-lethal dose of 7 Gy of γ-irradiation showed a subsequent depression of
counts for white blood cells, red blood cells, lymphocytes and platelets, as expected after
immunoablation. Recovery to normal levels took place in Polq−/− mice as well as wild-type
mice (Goff et al., 2009). Due to its unique properties and clinical interest, further work to
understand POLQ and its role in the cell is pivotal.

Body Site
adipose tissue
adrenal gland
ascites
bladder
blood
bone
bone marrow
brain
cervix
connective tissue
ear
embryonic tissue
esophagus
eye
heart
intestine
kidney
larynx
liver
lung
lymph
lymph node
mammary gland
mouth
muscle

TPM Gene EST
0
0
30
1
0
0
0
0
32
4
13
1
0
0
1
2
0
0
6
1
124
2
14
3
0
0
14
3
0
0
21
5
14
3
1022
24
9
2
5
2
22
1
66
6
26
4
15
1
9
1

/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/

EST Pool
12866
32940
39834
29860
122252
71618
48737
1092688
48486
149072
16100
212896
20154
208840
89524
231981
210778
23466
205291
334815
44302
89748
151230
66150
106371

Body Site
nerve
ovary
pancreas
parathyroid
pharynx
pituitary gland
placenta
prostate
salivary gland
skin
spleen
stomach
testis
thymus
thyroid
tonsil
trachea
umbilical cord
uterus
vascular

TPM Gene EST
0
0
19
2
0
0
0
0
24
1
0
0
0
0
0
0
0
0
4
1
0
0
10
1
9
4
25
2
0
0
0
0
38
2
0
0
30
7
19
1

/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/
/

EST Pool
15535
101488
213440
20594
40725
16526
283019
189536
20265
210759
53397
95679
435204
79697
46583
17021
51780
13764
232093
51649

Table 3. POLQ transcripts are found throughout the body. Expressed Sequence Tag
(EST) data collected from Unigene for POLQ. For each body site, transcript per million
(TPM), gene-specific (Gene) EST and total EST’s for each body site (EST Pool).
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1.3 Aims of this thesis
The full-length POLQ cDNA was cloned in the Wood Laboratory in 2003, sparking
research into this specialized DNA polymerase (Seki et al., 2003). From the initial discovery
POLQ was unique, it was a fairly large enzyme (predicted molecular weight of 290 kDa) and
stood out from the other mammalian DNA polymerases because POLQ also contained a
helicase (-like) domain. When I started in the Wood Laboratory, a fair amount of information
regarding the in vitro biochemical properties of recombinant human POLQ was known;
however, a cellular function for POLQ was still unclear. From the outset of the project, Dr.
Wood and I felt a profound sense of excitement to determine what mammalian POLQ was
doing in the cell. With a minimal amount of knowledge of the DNA repair field, a lot of
curiosity, and the steady guidance of a mentor, I embarked on a roughly six year intellectual
journey to determine the function of mammalian POLQ.
An early hypothesis that I had in the infancy of my dissertation project was that
POLQ played a role in at least one or more DNA repair pathways.

Specific Aim 1 – To determine what DNA repair pathway(s) POLQ participates in.
Investigation of this aim was accomplished by analyzing isogenic sets of long-term bone
marrow stromal cells derived from Polq-null mice and their wild-type littermate controls for
hypersensitivity to different DNA damaging agents by clonogenic survival assays. Further
mechanistic investigation into the repair of DNA damage utilized in vivo analysis of wild-type
and Polq-null mice, in vitro and biochemical assays.
Specific Aim 2 – To determine the biological consequences of the loss of POLQ.
Polq-deficient mice and cells derived from them were analyzed for hypersensitivity to DNA
damage, markers of DNA damage signaling, cytologic markers of chromosomal instability,
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and in vivo chromosomal translocation. The working hypothesis is that loss of POLQ
contributes to impaired DNA repair and enhanced genomic instability.

Specific Aim 3 – To determine the role of POLQ in immunological diversity
mechanisms through high-resolution analysis.
In order to investigate the role of POLQ in immunological diversification mechanisms,
Peyer’s patches and stimulated naïve B cells from wild-type and Polq-null mice were
analyzed for V region mutagenesis, and class switch recombinant junction composition,
respectively, through a mix of standard and next-generation DNA sequencing.

Specific Aim 4 – To determine the interplay between POLN and POLQ.
A colony of Polq-null mice were established at Science Park and then crossed to Poln
knockout mice developed by Dr. Kei-ichi Takata to generate Poln−/− Polq−/− mice. Functional
analysis of single mutant mouse controls as well as Poln−/− Polq−/− mice, and cells derived
from them, were performed to determine whether POLN and POLQ operate within the DNA
repair pathway.
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Chapter 2. Mechanism of suppression of chromosomal instability by DNA polymerase
POLQ
Note this chapter is based on: Yousefzadeh, M.J., Wyatt, D.W., Takata, K., Mu, Y., Hensley,
S.C., Tomida, J., Bylund, G.O., Doublie, S., Johansson, E., Ramsden, D.A., et al. (2014).
Mechanism of suppression of chromosomal instability by DNA polymerase POLQ. PLoS
Genet 10, e1004654. With permission from the copyright holder.

2.1 Introduction
DNA double-strand breaks (DSBs) can be formed in cellular genomes by
environmental agents such as ionizing radiation. DSBs also arise during normal cellular
duplication cycles, when DNA replication stalls at naturally occurring structures or at sites of
internally-generated DNA damage. In diversification steps of the mammalian immune
system, DSBs are deliberately formed by regulated enzymatic action, to initiate
rearrangement of antibody and receptor segments, and as a means to introduce local
variation. Because DSBs are toxic and/or mutagenic if not repaired, organisms have multiple
mechanisms for DSB repair (Kass and Jasin, 2010; Rassool and Tomkinson, 2010). The
primary repair strategies are end-joining mechanisms, which process and rejoin the ends of
a DSB, and homologous recombination (HR) pathways which employ an undamaged copy
of the DNA as a repair template (Figure 3) (Thompson, 2012). End-joining pathways appear
to be the first line of defense against DSBs. The most studied pathway is “classical” nonhomologous end-joining (cNHEJ), which relies on the DNA-binding Ku70 (XRCC6) and
Ku80 (XRCC5) gene products, and the DNA protein kinase (DNA-PK, PRKDC). One or
more “alternative” end-joining pathways (altEJ) also exist, which are independent of these
factors (Figure 3) (Decottignies, 2013; Ramsden and Asagoshi, 2012).
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Figure 3. DNA double-strand break repair pathways. Upon recognition of a DNA doublestrand break (DSB), DNA damage signaling is activated. Dependent upon cell cycle and
sister chromatid availability, the homologous recombination (HR) pathway may be available.
Classical non-homologous end joining (cNHEJ), a repair process that is reliant upon the Ku
heterodimer and DNA Ligase IV (LIG4), is the predominant repair pathway in mammals and
does not rely upon DNA nucleolytic processing to create resected 3’ DNA ends. In the
absence of, or when either Ku or LIG4 are impaired, alternative end joining (altEJ) anneals
minimally resected DNA ends to anneal at existing or newly created microhomologies (5 or
nucleotides) as noted in orange. Longer resection is required in order to facilitate HR.

During immunoglobulin diversification, the regional end-joining process of class
switch recombination (CSR) replaces one constant region coding exon for another (Figure
4). This CSR process is known to occur through both cNHEJ and alternative end joining
pathways (Boboila et al., 2012a). In mammalian cells, an alternative end-joining repair
pathway repair of DSBs is thought to play a role in driving the formation of chromosomal
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translocations, although the specific enzymology is unclear (Simsek and Jasin, 2010; Zhang
and Jasin, 2011).
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Figure 4. Immunoglobulin class switch recombination. The mammalian immunoglobulin
heavy-chain locus of an IgM-expressing B cell is displayed. The heavy-chain variable (VH),
diversity region (D), and joining region (JH) gene segments are shown in orange, grey, and
teal, respectively. The other shaded rectangles represent different constant region exons,
and the black dots denote switch regions. After V(D)J recombination, which occurs in the
bone marrow, class switch recombination (CSR) takes place in the peripheral lymphoid
tissues. Upon AID-induced DNA double-strand breaks at different switch regions, CSR
facilitates the joining of a proximal variable region exon to a downstream constant region
exon. The diagram denotes the joining of a break between the Sµ and Sγ1 switch region to
yield a gene product that would produce functional IgG1. The deleted gene segment is
released as a circularized DNA product.

In this chapter, I report experiments that define a specific function and mechanism of
action for POLQ in a pathway for alternative end-joining of DNA double-strand breaks in
mammalian cells.

31

2.2 Material and Methods
Cellular proliferation assay
Polq+/+ and Polq−/− bone marrow stromal cells and mouse embryonic fibroblasts were plated
in triplicate (2 ×105 cells per 10 cm dish) with 15 mL of complete media (Dulbecco's Modified
Eagle Medium+Glutamax, 10% FBS, 1% PenStrep). On the indicated days, cells were
trypsinized and live cells were counted using trypan blue exclusion (Countess automated
cell counter, Life Technologies). Experiments were repeated three times in order to generate
standard deviations. Viability was consistently high for all cell lines examined (>95% trypan
blue-excluding cells).

Clonogenic assays with bone marrow stromal cells
For X-irradiation 5 ×105 cells were plated on a 10 cm plastic culture dish, and exposed the
following day at 2 Gy/min, 160 kV peak energy (Rad Source 2000 irradiator, Suwanee, GA).
Cells were then trypsinized for replating. For UVC-irradiation (254 nm peak germicidal lamp)
cells were irradiated in 500 µl PBSA (105 cells/ml) at 5 J m−2 min−1 and then plated. For
psoralen-UVA treatment, 5 ×105 cells were plated on a 10 cm dish and incubated in medium
with the indicated concentration of HMT-psoralen for 1 h, the dish was irradiated with 0.9 kJ
m−2 UVA (365 nm peak, 30 min, 0.5 J m−2 sec−1), the psoralen-containing medium was
removed, and fresh medium was added before UVA-irradiating for an additional 30 min
before replating. Chemicals were added at the indicated concentrations to dishes at the
beginning of the experiment. Drugs were solubilized in ethanol (mitomycin c), DMSO (ICRF193, etoposide, camptothecin, HMT-psoralen, temozolomide, olaparib), or 150 mM NaCl
(cisplatin). All chemicals were from Sigma (St. Louis, MO) except ICRF-193 (Enzo
LifeScience, Farmingdale, NY), olaparib (AZD2281, Selleck Chemicals, Houston, TX), and
mitomycin c (Calbiochem, Darmstadt, Germany). Cells were plated in triplicate in 10 cm
dishes and grown for 7–10 days before being fixed and stained with crystal violet. Colonies
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of 50 or more cells were quantified and experiments were repeated three times to generate
standard deviations. A clonogenic assay was performed
with Rad51D+/+ and Rad51D−/− Chinese hamster ovary (CHO) cell lines (generously
provided by Dr. Rodney Nairn) exposed to varying concentrations of olaparib.

Micronucleus assay
BMSCs were plated at 1.5 ×104 cells per well in chambered slides and treated with the
indicated amount of x-rays or etoposide the following day. 48 h later, cells were fixed with
2% para-formaldehyde, stained with DAPI and coverslips were added. Micronuclei were
scored by DAPI immunofluorescence. 300 cells were counted per group. Experiments were
repeated three times to generate standard deviations.

Human cell transfections
293T cells (kindly provided by Dr. Christopher Bakkenist, University of Pittsburgh Medical
School) were plated at 1.5 ×105 cells per well in six-well plates and transfected the following
day with 2.5 µg of either pCDH (System Biosciences, Mountain View, CA) containing empty
vector control, POLQ, POLQ-K121M, POLQ-D2330A,Y2331A, POLQ-S1977P, or POLQ-DM
cDNA using Lipofectamine 2000 (Life Technologies) according to manufacturer's
specifications. 48 hr after transfection, cells were harvested for RNA isolation (RNeasy,
Valencia, CA) or for immunoblotting.

Immunoblotting
For immunoblots, cells transfected in six-well dishes were resuspended in 200 µL of 2× SDS
loading buffer (4% SDS, 0.2% bromophenol blue, 20% glycerol, 100 mM Tris HCl pH 6.8,
12% 2-mercaptoethanol) and heated at 95°C for 5 min. 20 µL of extract was separated on a
4–20% polyacrylamide gel, transferred to PVDF membrane, blocked, and blotted with anti-
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alpha-Tubulin (Abcam, Cambridge, UK ab4074, 1:10,000), anti-FLAG (Sigma F7425,
1:5,000), anti-PCNA (Santa Cruz, Santa Cruz, CA, sc-56, 1:1,000), anti-HA (RW, 1:10,000),
or anti-POLQ (MDACC POLQ20, 1:250) antibodies and corresponding secondary antibodies
(Sigma A0168, A0545; 1:10,000) and visualized with ECL reagent (Pierce, Rockford, IL).

Generation and complementation of Polq MEFs
Polq-heterozygous (Polq+/−) mice (Shima et al., 2004) were obtained from Jackson
Laboratories and maintained in a C57BL/6J background. Polq-heterozygous mice were
crossed to generate Polq-null mice and maintained in a holding room that was positive for
mouse parvovirus, minute virus of the mouse, and H. pylori. Isogenic primary MEFs were
generated from 13.5 day pregnant females and cultured in a 2% O2 atmosphere. MEFs were
then transfected with 1 µg of pSV-Tag (Lange et al., 2012; Sobol et al., 1996) and grown in
atmospheric oxygen for six population doublings to allow for immortalization. To generate
lentivirus used for transduction, 293T cells were cotransfected with psPAX2 (6 µg), pMD2G
(6 µg), and pCDH (12 µg) expression vector (See below for construction of expression
vectors) using Lipofectamine 2000. One day prior to transduction Polq−/− MEFs were seeded
into a 10 cm dish at 1.5 ×105 cells with 12 mL complete media. 48 h post-transfection viruscontaining media was harvested, filtered through a 0.45 µm syringe filter and used to
replace the media on the plated MEFs. MEFs were incubated in the virus-containing media
for 24 h before being split into T-75 flasks and allowed to grow to 80% confluence before
undergoing three weeks of puromycin selection (2.5 µg/mL). Following selection, pure
clones were isolated and cultured with complete media containing puromycin (1 µg/mL).

Quantitative real-time PCR analysis of complemented MEFs
RNA isolated from the complemented MEF lines were analyzed for quality and purity using
an RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of total RNA was used
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to generate cDNA using the High Capacity cDNA RT kit (Life Technologies). qPCR analysis
was performed in triplicate using the ABI Prism 7900 HT thermocycler and the following
Taqman Probe set or primer set with iTAQ SYBR Green Supermix with ROX (Bio-Rad,
Hercules, CA): MmPolQ_FWD 5′-GGCTCTGAAGAACTCTTTGCCTTT-3′, MmPolQ_REV 5′GCTGCTTCCTCTTCTTCATCCA-3′, probe 5′-TCCGGGCACTTTTG-3′; HsPOLD1_FWD 5′CGACCTTCCGTACCTCATCTCT-3′ HsPOLD1_R 5′-ACACGGCCCAGGAAAGG-3′,
probe 5′-CCCTCAAGGTACAAACAT-3′; Qexon FWD 5′TGCCTTTCAAAAGTGCCCGGAAGGC3′, Qexon REV 5′TGCCAGTCACCCANATAGTTCNCAT-3′ (where dSpacer is represented as N to
compensate for mismatches between the mouse and human sequences). Data were
analyzed using the ∆∆Ct method. For absolute quantification, titration of pCR-XLTOPO/MmPolQ and pET/MmPold1 plasmids were used to generate standard curves for
expression. Transcript abundance was determined by extrapolation from linear regression
analysis of best-fit lines from titration experiments. GAPDH was used as an internal control
in all experiments.

Bleomycin sensitivity
Complemented MEF lines were plated in triplicate into white 96 well plates at 1250 cells per
well and grown overnight using complete media containing puromycin (1 µg/mL). The
following day, cells were cultured with complete media containing the indicated amounts of
bleomycin (dissolved in 150 mM NaCl) for 24 hr before the media was replaced. Cells were
allowed to recover for 72 hr before cellular viability was measured using the ATPlite 1Step
kit (Perkin Elmer, Waltham, MA) using a Biotek plate reader. Experiments were repeated
three times.

35

Immunofluorescence
Complemented MEF lines were plated at a density of 1.5 ×104 cells per well in 4-well
chamber slides and the following day were irradiated with either 0 or 6 Gy of x-rays. Media
was changed and cells were allowed to recover for 48 h after damage before fixation with
2% para-formaldehyde and permeabilization with Triton X-100. Samples were blocked with
donkey serum for 30 minutes before being incubated overnight with primary antibodies
against 53BP1 (Bethyl, Montgomery, TX, A300-272A, 1:500) and γH2AX (EMD Millipore 05636, 1:400). Cells were later incubated with AlexaFluor-488 goat-anti-mouse or AlexaFluor594 goat-anti-rabbit secondary (Life Technologies, 1:1000) and then stained with DAPI
before coverslips were placed. Cells were scored for DSBs by enumerating the percentage
of cells with >2 53BP1 foci and >2 γH2AX foci (Lange et al., 2012; Ward et al., 2003). The
majority of cells that contained >2 foci for each of the DSB markers, exhibited colocalization
of the foci. Cells with pan-staining of γH2AX were not included in the analysis as they are
proposed to represent pre-apoptotic cells (Marti et al., 2006). Many of the cells with 53BP1
foci, exhibited enlarged foci that are associated with nuclear OPT (Oct-1, PTF, transcription)
domains that sequester damaged DNA in G1 (Harrigan et al., 2011; Lukas et al., 2011).
Thus, most of the MEFs that were foci positive contained DSBs (Harrigan et al., 2011).
DAPI-stained micronuclei were also scored. For each experiment 250 cells were scored for
three independent experiments for a total of 750 cells.

DNA polymerase assays
Purified POLQ was as described (Hogg et al., 2011). Klenow Fragment (3′→5′ exo-) was
purchased from NEB. POLQ was diluted in buffer containing 30 mM Tris-HCl pH 8.0, 50 mM
NaCl, 2 mM DTT, 10% glycerol, 0.01% Triton X-100, and 0.1% BSA. Klenow Fragment
(3′→5′ exo-) was diluted in buffer containing 25 mM Tris-HCl pH 7.4, 1 mM DTT, and 0.1
mM EDTA. POLQ reaction mixtures (10 µl) contained 20 mM Tris-HCl pH 8.8, 4% glycerol,
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2 mM dithiothreitol (DTT), 80 µg/ml bovine serum albumin (BSA), 8 mM MgCl2, 0.1 mM
EDTA, 100 µM of each dNTP, 30 nM of the primer-template or primer (see below). Klenow
Fragment (3′→5′ exo-) reaction mixtures (10 µl) contained 10 mM Tris-HCl pH 7.9, 50 mM
NaCl, 1 mM DTT, 10 mM MgCl2, 100 µM of each dNTP, and 30 nM of the primer-template or
primer. After incubation at 37°C for 10 min for a 16-1+PA42 substrate or 20 min for 16-1,
C20, and C19THF substrates, reactions were terminated by adding 10 µl of formamide stop
buffer (98% formamide, 10 mM EDTA pH 8.0, 0.025% xylene cyanol FF, 0.025%
bromophenol blue) and boiling at 95°C for 3 min. Products were electrophoresed on a
denaturing 20% polyacrylamide-7 M urea gel, exposed to BioMax MS film, and analyzed
with a STORM 860 Phosphor Imager (Molecular Dynamics).

Oligonucleotide Substrates
Note: Substrates designed by Dr. Kei-ichi Takata and MJY. Assays performed by Dr. Keiichi Takata and analyzed by Dr. Kei-ichi Takata and MJY. Gel purified primer
oligonucleotides 16-1 and PA42 were purchased from Bio-Synthesis, C20 was purchased
from Midland, C19+THF was from IDT. 16-1, C20, C19+THF were 5'-labeled using
polynucleotide kinase (Promega) and [γ-32P] dATP (PerkinElmer). 5'-[32P]-labeled 16-1
primer was annealed to PA42 to generate a double stranded DNA substrate as described
(Takata et al., 2006)
16-1 (primer)+PA42 (template) substrate:
5'-32P-CACTGACTGTATGATG-3'
3'-GTGACTGACATACTACTTCTACGACTGCTC-5'
16-1 substrate (primer only):
5'-32P-CACTGACTGTATGATG-3'
C20 substrate (primer only):
5'-32P-CCCCCCCCCCCCCCCCCCCC-3'

37

C19+THF (tetrahydrofuran, an AP site analog) substrate (primer only):
5'-32P-CCCCCCCCCCCCCCCCCCC[THF]-3'

Sequencing of DNA extended by POLQ
Note: Substrate and experimental procedures were designed by Dr. Göran Bylund and Dr.
Erik Johansson. Polymerase assay and sequencing of extension products were performed
by Dr. Göran Bylund and Sara Lundsten. Data was analyzed by Dr. Göran Bylund and Dr.
Erik Johansson. A truncated version of human POLQ (residues 1792-2590) was expressed
in E. coli and purified as described (Hogg et al., 2011). Oligonucleotides were purchased
from Eurofins MWG operon (Germany). The 200 µl primer extension reaction contained:
[20mM Tris-HCl (pH 8.8), 4% glycerol, 10 mM MgCl2, 0.1 mM EDTA, 80 g/ml bovine serum
albumin (BSA), 10 pmol of the tetrachlorofluorescein (TET) labelled oligonucleotide “nohairpin” (5’-(TET)-GTTTGTGAGTTTCC-3’) and 1.25 g POLQ(1792-2590)]. The primer
extension reaction was incubated at 22 oC for 2 h and terminated by the addition of 10 µl 0.5
M EDTA and POLQ was heat inactivated for one min at 100 oC. As a control, 10 µl of the
reaction mixture was separated on a polyacrylamide sequencing gel and the amount of
POLQ extended products was evaluated with a Typhoon 9400 Variable Mode Imager (GE
Healthcare). The remaining DNA was precipitated overnight at -20 oC with 4 µg carrier
tRNA, 4 µg glycogen, 0.25 volumes of 5 M ammonium acetate and 2.5 volumes of ethanol.
Precipitated DNA was dissolved in 100 µl 10mM Tris-HCl (pH 8.0) and used as template for
terminal nucleotidyl transferase (TdT) (Thermo Scientific). 40 µl TdT reactions contained 20
µl POLQ extended oligonucleotide, 1X TdT buffer, 3.2 M either of dATP/dTTP or 1.5M
either of dCTP/dGTP and 30 U TdT. The reactions were incubated at 37 oC for 15 min
followed by heat inactivation of TdT at 70 oC for 10 min. In control experiments TdT
reactions were performed with a no-hairpin oligonucleotide, which had not been extended by
POLQ, as template. 10 µl from each reaction was separated on a polyacrylamide
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sequencing gel and the amount of TdT extended products was visualized and evaluated
with a Typhoon 9400 Variable Mode Imager. POLQ + TdT extended no-hairpin DNA and
only-TdT extended no-hairpin DNA were amplified by polymerase chain reaction (PCR). 25
µl PCR reactions contained: 0.2 l from each respective TdT reaction, 5 pmol of the
oligonucleotide EcoRI-nohairpin (5’- TTTTGAATTCGTTTGTGAGTTTCC-3’), 5 pmol of
either HindIII-25A (5’-TTTTAAGCTTAAAAAAAAAAAAAAAAAAAAAAAAA-3’), HindIII-25T-R
(5’-TTTTAAGCTTTTTTTTTTTTTTTTTTTTTTTTTTT-3’), HindIII-15C-R (5’TTTTAAGCTTCCCCCCCCCCCCCCC-3’) or HindIII-15G-R (5’-TTTTAAGCTTGGGGGGGGGGGGGGG-3’), 1X GoTaq buffer, 200 µM of each dNTP and 1 U GoTaq DNA
polymerase (Promega). PCR cycling conditions were: five cycles (94 oC 30 s, 50 oC 30 s
and 72 oC 10 s) followed by 30 cycles (94 oC 30 s, 55 oC 30 s and 72 oC 10 s). PCR
reactions were purified with QIAquick Nucleotide Removal Kit (Qiagen, Germany) and
digested with EcoRI and HindIII. Digested PCR products were then separated on a 2%
agarose gel containing Gel Green Nucleic Acid Stain. DNA was excised, purified with
QIAquick Gel Extraction Kit (Qiagen, Germany), ligated into an EcoRI-HindIII digested
pUC18 vector and transformed into competent XL1-Blue bacterial cells. Plasmid containing
bacterial clones were selected on LB plates containing 100µg/ml carbenicillin and plasmids
were isolated with the E-Z 96 fastfilter plasmid kit (Omega bio-tek) and sent for sequencing
(Eurofins MWG Operon, Germany).

Extrachromosomal substrate assays
Note: Substrates were designed by David Wyatt and Dr. Dale Ramsden, assays were
performed by David Wyatt, and data was analyzed by David Wyatt and Dr. Dale Ramsden.
Polq-null and complemented cell lines were generated and provided by MJY. A dermal
fibroblast line from Ku70 and p53 deficient mice (the gift of Dr. P. Hasty, University of Texas
Health Sciences Center) was transduced with empty vector (pBABE-puro) retrovirus or a
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retrovirus expressing mouse Ku70. Substrates were generated by ligating short linkers to
the head and tail of a 556 bp linear double-stranded DNA fragment. Linkers possessed 16–
17 bp of double-stranded DNA and either 6 or 45 nt 3′ single-stranded overhangs. The
linkers with 6 nt overhangs were made by annealing 5′AGTCTGAGATGGGTGTGAGATCTGC-3′ to 5′-CACTCTCTCACACCCATCTTA-3′ (“head”
linker), and 5′-TGACTATACAGCTAAGCGATGATGCAG-3′ to 5′-CATCGCTTAGCTGTATA3′ (“tail” linker). The linkers with 45 nucleotide 3′ overhangs were generated by annealing 5′AGTCTGAGATGGGTGTGAGAGTGAAGATCCTCACCTT
CGGAGTACTCCTTCTTTTGAGATCTGC-3′ to 5-CTCACACCCATCTCA-3′ (“head” linker)
and5′-TGACTATACAGCTAAGCGATGCTCTCACCGAGCGTAT
CTGCTGTGTTGTGGATGAATTAGATGCAG-3′ to 5′-CATCGCTTAGCTGTATA-3′ (“tail”
linker). Excess linker was removed by QiaQuick purification and substrate purity validated by
polyacrylamide gel electrophoresis. 75 ng of substrate was mixed with 1.1 µg of supercoiled
pMAX-GFP (Lonza) plasmid carrier and introduced into 2 ×105 cells in a 10 µl volume by
electroporation with one 30 ms 1350 V pulse (Neon, Invitrogen). Cells were harvested after
incubation for 1 h at 37 °C, washed, resuspended in Hank's buffered saline solution
supplemented with 5 mM MgCl2, and extracellular DNA digested by incubation with 6.25 U
Benzonase (Novagen) for 15 min at 37 °C. Cells were pelleted and DNA purified with the
Qiamp kit (Qiagen). Joining efficiency was determined by quantification of head-to-tail
junctions by qPCR using primers that either anneal within double-stranded flanks (5′CTTACGTTTGATTTCCCTGACTATACAG-3′ and 5′- GCAGGGTAGCCAGTCTGAGATG-3′;
6 nt overhang, Figure 5B) or, for the 45 nt overhang substrate only, which anneal to
overhang sequence (5′- TAAGCGATGCTCTCACCGAG and 5′GATGGGTGTGAGAGTGAAGATC; 45 nt overhang, Figure 5C). Results from electroporated
samples were further corrected for differences in transfection and sample processing
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efficiency qPCR specific for substrate (5′- GGCACTCTCCAAGGCAAAGA and 5′ACATGTCTAGCCTATTCCCGGCTT).

B cell culture and CSR analysis
Note: B cell isolation and culture was done with the assistance of Dr. Kevin McBride and
Sean Hensley. FACS analysis was performed by Dr. Kevin McBride and DNA isolation,
sequencing, and sequence analysis was performed by MJY. B cells were isolated from
mouse spleens (n = 6 per genotype) by surgical dissection of mice to isolate spleens.
Spleens were then ground up on a 70 µM filter using a syringe plunger to release B cells.
Naïve B cells were isolated by anti-CD43 (Ly-48) bead negative selection using a MACS
column (Miltenyi Biotec, Dallas, TX) and stimulated for class-switching in culture for 72 h.
Where indicated, cultures were incubated with DNA-PKcs inhibitor 20 µM NU7026 (Tocris,
Bristol, UK) dissolved in DMSO, or mock-treated. The stimulation procedure and flow-sorting
for CSR analysis was as described (Callen et al., 2009; Reina-San-Martin et al., 2003). Prior
to this analysis, cells were counted; numbers and viability were similar for all groups. Sµ-Sγ1
CSR junctions were amplified by PCR using the following conditions for 25 cycles at 95 °C
(30 s), 55 °C (30 s), 68 °C (180 s) using the primers (FWD 5′AATGGATACCTCAGTGGTTTTTAATGGTGGGTTTA-3′; REV 5′
CAATTAGCTCCTGCTCTTCTGTGG-3′) and Pfu Turbo (Stratagene, La Jolla, CA). To the
PCR reaction, 5 U of Taq polymerase (Promega, Madison, WI) was added and incubated at
72 °C for 10 min. The resulting product was TOPO TA cloned and transformed into
Top10 E. coli cells (Life Technologies, Carlsbad, CA) and plasmids were purified and sent
for sequencing using M13 FWD and REV primers in addition to the amplification primers for
sequencing. 100 clones for each group were analyzed for mutations, deletions, insertions,
and sequence overlaps at the junction and both 30 nt upstream and downstream of the
junction. p-values were determined by using the two-tailed Fisher's exact test.
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Translocation assay
Note: B cell isolation and culture and DNA isolation was performed by MJY. Sean Hensley
performed PCR amplification of translocation derivative and Dr. Yunxiang Mu performed
Southern Blotting. MJY and Dr. Kevin McBride analyzed the data. Naïve B cells from three
pairs of Polq+/+ and Polq−/− mice were harvested as above, cultured for 72 h, and DNA was
isolated. 32 separate PCR reactions, each containing the genome from 1 ×105 cells, was
performed with primers to amplify Myc/IgH translocations and amplified translocations were
verified by Southern blotting using internal probes to the Myc and IgH loci as described
(Kovalchuk et al., 1997; Loveday et al., 2011). Three independent experiments were
performed and the p-value was determined using the two-tailed Fisher's exact test. %IgG1
was also measured as an internal control to ensure the B cells from each genotype were
switching at a comparable level.

Generation of POLQ monoclonal antibody
The QL fragment of POLQ (Hogg et al, 2011) was used to immunize a mouse, and a
monoclonal antibody that recognizes POLQ was generated. The epitope recognized by this
antibody (MDACC POLQ20) was mapped using peptide arrays to amino acid residues
2147-2151. For more details see Chapter 6.

Generation of POLQ expression constructs
Note: All cloning and sequencing was performed by MJY. Dr. Junya Tomida generously
provided the pCDH vector backbone with the C-terminal FLAG-HA epitope tags. The POLQ
cDNA was cloned from pFastbacHTc/POLQ (Seki et al., 2003) using KOD Xtreme (EMD
Millipore, Billerica, MA) polymerase using the following primers and conditions (FWD
5’ CGGGATCCTAGCACCATGAATCTTCTGCGTCGGAGTG 3’, REV 5’-
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CACATCAAAGTCCTTTAGCTCTCCCGCCGGCGTTTTCCTTTT-3’); 20 cycles at 95 °C (30
s), 60 °C (30 s), 68 °C (10 min). PCR products were subsequently digested with BamHI and
NotI and ligated into a similarly digested pBluescript SKII+ vector. pBluescript/POLQ was
propagated and sequenced to ensure no mutations, before the POLQ cDNA was digested
with the aforementioned restriction enzymes and ligated into pCDH-FHC vector. The final
vector pCDH-FHC/POLQ was propagated and sequenced for insert verification and
mutation analysis. Engineering of the mutant pCDH/POLQ vectors is detailed below. The
individual domains of POLQ (Helicase-like, Central, and Pol domain) were amplified from
pBluescript/POLQ using KOD Xtreme and the following primers before being digested with
BamHI and NotI, then ligated into pBluescript:

Helicase-like (HLD) domain
CDH HLD5’ CGGGATCCTAGCACCATGAATCTTCTGCGTCGGAGTG;
CDH HLD3’ TGCCCATGCGGCCGCGATTATAAAACTCTCGAGCAATGATATCTGC
Central (CEN) domain
CDH CEN5’ AGGAAAGGATCCATTGCTCGAGAGTTTTATAATCTACATCATCAAGC; CDH
CEN3’ TCGTTGCGGCCGCTTCCTTTCGCAAGCAAGATTGAAGGTACCACATC
Polymerase (POL) domain
CDH POL5’ AGGAAAGGATCCGATGTGGTACCTTCAATCTTGCTTGCGAAAGGAA;
CDH POL3’ AAAAGGAAAagcggccgcCACATCAAAGTCCTTTAGCTCTCC

Vectors were sequenced to verify no mutations before site-directed mutagenesis was
performed with the following plasmid-primer combinations using KOD Xtreme:
POLQ-K121M
pBluescript/HLD
Forward: 5' CTACAAGTGCTGGGATGACTCTTGTGGCAG 3';
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Reverse: 5' CTGCCACAAGAGTCATCCCAGCACTTGTAG 3'
POLQ-D2330A/Y2331A
pBluescript/Pol
Forward: 5' GTTCAATACTGGCTGCTGCCGCCTCTCAGCTTGAACTGAG 3';
Reverse: 5' CTCAGTTCAAGCTGAGAGGCGGCAGCAGCCAGTATTGAAC 3'

POLQ-S1977P
PBluescript/Pol
Forward: 5' CTATAAAATTCTTCTTCTTCCTTGTGGCATCTCCTTGGAG 3';
Reverse: 5' CTCCAAGGAGATGCCACAAGGAAGAAGAAGAATTTTATAG 3'

Following mutational verification, the individual domains were digested with the
corresponding restriction enzymes before being ligated into pCDH-FHC that was previously
digested with BamHI and NotI:
pBluescript/HLD (BamHI, XhoI), pBluescript/CEN (XhoI, KpnI),
pBluescript/POL (KpnI, NotI)

Following ligation, plasmids were sequenced to ensure proper ligation and maintenance of
engineered mutations.
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2.3 Results
Hypersensitivity to DNA strand-breaking agents in the absence of Polq
As discussed in Chapter 1, mutants of POLQ in different species exhibit a broad
range of hypersensitivity to various DNA damaging agents (Table 2) (Yousefzadeh and
Wood, 2013). To clarify the cellular role of POLQ in response to DNA damage, we
measured the sensitivities of Polq-null and Polq-proficient bone marrow stromal cell (BMSC)
lines to various DNA damaging agents. BMSC lines lacking POLQ were previously shown to
exhibit hypersensitivity to ionizing radiation (Goff et al., 2009; Higgins et al., 2010b),
Interestingly, one of the reports found that only cancer cells with reduced POLQ levels were
hypersensitive to IR. “Normal” cell lines suppressed for POLQ by siRNA did not show
hypersensitivity to IR under the same conditions (Higgins et al., 2010b). These contrasting
results warrant further investigation.
We found that Polq−/− cells were also hypersensitive to agents that directly cause
DNA breaks (Figure 5). These included topoisomerase II inhibitors etoposide and ICRF-193
(Huang et al., 2001), and camptothecin, a topoisomerase I inhibitor. The observation of
hypersensitivity of cells to camptothecin in the absence of Polq was intriguing. Camptothecin
generates single-strand breaks and is only thought to induce DSBs indirectly when the
replication or transcription machinery collides with the trapped cleavage complex (Strumberg
et al., 2000). DSBs could also form if two trapped Topoisomerase I complexes on different
strands are near each other, or if the single-stranded DNA near the trapped cleavage
complex falls prey to nucleases. Loss of Polq did not cause hypersensitivity to agents that
primarily form DNA replication-blocking adducts on one DNA strand including, for example
ultraviolet radiation and the methylating agent temozolomide. The Polq−/− cells were also not
more sensitive than control cells to mitomycin C, cisplatin, and UVA-photoactivated psoralen
plus UVA, all of which induce some interstrand DNA crosslinks (ICLs) (Figure 5). In contrast
to a prior report (Higgins et al., 2010b), our findings show that at least some Polq−/− non-
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cancer cell lines do, in fact, exhibit hypersensitivity to IR (Figure 5) (Yousefzadeh et al.,
2014).
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Figure 5. Hypersensitivity of Polq−/− bone marrow stromal cells to DNA strandbreaking agents. BMSCs were exposed to x-rays or UVC at the indicated doses, and to
etoposide, ICRF-193, camptothecin, olaparib, temozolomide, mitomycin c, cisplatin, and
HMT psoralen+UVA at the indicated concentrations and plated in triplicate. Two isogenic
bone marrow stromal cell lines were used for each genotype: Polq+/+ or Polq−/−. Colonies
were stained with crystal violet and counted seven to ten days later. Experiments were
repeated three times. Circles, Polq+/+ clone 1; Squares, Polq+/+ clone 1;
Triangles, Polq−/− clone 1; inverted triangles, Polq−/− clone 3. Clonogenic assay of Rad51D+/+
and Rad51D-/- CHO cells treated with the indicated doses of olaparib, as a positive control
(Loveday et al., 2011). All clonogenic survival assays performed by MJY except those with
the Rad51D CHO cells, which were performed by Megan Lowery.
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These data indicate that POLQ is most important for a process conferring resistance
to DNA strand-breaks, particularly double-strand breaks. Sensitivity to olaparib, a PARP
inhibitor, was measured because homologous recombination mutants exhibit
hypersensitivity to this agent. A current theory is that cells are ill-equipped to deal with the
increase conversion of single-strand breaks that are converted to DSBs when PARP is
impaired (Bryant et al., 2005; Farmer et al., 2005; Loveday et al., 2011). Cells
lacking Polq were not hypersensitive to the PARP inhibitor olaparib (Figure 5) while control
Rad51D-defective cells were hypersensitive (Figure 5). This suggests that POLQ does not
function in the BRCA/homologous recombination pathway (Farmer et al., 2005). POLQproficient cells treated with both olaparib and camptothecin were significantly sensitized
compared to camptothecin alone. However, addition of olaparib to Polq-null cells only
modestly increased the sensitivity to camptothecin (Figure 5). Besides being involved in
single-strand break repair, PARP is also thought to operate within altEJ, that functions
independently of cNHEJ factors Ku and DNA Ligase 4. Consequently, PARP and POLQ
may operate within the same subpathway of DNA repair.

Loss of Polq enhances chromosomal instability in somatic cells
Previous work revealed an increase in micronuclei in Polq-defective cells in
peripheral erythrocytes. To determine whether this phenomenon is also true in other cell
types, matched wild-type and Polq−/− BMSC lines were exposed to etoposide or x-rays, and
the number of cells with micronuclei after 48 h were enumerated (Figure 6A and B). Polqnull cells exhibited a ~3 fold increase in the frequency of spontaneous micronuclei formation
(Figure 6C). Upon exposure to DNA damaging agents, the percentage of cells with
micronuclei increased about 1.5-fold more per unit of damage for Polq−/− cells in comparison
to Polq+/+ cells (Figure 6A and B). This shows that the susceptibility to micronucleus
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formation in Polq−/− cells is not confined to cells of the hematopoietic lineage, but occurs also
in cultured cells, including fibroblast-like BMSCs.
Cells lacking Polq were analyzed for their ability to proliferate in culture. Two
independent BMSC lines devoid of Polq expression proliferated at a rate comparable to a
pair of wild-type control cells. The Polq−/− BMSCs showed only a 5% lengthening of
population doubling times (Figure 6D and E). I extended this analysis to isogenic
immortalized mouse embryonic fibroblast (MEF) cell lines (Figure 6F and G).
Again, Polq−/− cells divided at a rate comparable to Polq+/+ cells. These findings fit with
previous observations from the Wood laboratory that hematopoietic cell counts in
irradiated Polq-null mice recovered at rates comparable to wild-type mice (Goff et al., 2009).
I observed no major alterations in growth or development in unchallenged Polq null or
mutant mice, consistent with previous reports (Shima et al., 2003; Shima et al., 2004; Zan et
al., 2005). These observations indicate that despite some increased chromosomal
instability, POLQ-defective cells originating from a variety of tissues can proliferate at nearnormal rates.
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Figure 6. Loss of Polq contributes to chromosomal instability both spontaneously
and in the presence of DNA damage. Polq+/+ or Polq−/− bone marrow stromal cells
(BMSCs)plated in chamber slides were exposed to (A) X-rays or (B) etoposide. 48 h after
damage cells were fixed and stained with DAPI to enumerate cells with micronuclei. Counts
represent the average percentage of cells with micronuclei scored in three independent
experiments. [Slopes for X-ray and etoposide-induced MN: Polq+/+ clone 1 (2.8,
0.73); Polq+/+ clone 2 (3.1, 0.85); Polq−/− clone 1 (4.8, 1.2); Polq−/− clone 3 (6.2, 1.3)] The
frequency of spontaneous micronuclei for each of the clones in Figure 6A and B were
combined to generate (C) total spontaneous micronuclei observed for all genotypes. The pvalue was determined by the Wilcoxon Mann Whitney rank sum test. Polq+/+ or Polq−/− (D)
BMSCs and (F) mouse embryonic fibroblasts were plated in growth medium in triplicate.
Cells were counted at the indicated days and cumulative population doublings were
recorded. The experiment was repeated three times. (E and G) Absolute quantification

51

of Polq transcript numbers in three independent experiments. Enumeration of micronuclei,
cell culture, RNA isolation, cumulative population doubling analysis, and data analysis was
performed by MJY. qRT-PCR was performed by the Science Park Molecular Biology Core.

The DNA polymerase activity of POLQ is required to confer resistance to DNA damaging
agents
Next I sought to investigate which catalytic activities of POLQ are necessary to
confer resistance to DNA damaging agents. Lentiviral-delivered expression vectors were
constructed with the assistance of Dr. Junya Tomida to express wild-type or mutant versions
of POLQ in immortalized Polq−/− MEFs, in order to test for functional complementation
(Figure 7A). A tandem (D2330A, Y2331A) mutation was introduced into the DNA
polymerase domain (POL) mutation of the corresponding residues in other DNA
polymerases completely inactivates polymerase activity (Patel and Loeb, 2000). In a
separate construct, a mutation was introduced into the conserved ATP-binding site of the
Walker A motif (K121M) in the helicase-like domain (HLD). An equivalent mutation
eliminates DNA helicase activity in related enzymes, including HELQ (Marini and Wood,
2002). A third construct (DM) was made harboring mutations in both domains. These
vectors expressed full-length recombinant POLQ as tested in transfected 293T cells (Figure
7B and C).
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Figure 7. Complementation of the polymerase activity of POLQ rescues DNA damage
hypersensitivity of cells lacking Polq. (A) POLQ cDNA was cloned into the pCDH-FH
vector containing a FLAG-HA epitope tag on the C-terminus. (B) 293T cells were transiently
transfected with pCDH containing either empty-vector control or POLQ cDNA. Crude
extracts were immunoblotted with the indicated antibodies to confirm expression of fulllength recombinant POLQ and (C) mutant constructs that were transiently transfected in
293T cells. (D) Stable Polq−/− MEF lines complemented with POLQ expression vectors (or
empty vector control) were assayed for Polq expression by qPCR. WT4 and WT6 are
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independent clones complemented by wild-type POLQ; POL, mutation in the DNA
polymerase domain; HLD, mutation in the DNA helicase domain, DM, mutation in both
domains. (E) The complemented MEF lines were treated with bleomycin for 24 hr and
cellular ATP levels were measured 72 h later. (F) Spontaneous micronuclei and (G) DNA
double-strand breaks (>2 colocalized γH2AX and 53BP1 foci per cell) were quantified for
three independent experiments. The brightness of the entire microscope field was increased
to better display the fluorescence for print, using Adobe Photoshop CS6. Dr. Junya Tomida
generously provided the pCDH vector backbone containing the C-terminal FLAG-HA epitope
tags and technical advice. All cloning of POLQ cDNA, transfections, lentiviral transductions,
immunoblotting, cell sensitivity and DNA damage marker assays, and data analysis was
performed by MJY. qRT-PCR was performed by the Science Park Molecular Biology Core.

The mutant cDNAs were tested for their ability to genetically complement the
bleomycin sensitivity of Polq-null MEFs. Stable clones with each of the constructs were
generated and analyzed for expression of POLQ (Figure 7D). Two independent clones of
knockout MEFs expressing wild-type recombinant POLQ (WT4 and WT6) were able to
rescue bleomycin hypersensitivity (Figure 7E). Neither the polymerase domain mutant
(POL) nor the polymerase-helicase double mutant (DM) restored bleomycin sensitivity
(Figure 7E, Figure 8). Expression of a construct with a mutation in only the helicase-like
domain (HLD) was, however, still able to restore resistance to bleomycin. These data
indicate that POLQ polymerase activity is essential for conferring resistance to DNA
damage, whereas the ATPase activity of the helicase-like domain is not necessary.
Similarly, reintroduction of POLQ polymerase activity into Polq-deficient MEFs was able to
rescue chromosomal instability based on the analysis of micronuclei and DNA DSBs, as
measured by 53BP1 and γH2AX colocalization (Figure 7F and G, Figure 9).
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Figure 8. Complementation of polymerase-dead POLQ does not rescue DNA damage
sensitivity. Polq+/+, Polq-/-, Polq-/-Empty, and multiple clones of Polq-/-POL and Polq-/-DM
MEF lines were treated with 1 µM bleomycin for 24 h and cellular ATP levels were
measured 72 h later. All sensitivity assays were performed by MJY.
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Figure 9. Analysis of DNA double-strand breaks and micronuclei in complemented
Polq MEFs. Representative immunofluorescence images of Polq-/-Empty and Polq-/-WT4
MEF lines stained with DAPI and antibodies against 53BP1 and γH2AX. Scale bar
represents 25 µm. Arrows note micronuclei. Pan staining of γH2AX (P), OPT domain
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staining by 53BP1 (OPT), and examples of colocalization (Co) are noted. All cell culture and
staining, imaging, and analysis performed by MJY.

Mice with an S1932P mutation in Polq (the “chaos1” allele) have an increased
spontaneous frequency of micronuclei (Shima et al., 2003). We generated a
human POLQ cDNA mimicking the chaos1 mutation (S1977P), but attempted expression of
POLQ with this mutation in 293T cells did not yield detectable protein despite ample
transcript levels (Figure 10). This suggests that the chaos1-encoded mutant protein is
unstable, consistent with the finding that chaos1 mice have a phenotype essentially
indistinguishable from Polq knockout mice (Shima et al., 2003).

Figure 10. Full-length chaosI mutant protein is poorly expressed. 293T cells were
transfected with pCDH constructs that contained either the human POLQ cDNA, ChaosI
mutant (S1977P, corresponding to the S1932P mutated residue in mice), or empty control.
(A) 48 h post transfection lysates were made and immunoblotted with antibodies against
FLAG and alpha-Tubulin. (B) Total RNA was isolated from cells and qPCR analysis of
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POLQ transcript levels were performed using the ∆∆Ct method. An asterisk (*) denotes a
non-specific band. All cell culture, transfections, immunoblotting, RNA isolation, and data
analysis were performed by MJY. qRT-PCR was performed by the Science Park Molecular
Biology Core.

POLQ operates in a pathway of altEJ during mouse Ig class-switching
Immunoglobulin class-switch recombination (CSR) uses DNA end joining to
exchange one constant region of an antibody gene for another constant region (Figure 4).
CSR can occur by both Ku-dependent classical non-homologous end joining and Kuindependent altEJ (Boboila et al., 2012a). The overall frequencies of CSR are similar
in Polq-defective mice (Martomo et al., 2008) and cultured B cells (Li et al., 2011). To
determine whether POLQ is involved in a mechanistically distinct subset of CSR joins, In
2012 our lab began a collaboration with Dr. Kevin McBride, a molecular immunologist on the
department faculty, who had expertise in CSR. I, with help from Dr. Kevin McBride and his
laboratory, isolated and analyzed DNA sequences at such joins. Naïve B cells were isolated
from the spleens of wild-type and Polq-null mice and stimulated for IgM to IgG class
switching, and then the fraction of IgG1-positive B cells was measured by flow cytometry.
Parallel B-cell cultures were incubated with NU7026, a DNA-PKcs inhibitor that suppresses
cNHEJ (Callen et al., 2009). It has been shown that B cells incubated with NU7026 have an
increased proportion of CSR junctions with >1 bp insertion at the junction (Callen et al.,
2009). This suggests that when altEJ is used during CSR, it more frequently results in the
insertion of nucleotides.
I found that B cells from Polq-proficient and deficient mice had similar overall
frequencies of CSR (Figure 11A), and that inhibition of DNA-PKcs increased the frequency
of CSR in both genotypes by 1.5 to 2-fold (Figure 11B). The Sµ-Sγ1 junction was then
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sequenced from 100 clones of each group of IgG1-positive B cells. In wild-type B cells,
insertions of >1 bp at Sµ-Sγ1 junctions, that are thought to be altEJ-dependent, comprised
about 9% of total events, and was increased to ~21% in cells incubated with NU7026
(Figure 11C, Table 4).
Strikingly, in cells lacking Polq, this class of longer insertions at CSR junctions was
absent, even in the presence of NU7026 (Figure 11D), only one insertion of 2 bp was
observed, therefore insertions of >1 bp require POLQ. Polq-dependent joining events
included insertions of between 2 and 35 bp. For longer insertions (greater than ~10 bp)
homologous sequences were unambiguously detected up to 2–5 kbp away from the junction
site (Table 4), as has been reported for long insertions at Sµ-Sγ1 junctions in ATM-defective
B cells (Callen et al., 2009). This suggests that most, if not all, such insertions are formed in
a templated manner during altEJ by POLQ.
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Figure 11. Insertions >1 nt at CSR junctions are Polq-dependent. Isolated wild-type
(WT) and Polq−/− (KO) naïve splenic B cells were stimulated for CSR and either mocktreated or treated with NU7026. (A) Cells were assayed for IgG1 levels (y-axis) by flow
cytometry. The x-axis displays forward scatter (FSC) for cell viability. Aicda−/− splenic B cells
were used as a negative control since they do not undergo CSR. Numbers in boxes show
the percentage of the population that is IgG1 positive; in (B) these data are plotted relative
to wild-type. Genomic DNA isolated from B cells of wild-type (C) and Polq KO (D) mice was
amplified by PCR and 100 Sµ-Sγ1 junctions from each group were sequenced and analyzed
for overlaps and insertions at breakpoints. (E) Insertions >1 nt are plotted; p-values were
determined by the two-tailed Fisher's exact test. Cell viabilities were comparable between
genotypes. B cell isolation and culture was performed by MJY with assistance from Dr.
Kevin McBride and Sean Hensley. FACS analysis was performed by Dr. Kevin McBride, and
DNA isolation, PCR amplification, and sequencing analysis of switch junctions was
performed by MJY. DNA sequencing was performed by the Science Park Molecular Biology
Core.
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Table 4. Sequence composition of >1 nucleotide CSR insertions in Polq mice. New
mutations (different from the reference sequence) are shown in red. For some longer
insertions (blue), homologies were identified in the switch region, at the positions indicated
in the right column. Microhomologies at the junction site are underlined. Sequences
(graphed in Figure 11) are from wild-type (Polq+/+) and Polq-null (Polq-/-) splenic B cells that
were treated with NU7026 or mock-treated. Schematic below table shows CSR mu (Sµ) and
gamma 1 (Sγ1) switch regions with areas of DNA breakage noted by red boxes. Numbers
correlate to switch region length. Sequence analysis performed by MJY.
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Loss of Polq impairs an altEJ pathway but not cNHEJ in cultured cells
The most important factor in determining which double-strand break repair pathway
is used is whether or not the 5′ termini of broken ends are resected (Symington and Gautier,
2011). Ends with little or no single stranded overhang are typically rejoined by Ku-dependent
cNHEJ. In contrast, CtIP and MRN-dependent resection of 5′ termini generates ends with
extended single stranded 3′ overhangs; resection is thought to block cNHEJ (Frank-Vaillant
and Marcand, 2002) and enable repair by altEJ (Bennardo et al., 2008; Lee and Lee, 2007).
In 2013, Dr. Dale Ramsden (UNC Chapel Hill) contacted Dr. Wood to enquire about
POLQ and DNA end joining. We initiated collaboration where I sent my complemented Polq
MEF lines to be used to determine the impact of POLQ status on cNHEJ and altEJ. To
analyze differing requirements for end joining, with or without end resection. David Wyatt, a
graduate student in the Ramsden laboratory, prepared two linear DNA substrates with 3′
single stranded overhangs; one with a short overhang (6 nt), and one a long overhang (45
nt, a “pre-resected end”) (Figure 12A). Both can be aligned with the same 4 nt of terminal
complementary sequence. These substrates were then introduced into wild-type mouse
fibroblasts or fibroblasts harboring deficiencies in Ku70 or Polq. Repaired products were
recovered from cells and quantified. Repair of the short overhang substrate was, as
anticipated, over 10-fold less efficient in cells without Ku70 (Figure 12B) when compared to
Ku70-complemented controls. The absence of Polq had no consequence for the repair of
this substrate.
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Figure 12. End joining with extrachromosomal substrates. (A) Substrates were
designed to resemble DNA double-strand breaks that are repaired through Ku-dependent
NHEJ (6 nt tail with 4 nt of terminal complementary sequence) or alternate end joining of
resected DNA substrates (45 nt tail with 4 nt terminal complementary sequence), introduced
into cells, and joining of head-to-tail products assessed by qPCR. (B) qPCR for the classical
NHEJ assay uses primers to detect all events having sequences in the duplex immediately
flanking the break. Joining efficiencies are expressed as fractions of the mean joining
determined for matched wild-type controls (Polq+/+ or Ku70 complemented lines, as
appropriate). Three independent triplicate measurements were made for the Polq cell lines
and two independent triplicates for the Ku cell lines. Error bars represent the standard error
of the mean. Joining efficiency was not significantly different, whether cells were deficient
in Polq(Polq−/−Empty) or not (Polq+/+, Polq−/−WT4, Polq−/−WT6), but was different when cells
expressed Ku (Ku70−/−Ku70) when compared to Ku70−/−Empty cells (t-test, p<0.05) (C)
qPCR for the altEJ assay used primers to detect that subset of products including at least 10
nt of each 3′ overhang. Mean relative joining efficiencies, standard error of the mean, and
statistical analysis performed as for panel B. Joining efficiency was significantly different in
cells expressing Polq (Polq+/+, Polq−/−WT4, or Polq−/−WT6) when compared to Polq−/−Empty
cells (p<0.05), and in cells expressing Ku (Ku70−/−Ku70) when compared to Ku70−/−Empty
cells (t-test, p<0.05). The background observed in a mock transfected sample was
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determined to be 0.038, +/− 0.02 of wild-type controls. p values are represented as: * p<.05,
** p<.01, *** p<.001, ****p<.0001, and not significant (ns). Substrates were designed by
David Wyatt and Dr. Dale Ramsden, assay performed by David Wyatt, and data analyzed by
David Wyatt and Dr. Dale Ramsden. Polq-null and complemented cell lines were generated
and provided by MJY

End joining with the 45 nt overhang substrate was assessed using qPCR primers
located to ensure that at least 10 nt of overhang was included in joined products (Figure
12A). Recovery of these products was no longer dependent on Ku; instead, it was increased
2.8-fold in Ku70-deficient cells (Figure 12C). This is consistent with previous studies
demonstrating that Ku suppresses repair by altEJ. Strikingly, joining of the long overhang
substrate in Polq−/− cells was reduced 10-fold, approaching background levels of signal
observed using this assay. Complementation of the knockout cells with POLQ returned altEJ
joining to wild-type levels (Figure 12C). These data demonstrate that POLQ participates in
some form of altEJ, but that cells lacking POLQ maintain proficiency for cNHEJ.

POLQ extends 3′ DNA ends in a template-dependent manner
Our results demonstrate that POLQ is necessary to form the insertions found in CSR
junctions in a process of altEJ. We next sought to determine the mechanism. Dr. Kei-ichi
Takata, an expert in DNA polymerase assays in the Wood laboratory, generously provided
technical advice and performed primer extension analysis to further analyze the polymerase
properties of POLQ in vitro. Like other DNA polymerases, an active polymerase fragment of
POLQ (Hogg et al., 2011) can catalyze template-dependent DNA synthesis from an
annealed primer (Figure 13A). As is common for family-A DNA polymerases, only a single
nucleotide is added to the end of duplex DNA (Seki et al., 2004). Unusually, however, POLQ
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can catalyze extension of single-stranded oligonucleotides (Hogg et al., 2012). It was
unclear whether this reflects a robust terminal deoxynucleotide transferase activity of POLQ
on single-stranded DNA, or some form of template-dependent synthesis. For example,
POLQ can extend a single-stranded 16-mer oligonucleotide provided without a
complementary template (products up to 35 nt long), while E. coli pol I Klenow fragment has
no activity on this substrate (Figure 13B). The major 22 nt extension product produced by
POLQ on the 16-mer used in Figure 13B may be accounted for by inter- or intraoligonucleotide pairing (Figure 13C). Neither POLQ nor Klenow fragment could extend an
oligonucleotide that was incapable of annealing to itself (Figure 13D and E) (Hogg et al.,
2012).
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Figure 13. Unique template dependent DNA polymerase activity of POLQ.
Exonuclease-defective E. coli pol I Klenow fragment (Kf exo-) or POLQ was incubated at the
indicated protein concentrations with (A) a 5′-32P-labeled 16-mer primer and 30-mer
complementary template, or a (B) 5′-32P-labeled 16-mer primer and no template. All reaction
mixtures included all four deoxynucleotide triphosphates and were incubated at 37°C for 10
min (A) or 20 min (B). The first lane contained no enzyme. The percentage (%) of the primer
extended is shown below each lane. (C) Model of major 22 nt product formation produced
by extension from the primer in Figure 13B, which has a limited ability to self-anneal.
Similar reactions were performed with (D) 5′-32P-labeled 20-mer dC oligonucleotide or (E) a
20-mer dC oligonucleotide with a synthetic abasic site on the 3’ end. Primer extension
assays were performed by Dr. Kei-ichi Takata and MJY.

In the summer of 2013 at a meeting in St. Petersburg, Russia, Dr. Erik Johansson
(Umeå University, Umeå, Sweden) approached Dr. Wood with some very interesting
biochemical data about POLQ. To identify the mechanism of 3′ single-stranded DNA
extension by POLQ, Dr. Göran Bylund and Sara Lundsten of the Johansson laboratory.
They used a single-stranded oligonucleotide designed to be unable to form selfcomplementary base pairs longer than a single nucleotide (Hogg et al., 2012), and
sequenced the products of POLQ-mediated extension. Individual extension products of 1 to
30 nt were found (Table 5). Most of the sequenced extension products feature AAC or
AAAC sequences that could arise from copying GTTT sequences in the template via interor intra-molecular priming and re-priming (Figure 14) following minimal base pairing at the
3′-primer end. My analysis of these data reveal that POLQ uniquely extends 3′ DNA tails
through template-dependent DNA synthesis from a primer with minimal base pairing rather
than through a true TdT-like activity. POLQ indeed has unique biochemical properties
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compatible with these observations. Unlike other DNA polymerases, POLQ can efficiently
extend a DNA chain with a nucleotide incorporated opposite an abasic site (Seki et al.,
2004), or from a mismatched primer-terminus (Seki and Wood, 2008). Further, there is
evidence that primers slip on DNA templates with an increased frequency during POLQmediated synthesis, as shown by the high frequency of single base pair frameshift mutations
generated by purified POLQ (Arana et al., 2008).

Substrate
Seq Length
1
30
2
26
3
25
4
24
5
23
6
21
7
21
8
20
9
20
10
20
11
19
12
19
13
18
14
18
15
17
16
17
17
17
18
16
19
16
20
14
21
14
22
14
23
13
24
13
25
13
26
12
27
12
28
12

GTTTGTGAGTTTCC
Extension Product
AAACAAACAAACAAACAAACAAACAAACAA
AAAACAAGCAAACAACCAAACTTTTG
AAAAAAAAAAACAAACTCACGCGAT
AACACAAACAAAACAACCCGCAAT
ACAAACAAACAAACAAACACACG
AAAACAACAAACAAAACTCCG
AAACAAAACAAACAAACAAAG
AAACAAACAAACAAGCCGGG
AACAAACCTGTACCGGCCCG
TCAAAAAACTCAAAACAAAC
AAAACAAAACAAAACAAAC
CAAACTCATCTCACGCGAA
AAACAAACAAAACAAACC
ACAAACAAACAAACACAC
AACAAACAAAACAAACA
ACAAACAAACAAACCGG
AAAAACAAAAAAAACTC
AAGCAAACAACAAAAA
AAAAACAAAAAAAAAA
AAAACAAAACAAAA
AAACAAACAAACAC
ACAAACAAACAAAC
AAACAAACAAACG
AAACAAACAAGAG
AAACAAACAAACG
ACAAAACAAACG
AAACAAACAAAC
AAACAAACAAAC

Homopolymer
T
T
G
C
C
C
A
C
C
A
G
C
A
A
C
C
A
G
G
G
G
A
A
A
A
C
A
A

Substrate
Seq Length
29
11
30
11
31
9
32
8
33
8
34
8
35
6
36
5
37
5
38
5
39
5
40
5
41
4
42
4
43
4
44
3
45
3
46
2
47
2
48
1
49
1
50
1
51
1
52
1
53
1
54
1

GTTTGTGAGTTTCC
Extension Product
AAACAACCAAC
ACAACCCCAAC
AAACAAACG
GGGCGAGT
AAACAAAC
AACAAGAC
GCGCCG
AAAAC
AAGAC
CACCC
CACAC
AAGAC
TCGT
GAGG
AAGC
AAA
CAC
AA
CC
A
T
T
T
C
T
C

Homopolymer
A
A
A
G
A
A
C
A
A
A
A
A
G
A
A
G
A
G
A
G
G
G
G
G
A
A

Table 5. POLQ-dependent extension of 3’ DNA ends relies upon homology. Primer
extension assays were carried out with a defined substrate (top) incubated in the presence
of an active polymerase fragment of POLQ. Products were then incubated with terminal
deoxynucleotidyl transferase (TdT) in the presence of only dA, dC, dG, or dTTP to create
extension products that terminate with homopolymeric runs. The reaction products were
then cloned and sequenced for analysis of extension products. Extension products are listed
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above for each homopolymeric run. Polymerase assay and sequencing of extension
products were performed by Dr. Göran Bylund and Sara Lundsten. Data analysis was
performed by MJY to make the model in Figure 14.
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Figure 14. POLQ promiscuously extends single-stranded DNA ends through
intermolecular templating. Model of intermolecular templating performed by POLQ in the
process of extending a single-stranded oligonucleotide, used to produce the data in Table 5.
This model depicts a 12 nt extension product in Table 5. The product can be produced by a
series of annealing, extension, slippage and repriming events. DNA ends could also be
elongated, in some cases, through intramolecular templating, extension, followed by
slippage.

POLQ suppresses Myc/IgH translocations in B cells
Double-strand breaks initiated by AID activity in the immunoglobulin heavy chain
(IgH) locus of B cells are necessary to generate immunological diversity, but breaks are
sometimes generated at other chromosomal sites, providing an opportunity for dangerous
chromosome translocations (Chiarle et al., 2011; Klein et al., 2011; Simsek and Jasin, 2010;
Zhang and Jasin, 2011). For instance the oncogenic Myc/IgH translocation that causes
Burkitt lymphoma is AID-dependent and requires breaks at both Myc and IgH, with breaks in
the Myc gene being rate-limiting (Robbiani et al., 2008). An altEJ process is implicated in the
formation of oncogenic translocations in lymphoid tissues, including
the Myc/IgH translocation in murine B cells (Boboila et al., 2012b; Simsek et al., 2011a;
Simsek and Jasin, 2010). cNHEJ suppresses the formation of such chromosomal
translocations (Ferguson et al., 2000). To determine the role of POLQ in chromosomal
translocations, Polq+/+ and Polq−/− naïve splenic B cells were stimulated in culture and
assayed for the frequency of Myc/IgH translocations (Figure 15A). Notably, in the absence
of Polq there was a 4-fold increase in translocation frequency (Figure 15B and C). This
indicates that mammalian POLQ acts in a subset of altEJ events to suppress chromosomal
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translocations. Additionally, an increase in intramolecular IgH rearrangements was found in
B cells lacking Polq (Figure 15B). Therefore, although POLQ is involved in an altEJ
pathway, it prevents rather than promotes chromosomal instability, rearrangements and the
formation of Myc/IgH translocations.
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Figure 15. POLQ suppresses chromosomal translocation in vivo. (A) Representative
schematic for the Myc/IgH translocation assay. PCR amplification primers are represented
by black arrows. Closed circles denote centromeric locations on the chromosomes. Naïve B
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cells from wild-type (WT) or Polq−/− mice were assayed for translocations after 72 h in
culture. (B) Representative agarose gels stained with ethidium bromide and Southern blots
probed with IgH and Myc probes as indicated. Each lane contains the DNA content of 1
×105 genomes. Three independent experiments were performed. (C) Frequency of
translocations was plotted and p-values determined using the two-tailed Fisher's exact test.
Frequencies were calculated from the total number of translocations (Polq+/+: 5; Polq−/−: 17)
divided by the total number of genomes surveyed (9.6 ×106). (D) Model of end joiningmediated repair of DNA double-strand breaks (DSBs). (i) Schematic representing a DSB
with existing microhomologies shown in orange. (ii) DSBs are preferentially processed by
classical non-homologous end joining (cNHEJ), dependent upon Ku70–80 and Ligase4XRCC4. This pathway is not thought to promote DNA translocations. In the absence or
impairment of critical cNHEJ factors (iii) alternative end joining (altEJ) pathways are utilized.
These pathways appear to be suppressed by Ku70–80 and Ligase4-XRCC4. The MMEJ
pathway (iv) can orchestrate annealing of ends at pre-existing microhomologies (2–5 bp)
resulting in a net deletion of genomic information. Utilization of this pathway can enhance
the formation of chromosomal translocations. In the SD-EJ pathway, also known as SDMMEJ, (v) POLQ can catalyze extension of minimally paired 3′ single-stranded DNA ends
(shown in blue) to facilitate end joining and suppress the formation of chromosomal
translocations. POLQ-independent alternative end joining pathways (vi) may exist but are
still unclear. B cell isolation and culture and DNA isolation was performed by MJY. Sean
Hensley performed PCR amplification of translocation derivative and Dr. Yunxiang Mu
performed Southern Blotting.

74

2.4 Conclusion
POLQ suppresses hypersensitivity to direct DNA double-strand breaks
Taken together, the data presented in this chapter show that in mammalian cells,
POLQ has a specific role in defense against DNA damaging agents that directly cause DNA
double-strand breaks, including ionizing radiation, bleomycin, and certain topoisomerase
inhibitors. Our findings indicate that POLQ participates in a novel pathway of alternative-end
joining of DSBs, a process that can occur throughout the cell cycle in mammalian cells
(Thompson, 2012). The minimal additional sensitization to camptothecin by olaparib in Polqdefective cells suggests that one function of PARP is to participate in a Polq-dependent
altEJ pathway, which could serve as a backup pathway in homologous recombinationdeficient cells. Our experiments indicate that POLQ is an important factor in DNA DSB repair
in all cells, not just cells of the hematopoietic lineage. Indeed, Polq is broadly expressed in
murine tissues (Figure 16).
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Figure 16. Absolute quantification of transcript number shows that Polq is broadly
expressed in tissues. Total RNA was isolated from necropsied C57BL/6 mice using Trizol
(Life Technologies). Transcript abundance for Polq and DNA polymerase delta catalytic
subunit Pold1 was determined by the absolute quantification method as described in the
Material and Methods. Gapdh was used as an internal control to normalize samples. Tissue
collection and RNA isolation were performed by MJY with assistance from Dr. Kei-ichi
Takata. qPCR probe and primer sets were designed by MJY and Dr. Kei-ichi Takata. qRTPCR was performed by the Science Park Molecular Biology Core and the data were
analyzed by MJY and Dr. Kei-ichi Takata with the generous assistance of Dr. John Repass.

Mutants of POLQ homologs in Arabidopsis (TEBICHI), C. elegans (polq-1),
and Drosophila (Mus308) are hypersensitive to ICL-inducing agents (Yousefzadeh and
Wood, 2013), whereas Polq-defective mammalian cells are not appreciably hypersensitive
to such agents (Figure 5). This difference may arise because of differences between
organisms in the priority of DNA repair pathway engagement. In proliferating mammalian
cells, ICLs are usually dealt with through the Fanconi anemia pathway, which produces
enzymatically induced double-strand breaks that are channeled into homologous
recombination repair (Kottemann and Smogorzewska, 2013). In Drosophila and some other
organisms, an altEJ-dependent pathway may be more important for resolving ICLassociated double-strand breaks. Although Drosophila Mus308 mutants are not
hypersensitive to IR, pronounced IR sensitivity occurs in a double mutant when HR is also
inactivated (Chan et al., 2010). The phenotypic consequences of POLQ-dependent altEJ
repair of double-strand breaks may thus depend on the relative dominance of HR, which
varies between organisms.
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In this chapter I show that the DNA polymerase activity of POLQ is necessary to
prevent cell death and chromosome breaks (micronuclei) caused by a double-strand breakinducing agent (Figure 5 and 6). Disruption of the ATPase activity in the helicase-like
domain of POLQ did not, however, alter the correcting function of POLQ addition to
knockout cells (Figure 7). A previous study with mouse cell lines suggested that disruption
of the polymerase domain of the murine Polq gene has less severe consequences than
complete disruption of Polq (Li et al., 2011), but the result is difficult to evaluate in the
absence of quantitative measurements of expression of the disrupted form. No activity has
yet been shown for the helicase-like domain, other than a DNA-dependent ATPase function
(Seki et al., 2003). It is likely that an additional role remains to be discovered that is
dependent on the ATPase function of POLQ.

POLQ aids DNA double-strand break repair through alternative end joining and nucleotide
insertions
When double-strand breaks form in mammalian cells, a majority will be repaired
through cNHEJ. However, a subset of these breaks will be handled by alternative endjoining pathways, for example, in situations where the DNA end is not compatible with
processing by Ku-dependent cNHEJ, or if core components of the cNHEJ machinery are
absent or unavailable (Figure 15D). In general, altEJ is defined as a DNA repair mechanism
distinct from Ku-dependent, classically defined NHEJ (Deriano and Roth, 2013), and
dependent on other factors (CtIP, MRN) that resect double-strand breaks to generate
extended 3′ ssDNA tails (Bennardo et al., 2008; Lee and Lee, 2007) (Figure 12A and 15D).
Accordingly, we showed that joining of a “pre-resected” extrachromosomal substrate
(substrate with 45 nucleotide 3′-ssDNA tails) was stimulated in Ku-deficient cells, similar to
results using chromosomal substrates (Bennardo et al., 2008). Joining of this substrate was
also dependent on Polq (Figure 12C). Thus, our experiments define an altEJ subpathway in
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mammalian cells that involves POLQ (termed synthesis-dependent end joining, SD-EJ or
SD-MMEJ) (Figure 15D). Additional POLQ-independent altEJ subpathways may also be
operational (Figure 15D). To some extent, different end-joining pathways can be been
distinguished from one another by the ligase employed in the pathway, with DNA ligase IV
(LIG4) suggested as essential for cNHEJ, and DNA ligase III (LIG3) for altEJ in mammalian
cells (Frit et al., 2014; Simsek et al., 2011a; Simsek and Jasin, 2010). There are caveats,
however. For example, some functional redundancy is apparent between LIG1 and LIG3 in
altEJ (Arakawa et al., 2012; Boboila et al., 2012b; Han et al., 2014; Simsek et al., 2011b).
Ligase deficiencies may thus not be the best means for distinguishing different end-joining
pathways. For the altEJ subpathway under consideration here, dependence on POLQ is the
best available definition.
The biochemical properties of POLQ provide a mechanistic explanation for its
contribution to altEJ. POLQ has a unique ability to add nucleotides to the 3′ ends of singlestranded DNA (Hogg et al., 2012), primed by minimal pairing with other available DNA
molecules (Figure 13 and Figure 17). The distinct ability for POLQ to catalyze DNA
synthesis from the minimally paired ends is supported by recent structural evidence that
POLQ uniquely grasps the primer terminus via additional protein-DNA contacts that are not
present in bacterial A-family DNA polymerases (Zahn et al., 2015). Synthesis by POLQ in
this context is consistent with the unusually efficient ability of the polymerase to extend from
mismatched DNA termini (Seki et al., 2004; Seki and Wood, 2008), and its tendency towards
primer-template slippage (Arana et al., 2008). In future studies it will be of interest to
examine the action of POLQ and DNA ligases at double strand breaks with 3′-singlestranded overhangs that closely mimic the resected ends of a DNA double-strand break. In
vivo studies with such substrates, including those that can form hairpins in the singlestranded region, would give insight as to the preferred structures for POLQ-catalyzed
extension.
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Figure 17. Mechanism of insertion formation by POLQ during double-strand break
repair. After a double-strand break is formed (i), the broken ends are frequently resected
enzymatically to form 3’ single-stranded tails (ii). POLQ can extend a 3’ end by templated
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synthesis from another available DNA strand (iii). This may be the 3’-tailed end near the
break, or a DNA strand available at a more distant location, or through possible “snapback
synthesis” whereby the tail serves as its own intramolecular template. POLQ has the unique
ability to prime DNA synthesis (blue) with minimal base pairing, sometimes slipping in the
process (Figure 14). The newly synthesized DNA end then anneals via microhomology to
the other 3’ tail at the break (iv), and repair is completed (v) after further DNA synthesis
(gray). This process results in an insertion of DNA sequences (blue).

A unique marker of the POLQ-dependent altEJ process is repair junctions that
display templated DNA insertions. Some form of altEJ has been implicated in resolution of a
subset of double-strand break intermediates in CSR, producing templated
insertions (Boboila et al., 2012a). Our data support a role for POLQ in generating the CSR
products with these templated insertions. These events are consistent with the templated
insertions that occur during Mus308-dependent repair of directed double-strand breaks
in Drosophila (Chan et al., 2010; White and Lambowitz, 2012) and in C. elegans (Koole et
al., 2014). In the absence of POLQ, the lack of insertion-containing joins is observed, but the
global CSR frequency is relatively unchanged (Figure 11). These insertions are best
explained by repeated initiation of synthesis by POLQ (Figure 14) on template sites,
ultimately leading to a joined product. An open question is whether these newly created
POLQ-dependent insertions create novel microhomologies (2-5 bp) that allow for annealing
of ends or the insertions produce a 3’ DNA end that anneals through minimal pairing of a
single base. Further analysis into the end joining properties of POLQ is warranted.
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POLQ prevents the formation of Myc/IgH chromosomal translocations
In the absence of POLQ, we found a ~4-fold increase in the formation of the
oncogenic translocation Myc/IgH in mice (Figure 15C). This increase is comparable to that
seen in B cells that have lost Tdrd3, a regulator of R-loop formation during transcription
(Yang et al., 2014) and miRNA-155 which regulates AID and suppresses oncogenic
translocations (Dorsett et al., 2008). In the absence of Polq there is also an apparent
enhancement of rearrangement events in the IgH locus, consistent with the elevated level of
chromosomal instability observed in cells lacking POLQ (Roerink et al., 2014).
altEJ is typically associated with frequent annealing of the DNA ends at existing
microhomologies (2–5 bp) and large deletions at repair junctions (Decottignies, 2013). Since
translocations commonly feature such microhomologies at their breakpoint junctions
(Bunting and Nussenzweig, 2013; Weinstock et al., 2006) and occur more frequently in
cNHEJ defective cells, altEJ is considered the primary mechanism by which translocations
occur. Thus, a striking finding of the present work is that the formation of
Myc/IgH translocations is suppressed when the POLQ-dependent altEJ subpathway is
operational. It is possible that DNA DSBs persist for a longer time in the absence of POLQ,
giving more opportunity for the formation of translocations. Alternatively, the POLQdependent pathway may be the most efficient at repairing a structurally distinct class of
translocation-prone DNA breaks.
These studies clearly define a role for POLQ in DNA repair and provide a
mechanism for template-dependent extension of DNA ends necessary to repair breaks in a
subpathway of altEJ. This distinct altEJ pathway is required to prevent the formation of
Myc/IgH translocations as shown by our in vivo experiments.
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Chapter 3. Does a POLQ “signature” exist in translocations and immunoglobulin V
regions.
3.1 Introduction
As just described, there is an “insertional” signature for POLQ in the immunoglobulin
(Ig) switch regions of murine B cells. Sequencing of the switch regions showed that POLQ
was required for longer insertions observed at the Sµ-Sγ1 junctions of B cells that result in
IgG1+ antibodies displayed on the B cell surface (Figure 11, Table 4) (Yousefzadeh et al.,
2014). These longer insertions feature homologies found up to 2-5 kb away from the
breakpoint junction and this synthesis-dependent end joining (SD-EJ) function of POLQ is
conserved in homologs found in Drosophila and C. elegans (Chan et al., 2010; Roerink et
al., 2014; Yousefzadeh et al., 2014). This alternative end joining (altEJ) pathway is
independent of the canonical non-homologous end joining (cNHEJ) factors Ku70 and Ku80
(Figure 11 and 12) (Yousefzadeh et al., 2014). POLQ-mediated SD-EJ is supported by
biochemical evidence of POLQ’s ability to prime synthesis from minimally-paired ends, +1/-1
slippages, and to extend from a mismatched terminus (Arana et al., 2008; Seki and Wood,
2008; Yousefzadeh et al., 2014).
This POLQ-dependent subpathway of altEJ repair of DNA double-strand breaks
(DSBs) is hypothesized to promote chromosomal translocation; however the mechanism
through which this occurs is still unclear (Simsek and Jasin, 2010; Zhang and Jasin, 2011).
We analyzed translocations between the Ig heavy chain locus and the Myc oncogene and
found a 4-fold increase in the translocation frequency in Polq-null B cells when compared to
wild-type controls. Our findings were surprising in that we found that POLQ-dependent SDEJ, an altEJ pathway, is actually suppressive to chromosomal translocations, which breaks
with the current paradigm (Figure 15) (Yousefzadeh et al., 2014).
During the development of B cells, programmed induction of DNA damage is
required for the diversification of immunoglobulin genes. RAG1/2 are required for initial
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assembly of antibody gene segments. Further immunological diversification through class
switch recombination (CSR) and somatic hypermutation (SHM) occur later on in an
activation-induced cytosine deaminase (AID)-dependent fashion (Chahwan et al., 2011; Di
Noia and Neuberger, 2007; Stavnezer et al., 2008). U:G mismatches, created when AID
deaminates cytosines, are processed by uracil-DNA glycosylases and error prone
polymerases to generate point mutations in SHM (Rajewsky, 1996). DSBs are also
generated in an AID-dependent fashion that initiates CSR, causing a change in antibody
isotype class without modifying antigen affinity (Chahwan et al., 2011; Di Noia and
Neuberger, 2007; Stavnezer et al., 2008). The bulk of AID activity is targeted at the Ig
locus, but AID also targets a number of transcribed genes, including tumor suppressor
genes (p53) and oncogenes (MYC), which are associated with lymphomas (Gazumyan et
al., 2012; Yamane et al., 2011). The DNA DSBs generated by AID are common substrates
for chromosomal translocations like translocations between IgH and MYC, which are
commonly observed in Burkitt lymphoma patients (Gazumyan et al., 2012; Ramiro et al.,
2006).
During the repair of AID-generated DSBs, both cNHEJ and altEJ are involved but
have divergent roles in the formation of chromosomal translocations. Previously altEJ, and
specifically the microhomology-mediated end joining (MMEJ) pathway, was shown to
promote translocations, suggesting that altEJ may be the primary pathway underlying these
chromosomal aberrations in mice, while translocations appear to be dependent upon cNHEJ
in humans (Boboila et al., 2012a; Ghezraoui et al., 2014; Simsek and Jasin, 2010). Our data
suggests that the SD-EJ pathway that is dependent upon POLQ-catalyzed extension of 3’
DNA ends serves as a genome stability mechanism that limits chromosomal translocations
(Yousefzadeh et al., 2014). We hypothesize that POLQ suppresses translocations at the
cost of nucleotide insertions and deletions (indels). However the impact of POLQ on
translocation at the genomic sequence level is not known and would be of great value. We
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hypothesize that the sequence composition of breakpoint junctions from translocations that
occur when POLQ is impaired or absent are different from those that occur in the presence
of POLQ.
Indels can disrupt the open reading frames of genes, but in the current context, these
indels are another important antibody diversification mechanism. Nucleotide additions and
deletions are found in V(D)J junctions during RAG-mediated recombination and in the
variable (V) region of Ig genes during SHM (Helmink and Sleckman, 2012; Sale and
Neuberger, 1998). The latter group of indels are termed somatic hypermutation associated
(SHA) indels and can be found in the antigen-binding complementarity determining region
(CDR) of Ig V regions and result from SHM (Reason and Zhou, 2006). Approximately 2-6%
of peripherally-circulating human B cells feature SHA indels in their V regions (Briney et al.,
2012; Wilson et al., 1998). While the frequency of these indels is low, they are crucial for
antibody response to pathogens like influenza, HIV-1, and S. pneumonia (Krause et al.,
2011; Reason and Zhou, 2006; Yu et al., 2008). Certain individuals infected with HIV-1
(termed “elite controller individuals) harbor neutralizing antibodies to HIV-1. Sequencing
revealed that some of these neutralizing antibodies have nucleotide insertions in the
framework regions either the heavy or light chain V regions, and functional analysis affirms
that these indels are required for the neutralizing capacity of these antibodies (Klein et al.,
2013). Therefore, these insertions create significant structural alterations resulting in novel
antigen-antibody interactions. SHA-indels present a unique and understudied antibody
diversification mechanism that is associated with SHM, but is distinct from point muations
that arise during SHM. Our prior study supports a role for POLQ-dependent insertions in
CSR junctions and we hypothesize that SHA-indels are POLQ-dependent as well.
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3.2 Material and methods
Experimental Mice
Polq-heterozygous (Polq+/−) (Shima et al., 2004) and wild-type mice were obtained from
Jackson Laboratories and maintained in a C57BL/6J background. Polq-heterozygous mice
were crossed to generate Polq-null mice. Mice were maintained in specific pathogen free
conditions before experimental mice (2-6 mo) were transferred to a holding room that was
positive for mouse parvovirus, minute virus of the mouse, and H. pylori. Mice were sacrificed
by CO2 euthanasia followed by cervical dislocation. Three mice per genotype were used for
four independent experiments. Peyer’s patches were isolated from the mice and filtered
through 70 µm filters into 1X PBS. Cells were stained with the following: Propidium Iodide
(PI), anti-CD19-APC, anti-CD19-PE, anti-CD95-PE-Cy7, and anti-GL7-FITC. Cells were
then sorted for germinal center B cells based on the following scheme: PI-, CD19++, CD95+,
and GL7+. Cells were plated into 96 well plates at 50-100 cells per well and frozen at -80°C.
RNA isolation and cDNA amplification of IgK and IgH V(D)J regions were performed by the
McBride laboratory. 2 µL of PCR product was TOPO TA (Life Technologies, Carlsbad, CA)
cloned according to manufacturer’s specifications and sequenced using M13 reverse
primers at Molecular Biology Core Facility. Sequences were analyzed via the IgBLAST
database (NCBI).
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3.3 Results and Future Work
Immunoglobulin V region sample preparation and sequencing
In order to examine V region indels in Polq mice, Peyer’s patches were isolated with
Dr. Kevin McBride from mice and germinal center B cells were sorted by FACS.
Immunoglobulin transcripts were amplified with the assistance of Sean Hensley and Monika
Zelazowska and prepared for next generation sequencing analysis to determine if Polq
status had an effect on V region indels. Before initiating next generation sequencing of
immunoglobulin V regions in Polq mice, I wanted to ascertain population diversity of
amplified transcripts. Initial sequencing of immunoglobulin genes showed numerous clonal
populations, along with clonal derivations and some unique immunoglobulin genes by
(Table 6). Following this, samples were prepared and submitted to the Next Generation
Sequencing Core for analysis on the MiSeq sequencing platform (Illumina, San Diego, CA)
using 300 bp paired end reading. NGS data will be analyzed by the Bioinformatics Core at
the Science Park Molecular Biology Core. Our hypothesis is that based upon our findings
that insertions in CSR junctions are POLQ-dependent that in the absence of Polq we will
see a significant reduction in SHA-indels (Yousefzadeh et al., 2014). Future experiments
could include the investigation of POLQ influencing antibody repertoire and responses to
model antigens.
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Identical Clones
genotype sequence
Polq +/+
IgK
IgH
Polq +/+
Polq +/+
IgH
IgK
Polq -/-/Polq
IgH
IgH
Polq -/IgH
Polq -/-

clone ID
K6, K17
M3, M6
M7, M16
K6, K8
M5, M11
M8, M9
M10, M13

V gene
V19-93*02
V1-67*01
V6-3*01
V3-4*01
V14-2*01
V7-3*01
V2-9*01

D gene
ND
D2-5*01
D1-3*01
ND
D3-3*01
D1-1*02
D2-3*01

J gene
J5*01
J3*01
J4*01
J5
ND
J4*01
J1*03

Mutations
3
5
12
9
11
8
8

Clonal Derivation
genotype sequence
Polq +/+
IgK
Polq +/+
IgK
+/+
Polq
IgK
Polq +/+
IgK
Polq +/+
IgK
Polq +/+
IgK
+/+
Polq
IgH
Polq +/+
IgH
Polq +/+
IgH
IgH
Polq +/+
-/Polq
IgK
IgK
Polq -/IgH
Polq -/Polq -/IgH

clone ID
K2
K20
K4
K10
K13
K21
M12
M20
M13
M18
K2
K7
M4
M6

V gene
V3-12*01
V3-12*01
V14-111*01
V14-111*01
V14-111*01
V14-111*01
V7-3*01
V7-3*01
V1-9*01
V1-9*01
V3-4*01
V3-4*01
V7-3*01
V2-9*01

D gene
ND
ND
ND
ND
ND
ND
D3-2*01
D3-2*01
D4-1*02
D4-1*02
ND
ND
D1-1*02
D2-3*01

J gene
J2*01
J2*01
J4*01
J4*01
ND
J5*01
J4*01
J4*01
J2*01
J2*01
J5
J5
J4*01
J1*03

Mutations
10
9
10
7
7
8
10
11
11
12
12
12
9
12

Unique Clones
genotype sequence
IgK
Polq +/+
+/+
Polq
IgK
Polq +/+
IgK
Polq +/+
IgH
+/+
IgH
Polq
Polq -/IgK
IgH
Polq -/Polq -/IgH
-/Polq
IgH

clone ID
K1
K5
K7
M10
M21
K3
M1
M5
M17

V gene
V6-23*01
V3-10*01
V3-7*01
V1-85*01
V1-34*01
V14-111*01
V6-3*01
V14-2*01
V14-3*01

D gene
ND
ND
ND
D1-1*02
D2-5*01
ND
D4-1*02
D3-3*01
D2-12*01

J gene
J2*01
J4*01
J2*03
J2*01
J1*03
J4*01
J2*01
ND
J3*01

Mutations
0
5
18
16
17
9
18
11
6

Table 6. Sequencing of IgH and IgK sequences from Polq mice. cDNA amplicons were
TOPO TA cloned and sequenced. Sequences were analyzed by IgBLAST. Individual V, D,
J recombinants are denoted and amino acid mutations are enumerated. Clonal sequences
with identical VDJ gene segments and mutations, their clonal derivatives featuring novel
mutations (bracketed into groups), and unique sequences are stratified. Germinal Center B
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cells were isolated by Dr. Kevin McBride and MJY. Immunoglobulin transcript amplification
was performed by Sean Hensley, Monika Zelazowska, and MJY. MJY cloned the cDNA
amplicons and analyzed the sequencing results generated by the Science Park Molecular
Biology Core.

Translocation analysis is Polq/Tp53 mice
In the absence of Polq, Myc/IgH translocation frequency increases nearly four-fold
relative to the wild-type control (Figure 15) (Yousefzadeh et al., 2014). However, in
stimulated B cells from wild-type mice, the translocation frequency is quite low (~1
translocation per 500,000 cells), making translocation analysis reagent-intensive (Figure 15)
(Yousefzadeh et al., 2014). Therefore I am crossing of Polq mice to Tp53 mice to enhance
the translocation frequency. Tp53-null mice exhibit a 5 to 10-fold increase in the frequency
of Myc/IgH translocations compared to wild-type mice (Ramiro et al., 2006). Our hypothesis
is that POLQ prevents the formation of chromosomal translocations but it comes at the cost
of creating indels. Thus it is important to learn the locations and compositions (insertions,
microhomologies, etc.) of translocation junctions that are dependent upon POLQ. C57BL/6JPolq- and FVB-Tp53-null mice are being crossed to generate Polq-/- Tp53-/- mice and will be
available for use soon. These mice will be used for analysis of translocation breakpoints by
NGS. Future studies could spring from this initial analysis such as the investigation of
POLQ’s impact on other common translocations.

88

Chapter 4: The effect of POLQ suppression on radiosensitivity of breast cancer cells.
4.1 Introduction
For many breast cancer patients, surgical tumor resection is followed by treatment
with ionizing radiation (IR). A salient need in breast cancer therapeutics is to enhance the
effectiveness of IR. “Triple-negative” breast cancer (TNBC), a particular subset of breast
cancers, are refractory to most conventional therapies (André and Zielinski, 2012), including
IR, and pose a major clinical challenge (Lehmann et al., 2011). As previously reported, cells
lacking POLQ are notably hypersensitive to IR and the radiomimetic bleomycin (Goff et al.,
2009; Higgins et al., 2010b; Yousefzadeh et al., 2014). Our lab and others demonstrated
that abnormally high levels of POLQ in breast cancer patients correlates with poorer
outcomes (Begg, 2010; Higgins et al., 2010a; Lemée et al., 2010). Notably POLQ is a
component in the Genomic Grade Index (GGI) signature and “76-gene signature” set which
are used to assess tumor grade and prognosis (Sotiriou et al., 2006; Wang et al., 2005).
While multiple studies have delved into the correlation between POLQ expression
and breast cancer outcomes, very little was known about POLQ single nucleotide
polymorphisms (SNPs) and breast cancer until recently. A SNP of POLQ (c.-1060A>G) was
shown to be significantly more frequent in hereditary breast cancer patients than in sporadic
breast cancer patients or control individuals (Brandalize et al., 2014). This SNP is located in
the promoter region of POLQ but it is not known how this SNP affects POLQ expression or
how it modifies the disease in these hereditary breast cancers.
The mounting evidence supporting a role for POLQ in breast cancer, makes it an
ideal new therapeutic target. Targeting DNA replication as a therapeutic intervention is a
time tested and clinically used principle. For example chemotherapeutics like 5-fluorouracil
and hydroxyurea, and nucleoside analogs such as gemcitabine and cytarabine are
commonly used in the treatment of cancer patients (Kelley, 2011). Since POLQ is the only
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DNA polymerase to be significantly overexpressed in breast cancer, is involved in replication
timing, and is not essential for cell viability (Fernandez-Vidal et al., 2014; Lemée et al., 2010;
Yousefzadeh and Wood, 2013). POLQ a logical choice and appealing target for therapeutic
development.
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4.2 Material and methods
Cell lines
The following cell lines were purchased from American Type Culture Collection: MCF7,
MCF10, HCC1569, HCC1599, HCC1806, BT-474, MDA-MB-361, and MDA-MB-436. Cells
were STR fingerprinted, checked for mycoplasma contamination, and cultured in their
appropriate media (Neve et al., 2006).

RNA isolation and qPCR analysis
Total RNA was isolated from the each of the breast cancer cell lines. RNA quality and purity
was analyzed using a RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of
total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT
thermocycler and the following Taqman Probe set or primer set with iTAQ SYBR Green
Supermix with ROX (Bio-Rad, Hercules, CA): (POLQ) Qexon FWD 5′TGCCTTTCAAAAGTGCCCGGAAGGC3′, Qexon REV 5′TGCCAGTCACCCANATAGTTCNCAT-3′ (where N represents a dSpacer); (POLD1)
HsPOLD1_FWD 5′-CGACCTTCCGTACCTCATCTCT-3′, HsPOLD1_R 5′ACACGGCCCAGGAAAGG-3′, probe 5′-CCCTCAAGGTACAAACAT-3′; (POLN)
HsPOLN_FWD 5’-ACTGATGGTTCCACCCAGCTA-3’, HsPOLN_REV 5’GCGTTTTACTAACACCACAATTCCT-3’, probe 5’-ACCAGACCCCCGTTTCT-3’; HELQ
(Hs00431095_m1); REV3L (Hs01076848_m1); REV7 (Hs01057448_m1); EXO1
(Hs01116195_m1); MCM2 (Hs01091564_m1); RAD51C (Hs00427442_m1). Data were
analyzed using the ∆∆Ct method. GAPDH was used as an internal control in all experiments
and relative quantification analysis was performed with MCF10 cells serving as the nontumorigenic control.
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Transfections and Transductions
293T cells (kindly provided by Dr. Christopher Bakkenist, University of Pittsburgh Medical
School) were plated at 1.5 x105 cells per well in six-well plates and transfected the following
day with 5 µg of either SIGMA Mission shRNA non-targeting control (shCTRL); or five
different shRNAs against POLQ (shQ46, shQ47, shQ48, shQ49, shQ50) using jetPRIME
(Polyplus, New York, NY) according to manufacturer's specifications. 48 h after transfection,
cells were harvested for RNA isolation (RNeasy, Valencia, CA) or for immunoblotting. To
generate lentivirus used for transduction, 2.5 ×106 293T cells were plated and cotransfected
the following day with psPAX2 (6 µg), pMD2G (6 µg), and (12 µg) SIGMA Mission shRNA
vector (shCTRL, shQ46, shQ50) using jetPRIME. One day prior to transduction, HCC1806
cells were seeded into a 10 cm dish at 1.5 ×105 cells with 15 mL complete media. 48 h posttransfection virus-containing media was harvested, filtered through a 0.45 µm syringe filter
and used to replace the media on the plated HCC1806 cells with 15 µL of 4 µg/mL
polybrene (1 µL of polybrene stock per mL of complete media). Cells were incubated in the
virus-containing media for 24 h before being split into T-75 flasks and grown to 80%
confluence before undergoing three weeks of puromycin selection (2.5 µg/mL). Following
selection, pure clones were isolated and cultured with complete media containing puromycin
(1 µg/mL).
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shRNA sequences
shCTRL (SHC002) 5’-CCGGCAACAAGATGAAGAGCACCAACTC-3’

shQ46 (TRCN0000290546) 5’CCGGCCTTCAATCTTGCTTGCGAAACTCGAGTTTCGCAAGCAAGATTGAAGGTTTTTG3’ (anneals to POLQ cDNA sequence 5840:5861)

shQ47 (TRCN0000290547) 5’CCGGCGGGCCTCTTTAGATATAAATCTCGAGATTTATATCTAAAGAGGCCCGTTTTTG-3’
(anneals to POLQ cDNA sequence 2967:2991)

shQ48 (TRCN0000290548) 5’CCGGCGTCGTCTCATTCAAGTGTTACTCGAGTAACACTTGAATGAGACGACGTTTTTG3’ (anneals to POLQ cDNA sequence 7036:7056)

shQ49 (TRCN0000290549) 5’CCGGCCCTGTTACATTCTAGTACATCTCGAGATGTACTAGAATGTAACAGGGTTTTTG-3’
(anneals to POLQ cDNA sequence 2705:2725)

shQ50 (TRCN0000290550) 5’CCGGGCTGACCAAGATTTGCTATATCTCGAGATATAGCAAATCTTGGTCAGCTTTTTG-3’
(anneals to POLQ cDNA sequence 699:719)
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4.3 Results and future work
To evaluate our hypothesis that suppression of POLQ in breast cancer cells confers
radiosensitivity, we chose a number of breast cancer cell lines of different statuses (p53, ER,
PR). We are particularly interested in triple-negative breast cancers (TNBC), which, through
bioinformatics analyses, have been shown to overexpress POLQ and are quite refractory to
treatment. Relevant cells lines from the Basal A (MCF10, MDA-MB-436), B (HCC1569,
HCC1806, HCC1599), and luminal (MCF7, BT-474, MDA-MB361) subtypes were obtained
from ATCC and tested to ensure no mycoplasma contamination. The cell lines were then
analyzed for expression of POLQ and other DNA replication and repair genes (Figure 18A)
with similar expression patterns to POLQ as previously determined through microarray
analysis of breast tumor subtypes.
In the various breast cancer cell lines POLQ was expressed at 8 to 114-fold higher
levels than in the non-tumorigenic MCF10 control cell line (Figure 18B), whereas related
gene family members POLN and HELQ show very little variability in expression amongst all
the cell lines (Figure 18C). Other DNA polymerases are expressed at comparable levels
between the cell lines (Figure 18D and E). Thus, the high degree of POLQ expression in
multiple breast cancer cell lines, including TNBC cell lines, is unique to this DNA
polymerase. These results are consistent with a previous study that also found that POLQ
was the only DNA polymerase significantly overexpressed in multiple breast cancer tumors
(Lemée et al., 2010). However, there was a broad range of expression patterns amongst
different DNA repair genes (EXO1, MCM2, and RAD51C) (Figure 18F).
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Figure 18. Survey of DNA polymerase and repair gene expression in breast cancer
cells. Expression of the indicated genes was quantified by qPCR in multiple breast cancer
cells. Relative quantification of gene expression was determined using Taqman probes,
data was analyzed using the ∆∆Ct method and GAPDH expression was used as an internal
control. Abbreviations: MT (mutated), ER (presence of estrogen receptor), PR (presence of
progesterone receptor), HER2 (amplification of HER2/neu).
Baseline POLQ expression levels have now been established for different breast
cancer cell lines and breast cancer subtypes. These studies provide insight for selecting cell
lines that will be candidates for POLQ-silencing. Initial analysis of shRNAs directed at POLQ
was performed in 293T cells and RNAi-mediated suppression was measured by qPCR
analysis (Figure 19A). Two individual POLQ shRNAs (shQ46 and shQ50) knockdown
POLQ by ~50-60% alone, but did not act synergistically or additively when combined
(Figure 19B).
Efficient shRNA suppression of POLQ is needed in order to test radiosensitivity by
clonogenic assays. Using this method, we wish to test our hypothesis that cell lines with
elevated levels of POLQ will exhibit greater radiosensitivity than cells with reduced POLQ
levels due to shRNA treatment. As a proof of principle experiment to test this hypothesis we
chose to test the HCC1806 cell line, as it had the highest relative level of POLQ expression
when compared to the MCF10 non-tumorigenic control cell line. Stable knockdown and
relevant control cell lines were generated after lentiviral transduction of shRNA constructs
and puromycin selection before testing for POLQ suppression. POLQ transcript levels were
reduced by ~50% in HCC1806 POLQ knockdown cells transduced with either shQ46 or
shQ50 (Figure 19C). Clonogenic survival assays of irradiated cells are currently in progress
to measure radiosensitivity upon suppression of POLQ by shRNA. We may fail to observe
enhanced radiosensitivity in breast cancer cell lines if the shRNA-mediated suppression of
POLQ fails to adequately suppress POLQ.
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Figure 19. shRNA knockdown of POLQ in cancer cell lines. 293T cells were transfected
with either shCTRL non-targeting control shRNA or an shRNA targeted against POLQ
(shQ46-50). RNA was harvested from the cells 48 h post transfection and analyzed for
POLQ expression by qPCR. qPCR analysis was performed in duplicate (A) or triplicate (B)
for the indicated experiments. (C) HCC1806 cells stably knocked down for POLQ by shRNA
were surveyed for POLQ expression in a similar manner. GAPDH was used as an internal
control and ∆∆Ct analysis was performed.

An alternative approach to combat this problem would be to employ CRISPRmediated deletion of POLQ from these cell lines to generate multiple POLQ knockout breast
cancer cell lines. Small molecule inhibitors of POLQ arising from an ongoing screen of
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POLQ inhibitors being performed in conjunction with the Texas Screening Alliance for
Cancer Therapeutics and Texas Institute for Drug and Diagnostic Discovery, will be
screened against the breast cancer cell lines and Polq knockout mouse embryonic fibroblast
(MEF) lines. If POLQ is the rate limiting factor for altEJ, then we hypothesize that small
molecule inhibitors of POLQ will further radiosensitize breast cancer cells with aberrantly
high levels of POLQ (responders) while having a smaller effect on radiosensitivity in those
cells with lower levels of POLQ (non-responders). Specificity of the small molecule inhibitors
will also be verified by looking at the enhancement of radiosensitization of Polq MEFs,
where Polq-proficient MEFs should only show a synergistic increase in sensitivity to ionizing
radiation while Polq-deficient MEFs should have no further increase in radiosensitivity above
their already elevated baseline. A validated compound could then be further analyzed to
understand its interaction with, and mechanism of, POLQ inhibition (catalytic, allosteric,
etc.). This compound could then be used for in vitro studies in Polq-deficient cell lines to
determine if its effects are POLQ-specific. Much work remains to be done but a small
molecule inhibitor of POLQ could be of great clinical value in breast cancer therapeutics by
enhancing radiosensitivity, particularly in TNBC patients, whose tumors already express
aberrantly high levels of POLQ (unpublished data, C. Marcelo Aldaz and Richard Wood),
and are quite refractory to most treatments (André and Zielinski, 2012).
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Chapter 5. A-family DNA polymerases and the repair of x-ray induced DNA damage.
5.1 Introduction
The human genome is under constant attack from both endogenous and exogenous
sources of damage. About 2% of our genome is committed to maintaining genomic stability.
There are more than 175 proteins involved in DNA repair (Friedberg et al., 2006)
(http://sciencepark.mdanderson.org/labs/wood/dna_repair_genes.html). These proteins are
critical in the repair or tolerance of lesions that result from many sources such as
endogenously generated reactive oxygen species or exogenous damage caused by
ultraviolet radiation. The “DNA damage response” is an a collective term for the various
molecular pathways including DNA repair and replication, and cellular checkpoints that
occur after DNA damage. The synergistic activities of these different processes allow cells
to detect DNA damage, arrest cells at given points in the cell cycle and potentially initiate
destruction of the cell if the damage is too great.
Various repair pathways can repair the damage but despite the prominence of these
repair mechanisms, lesions can escape the repair process. These lesions create
roadblocks for the replicative polymerases (α,δ,ε), which catalyze DNA synthesis during S
phase of the cell cycle (Lange et al., 2011). However, the replicative polymerases cannot
bypass the damaged DNA, thereby creating stalled replication forks that can lead to the
formation of double strand breaks. Replication through the damaged DNA is achieved by a
group of enzymes known as translesion synthesis (TLS) polymerases.
The mammalian genome encodes seven polymerases capable of performing TLS in
vitro: PrimPol, pol ζ, pol η, pol ι, pol κ, pol ν, and pol θ. Two models currently exist for TLS:
the one-step model in which a TLS polymerase inserts a nucleotide across from the
damaged template and catalyzes further extension along the template, or the two-step
model, in which one polymerase inserts across the damaged template and falls off, followed

99

by another TLS polymerase extending past the damage (Lange et al., 2011). The presence
of these specialized polymerases suggests that bypass of the DNA lesions is an important
component of DNA damage tolerance.
Human DNA polymerase ν (POLN) is an A-family DNA polymerase related to
Escherichia coli polymerase I. POLN was identified by searching for sequence similarity to
the mus308 Drosophila DNA polymerase (Figure 1) (Marini et al., 2003), which was
identified in a genetic screen for genes that granted resistance to DNA damaging agents
(Harris et al., 1996). The human POLN gene is 160 kb long and encompasses 24 exons
with conservation of C-terminal exons 14-24, producing a 4kb transcript and 900 amino acid
protein. Many inactive alternative splicing variants were found, as a result of exon skipping
or alternative exon inclusion, in cell lines (Marini et al., 2003). POLN is broadly conserved
amongst the vertebrate lineage. POLN possesses DNA polymerase activity in vitro,
including low fidelity DNA synthesis, as well as the ability to accurately and efficiently bypass
thymine glycol DNA adducts and specific protein-DNA crosslinks (Takata et al., 2006;
Yamanaka et al., 2010). By way of northern blot analysis, full-length POLN has been shown
to be present in both human and mouse testes (Marini et al., 2003). Due to its high
expression in testis, POLN may serve as a recombinase for spermatogenesis, which occurs
during meiosis. POLN may not be limited to the testis. Transcripts have also been found in
both human testis (833K) and hematopoietic cell lines from human (K562) and mouse
(L1210) cell lines (Marini et al., 2003). Previously, POLN was reported to play a role in DNA
interstrand crosslink (ICL) repair in human cells (Moldovan et al., 2010; Zietlow et al., 2009),
and a role for POLN in homology-directed repair was proposed in chicken DT40 cells
(Kohzaki et al., 2010). Further analysis is required to determine the in vivo role of POLN in
mammals.
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5.2 Material and methods
Mouse tissue RNA isolation
Wild-type C57BL/6 mice were sacrificed via carbon dioxide euthanasia and
immediately necropsied in order to isolate their organs. The organs were placed into RNA
Later buffer (Ambion) on ice and taken to the laboratory for RNA isolation. The tissues were
flash frozen with liquid nitrogen and ground by mortar and pestle into a fine powder. The
powder was placed into Trizol (Invitrogen) and homogenized using a 16-gauge needle to
lyse the cells. Chloroform extraction (Sigma-Aldrich) was performed to purify the RNA and
concentration was measured by absorbance at 260 nm using a Nanodrop spectrometer.
RNA quality was ensured by first measuring the 260/280 nm ratio and then running 5 µg of
total RNA on a 1% denaturing agarose gel. After ethidium bromide (Sigma-Aldrich) staining
and subsequent destaining, RNA quality was measure by the absence or presence of the
18S and 28S ribosomal RNA bands visualized by UV transillumination using an Alpha
Imager system.

Absolute quantification of Poln expression
1 µg of total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT
thermocycler and the following Taqman Probe set or primer set with iTAQ SYBR Green
Supermix with ROX (Bio-Rad, Hercules, CA): (Poln) FWD 5’GATGTACAAGGATGGTTCCACACA-3’, REV 5’GCCTACATGGCTTTTTAGTAACACTACAAT-3’, probe 5’-AAAGCCTCCTTGGCGCTCA-3’;
(Pold1) FWD 5’-TTTGACCTCCCATACCTCATCTCT-3’,

5’-ACGCGGCCCAGGAAAG-3’,

probe 5’-AAGCGGTCCACCTTTAG-3’ For absolute quantification, titration of
DEST17/MmPolN and pET/MmPold1 plasmids were used to generate standard curves.
Transcript abundance was determined by extrapolation from linear regression analysis of
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best-fit lines from titration experiments. Gapdh was used as an internal control in all
experiments.

B cell culture and CSR analysis
B cells were isolated from mouse spleens (n = 6 per genotype) and stimulated for classswitching, in culture, for 72 h as described in Chapter 2 by Dr. Kevin McBride, Dr. Kei-ichi
Takata, and Shelley Reh. Dr. Takata prepared genomic DNA from stimulated B cells using
the DNeasy kit rather than as described in Chapter 2, but was not able to PCR amplify SµSγ1 CSR junctions. I repurified the DNA by phenol chloroform extraction and PCR amplified
Sµ-Sγ1 CSR junctions were amplified as specified in Chapter 2. The resulting product was
TOPO TA cloned and transformed into Top10 E. coli cells (Life Technologies, Carlsbad,
CA). Plasmids were purified and sent for sequencing using M13 FWD and REV primers in
addition to the primers used for PCR amplification. 50 clones for each group were analyzed
for mutations, deletions, insertions, and sequence overlaps at the junction, and both 30 nt
upstream and downstream of the junction. p-values were determined by using the two-tailed
Fisher's exact test.

Generation and complementation of Poln-/- Polq-/- MEFs
Polq-heterozygous (Polq+/−) mice (Shima et al., 2004) were obtained from Jackson
Laboratories and were crossed to generate Polq-null mice. Mice were maintained in a
C57BL/6J background before being crossed with C57BL/6J Poln-/- mice (developed by Keiichi Takata). Double heterozygous mice (Poln+/- Polq+/-) were crossed to yield double
knockout mice (Poln-/- Polq-/-), which were used for timed pregnancies in order to generate
MEFs. Isogenic primary MEFs were harvested from 13.5 d pregnant females and cultured in
a 2% O2 atmosphere. MEFs were then transfected with 1 µg of pSV-Tag (Lange et al., 2012;
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Sobol et al., 1996; Yousefzadeh et al., 2014) and grown in atmospheric (~20%) oxygen for
six population doublings to allow for immortalization.

DNA damage sensitivity assays
Complemented MEF lines were plated in triplicate into white 96 well plates at 1250 cells per
well and grown overnight using complete media containing puromycin (1 µg/mL). The
following day, cells were cultured with complete media containing the indicated amounts of
bleomycin (dissolved in 150 mM NaCl) or mitomycin c (dissolved in ethanol). After 24 h of
bleomycin treatment, the medium was changed and cells were allowed to recover for 72 h
before cellular viability was measured using the ATPlite 1Step kit (Perkin Elmer, Waltham,
MA) using a Biotek plate reader. Cells treated with mitomycin c were incubated in drug for
48 h before cellular viability was measured. Experiments were repeated three times. Both
bleomycin and mitomycin c were purchased from Sigma-Aldrich (St. Louis, MO).

POLQ gain of function
293T cells were plated at 1.5 x105 cells per well in six-well plates and transfected the
following day with 2 µg of either pCDH/POLQ (Q), pCDH/POLQ-D2330A,Y2331A (P), or
empty vector control (E). The next day, cells were plated in triplicate into white 96 well
plates at 1250 cells per well and grown overnight using complete media. At 48 h posttransfection, cells were cultured with complete media containing the indicated amounts of
bleomycin (dissolved in 150 mM NaCl) for 72 h and cellular viability was measured using the
ATPlite 1Step kit (Perkin Elmer, Waltham, MA) using a Biotek plate reader. Experiments
were repeated three times.
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Immunoblotting
For immunoblots, cells were resuspended in 200 µL of 2X SDS loading buffer (4% SDS,
0.2% bromophenol blue, 20% glycerol, 100 mM Tris HCl pH 6.8, 12% 2-mercaptoethanol)
and heated at 95°C for 5 min. 20 µL of extract was separated on a 4-20% polyacrylamide
gel, transferred to PVDF membrane, blocked, and blotted with anti-αTubulin (Abcam,
Cambridge, UK) ab4074, 1:10,000), anti-FLAG (Sigma F7425, 1:5,000), or anti-POLQ
(MDACC POLQ20, 1:250) antibodies and corresponding secondary antibodies (Sigma
A0168, A0545; 1:10,000), and visualized with ECL reagent (Pierce, Rockford, IL).

2X SDS Loading Buffer
20% Glycerol
4% SDS
0.2% Bromophenol Blue
12% 2-Mercaptoethanol
100 mM Tris-HCl pH 6.8
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5.3 Results
Poln is highly-expressed in testis
To obtain a more definitive and precise picture of Poln expression, Poln transcript
levels were measured using qPCR and absolute quantification (AQ) of Poln in various
mouse tissues. Plasmids were obtained for Pold1 and Poln. These plasmids were used in
respective ABI Taqman assays to create a standard curve of CT values to be able to
determine absolute quantification of transcript level and copy number for Poln and Pold1.
qPCR analysis showed that the highest levels of Poln transcripts were found in the testis
(Figure 20), correlating with prior Northern blot data that suggested Poln expression is only
easily detectable in the testis (Marini et al., 2003). Thus it appears amongst all the mouse
tissues surveyed, POLN is most highly expressed in the testis.
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Figure 20. Absolute quantification of transcript number shows that Poln is highly
expressed in testis. Total RNA was isolated from necropsied C57BL/6 mice by Trizol (Life
Technologies). Transcript abundance for Poln and DNA polymerase delta catalytic subunit
Pold1 was determined by absolute quantification method as described in the Material and
Methods. Gapdh was used as an internal control to normalize samples. Dr. Kei-ichi Takata
and MJY isolated tissues, purified RNA and analyzed qPCR data generated by the Science
Park Molecular Biology Core.

POLN does not operate in the POLQ-dependent altEJ pathway
Within the past few years Dr. Kei-ichi Takata of the Wood Laboratory has generated
constitutive Poln knockout mice (data unpublished). Phenotyping of the mice is still ongoing
and includes everything from aging studies to analysis of cells derived from the mice. Due to
POLN being related to the POLQ gene family, we hypothesized that POLN could play a role
in synthesis-dependent end joining pathway in the repair of DNA DSBs as POLQ does
(Yousefzadeh et al., 2014). To test this hypothesis we performed class switch recombination
analysis on naïve B cells isolated from Poln-deficient and -proficient mice. The frequency of
IgG1+ B cells in mice lacking Poln were comparable to levels found in the wild-type mice, an
observation similar to that observed in the Polq mice (unpublished data, Kei-ichi Takata and
Richard Wood) (Yousefzadeh et al., 2014).
In an effort to bias this end joining-dependent pathway to further utilize alternative
end joining (altEJ), B cells were treated with NU7026, a DNA-PKcs inhibitor that inhibits
classical non-homologous end joining (cNHEJ). While inhibition of DNA-PKcs does increase
the frequency of switch as previously noted (Callen et al., 2009), there was no discernable
difference in switching between genotypes (unpublished data, Kei-ichi Takata and Richard
Wood). In my analysis of CSR junctions, Poln status, unlike Polq status, has no bearing on
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the long insertions into CSR junctions that are thought to be altEJ-dependent (Figure 21)
(Yousefzadeh et al., 2014). Longer insertions that are homologous to nearby sequences are
still found in the absence of POLN (Figure 21, Table 7). Although POLQ may still play a role
in DNA repair, it does not appear to function in the SD-EJ pathway of DNA DSB repair.
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Figure 21. Analysis of CSR junctions in Poln mice. Isolated wild-type (WT)
and Poln−/− (KO) naïve splenic B cells were stimulated for CSR and either mock-treated or
treated with NU7026. Genomic DNA isolated from B cells of wild-type (A) and Poln KO (B)
mice was amplified by PCR and 100 Sµ-Sγ1 junctions from each group were sequenced
and analyzed for overlaps and insertions at breakpoints.
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Table 7. Sequence composition of >1 nucleotide CSR insertions in Poln mice. New
mutations (different from the reference sequence) are shown in red. For some longer
insertions (blue), homologies were identified in the switch region, at the positions indicated
in the right column. Microhomologies at the junction site are underlined. Sequences
(graphed in Figure 21) are from wild-type (Poln+/+) and Poln-null (Poln-/-) splenic B cells that
were treated with NU7026 (Pki) or mock-treated.

Neither POLN nor POLQ alter DSB repair capacity or kinetics in the testis
Based upon knowledge that both Poln and Polq appear to be highly expressed in the
testis (Figure 20) (Yousefzadeh et al., 2014), we hypothesized that both enzymes are
involved in DNA repair in this tissue. The formation of H2AX foci and the resultant p53
signaling that occurs in mouse testis is known to occur independently of DNA-PK,
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suggesting that these γH2AX foci are involved in repair pathways outside cNHEJ (Hamer et
al., 2003). We hypothesize that these foci are formed during altEJ and that POLN, POLQ, or
both enzymes are required for in vivo DSB repair in the testis of mice. Wild-type, Poln, and
Polq-deficient mice were irradiated to study dose response, repair over time and check for
the presence of γH2AX foci in the spermatids of mice. Spermatids are post-meiotic cells and
thus are no longer undergoing programmed Spo11-dependent DSBs, therefore any observe
γH2AX foci should reflect DNA damage inflicted by radiation or spontaneous DNA damage
(Mahadevaiah et al., 2001).
γH2AX foci found in spermatids could either be the result of DSBs or replication
stress (Hamer et al., 2003; Mahadevaiah et al., 2001). As expected γH2AX foci increased in
a dose-dependent manner. Spermatids from the testis of Poln or Polq mice did not display
an elevated level of γH2AX foci above the wild-type mouse upon x-irradiation (Figure 22A).
γH2AX foci reached maximum levels at 30 min post-irradiation before returning to preirradiated levels 48 h later (Figure 22B). Both Poln and Polq mice behaved similar to wildtype mice. This data suggests that POLN and POLQ do not play a prominent role in the
repair of x-ray-induced DSBs in mouse testis. Note that unirradiated Polq mice do have
elevated spontaneous levels of γH2AX foci when compared to control mice (Figure 22).
However it does not appear that POLQ-dependent altEJ plays a significant role in the repair
of DSBs in the testis.
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Figure 22. Loss of Poln or Polq does not dramatically alter DNA repair capacity in
mouse testis. (A) Dose response study of wild-type (WT), Poln, and Polq mice. Mice were
irradiated at the indicated Gy and were sacrificed 0.5 h later. (B) Time course of DNA
repair. Mice were irradiated with 2 Gy and sacrificed at the indicated time points. Testis
were removed post-mortem and sent for immunohistochemical processing. γH2AX foci
were enumerated for 300 spermatids per mouse. 3 mice of each genotype were collected
per data point, yielding a total of 900 spermatids analyzed for each experimental group.
Mouse colonies were maintained by Dr. Kei-ichi Takata, Shelley Reh, and MJY. Mice were
irradiated by Dr. Kei-ichi Takata and MJY and testis were harvested by Dr. Kei-ichi Takata,
Shelley Reh, and MJY. Histologic preparations were made by the Science Park Histology
Core and stained for γH2AX and DAPI by the Science Park Histology Core and Shelley
Reh. Shelley Reh captured 63X immunofluorescence images on DMI6000B Leica
fluorescence microscope. Dr. Kei-ichi Takata, Shelley Reh, Allegra Abbey, and MJY
quantified foci. Data were analyzed by MJY.
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Loss of Poln does not enhance DNA damage sensitivity in Polq-/- cells
We hypothesized that deletion of Poln in a Polq-deficient background could
exacerbate the hypersensitivity to DNA damaging agents seen in Polq-null mouse cells
(Yousefzadeh and Wood, 2013; Yousefzadeh et al., 2014). Poln-/- mice were bred to Polq-/mice to eventually generate Poln-/- Polq-/- mice. The Poln-/- Polq-/- mice are fertile and no
gross alterations to testis morphology based on histologic samples, were found (data not
shown, MJY, Kei-ichi Takata, and Richard Wood). I isolated mouse embryonic fibroblast
(MEF) lines from these mice and along with the appropriate control cell lines, were exposed
to bleomycin and mitomycin c and analyzed for cell survival. Unlike loss of Polq, loss of Poln
did not induce hypersensitivity to bleomycin (Figure 23A). Furthermore, deletion of both
Poln and Polq did not cause a greater increase in bleomycin sensitivity when compared to
the Polq-/- MEFs (Figure 23A). These data suggest that POLN and POLQ are not epistatic to
one another and that POLN does not participate in the same repair pathway as POLQ. Poln
and Polq single or double knockout MEFs did not exhibit hypersensitivity to the ICL-forming
agent mitomycin c (MMC) (Figure 23B). Lack of MMC sensitivity suggests that neither
POLN nor POLQ function in the HR pathway to repair ICLs.
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Figure 23. Loss of Poln does not enhance DNA damage hypersensitivity found in Polq
MEFs. Poln and Polq-proficient and -deficient MEFs, as well as the newly created Poln
Polq double KO MEFs (NQ) were plated in 96 well plates and exposed to either (A)
bleomycin or (B) mitomycin c and cellular ATP levels were measured as a surrogate for cell
survival. Dr. Kei-ichi Takata and Shelley Reh derived and established the Poln MEFs. The
Polq MEFs and Poln Polq MEFs were derived and established by MJY. MJY performed
damage sensitivity assays.

As discussed in Chapter 4, multiple studies have shown that cells lacking POLQ are
hypersensitive to ionizing radiation and DSB-inducing compounds. POLQ confers resistance
to DNA damage through its polymerase activities and participates in an altEJ pathway
(Figure 7, Figure 11-12) (Yousefzadeh et al., 2014). Overexpression of POLQ in the tumors
of breast cancer patients also confers poorer patient outcomes (Begg, 2010; Higgins et al.,
2010a; Lemée et al., 2010). Coupling these facts together, I hypothesized that the aberrant
levels of POLQ observed in these breast cancer patients contributes to their poor outcomes
by making them resistant to DNA damage, possibly through elevated altEJ activity. To test
the hypothesis that aberrant levels of POLQ induces DNA damage resistance, 293T cells
were transfected with POLQ expression constructs to express either wild-type POLQ,
polymerase-dead POLQ, or an empty vector control and assayed for bleomycin sensitivity
(Figure 24). While empty vector control or polymerase-dead POLQ failed to confer
additional bleomycin resistance, ectopic expression of wild-type POLQ conferred increased
resistance to bleomycin. This finding suggests that ectopic levels of POLQ are mediating
DNA damage resistance in cancer cells through use of its polymerase activity and that
POLQ may be the rate limiting factor in POLQ-dependent altEJ.
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Figure 24. Ectopic expression of POLQ in cancer cells induces DNA damage
resistance. (A) 293T cells were transiently transfected with pCDH containing no insert (E),
wild-type POLQ (Q), or polymerase-dead POLQ (P) using jetPRIME (Polyplus) according to
manufacturer’s specifications. Cells were then plated in triplicate in 96 well plates and
exposed to the indicated concentrations of bleomycin for 72 h. Cellular ATP levels were
measured for three independent experiments as a surrogate for survival. (B)
Representative immunoblot of ectopic POLQ levels at the time of damage. αTubulin serves
as a loading control. Cell culture, transfections, immunoblotting, and damage sensitivity
assays were performed by MJY.
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5.4 Conclusion and future directions
The data presented here show that consistent with previous reports, Poln is highly
expressed in the testis (Figure 20) (Marini et al., 2003). This suggests that any in vivo
function for POLN may be detectable only be in the testis. Loss of Poln did not impair class
switch recombination or alter how the breaks are repaired in B cells (Figure 21). While
previous observations demonstrate that longer insertions in the CSR junctions of B cells are
POLQ-dependent (Figure 11) (Yousefzadeh et al., 2014), POLN appears to be dispensable
for the formation of these long insertions in this cell type (Figure 21, Table 7). Although the
polymerase domain of POLN shows homology to those of POLQ and Drosophila Mus308, it
does not appear to operate in the altEJ pathway they do (Figure 21, Table 7) (Chan et al.,
2010; Yousefzadeh et al., 2014; Yu and McVey, 2010). Furthermore, mice lacking Poln do
not show an increase in DNA damage signaling or a persistence of markers of DSBs after
irradiation (Figure 22). Mice lacking Polq do show an increase in DNA damage markers, but
only spontaneously and not upon exposure to ionizing radiation (Figure 22). This finding is
consistent with previous work showing inherent genome instability as measured by
micronuclei formation that spontaneously occur both in the cultured cells and the peripheral
blood of mice lacking Polq (Shima et al., 2004; Yousefzadeh et al., 2014). The lack of
enhanced or persistent DNA damage signaling in spermatids in the absence of POLQ, could
be explained by the fact that the POLQ-dependent SD-EJ pathways does not participate in
the repair of DSBs that occur in murine testis.
Prior reports provided evidence of ICL hypersensitivity upon suppression of POLN by
siRNA in human cancer cell lines (Moldovan et al., 2010; Zietlow et al., 2009). In contrast
with these published reports, we show that MEFs lacking Poln do not display
hypersensitivity to MMC (Figure 23B). This could be a cell-specific effect whereby MEFs
may not show hypersensitivity if they do not form full-length POLN (the majority of
transcripts could be non-functional splicing variants) but POLN may still play a role in the
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repair of ICL-mediated DNA damage. Loss of Poln did not enhance the DNA damage
sensitivity phenotype seen in Polq-null cells and loss of Poln, Polq, nor did both genes did
not affect MMC sensitivity (Figure 23). These results provide evidence that POLN and
POLQ are not epistatic with each other and that POLN does not function in the same altEJ
pathway as POLQ does. Based upon tissue expression data (Figure 20) and a suggested
function for POLN in homology-directed repair (Kohzaki et al., 2010), a role for POLN in
meiotic recombination may exist, but any evidence is lacking.
We have yet to find an unequivocal phenotype for mice lacking Poln, this may be
because Poln mice have an extremely subtle phenotype, or the redundancy of other
specialized DNA polymerases (or other DNA repair pathways) in mammals masks the
effects of Poln deficiency. The original intent of crossing the Poln mice to the Polq mice was
that loss of Poln would further stress the Polq mice and allow insight into the in vivo function
of POLN. Unfortunately, this exacerbation of the Polq phenotype did not occur and leaves
us with no phenotype for the Poln mice. Though they are related DNA polymerases, POLN
and POLQ do not appear to have similar functions in the cell. Crossing the Poln mice to
other mutants like Rev1 mice may give insight as to POLN’s function in the cell.
POLN was previously reported to interact with components of the Fanconi anemia
(FA) pathway (Moldovan et al., 2010) and Drs. Kei-ichi Takata and Junya Tomida found
interaction between POLN and FANCJ (unpublished data, Drs. Kei-ichi Takata, Junya
Tomida, and Richard Wood). While we have been unable to detect hypersensitivity of POLN
to ICL agents, the interaction with FANCJ may still be explained in a plausible fashion
(Figure 23B). It is known that FANCJ is quite adept at unwinding G-quadraplexes (G4) and
this activity occurs independently of the rest of the FA pathway (Brosh and Cantor,
2014). FANCJ could be opening up these G4s for specialized DNA polymerases (like POLN)
to synthesize through these structures. The lack of a significant detectable phenotype
in Poln knockouts could be explained through functional redundancy of the polymerases.
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For example, REV1 is the primary DNA polymerase involved in replicating past difficult G4mediated replication blocks in chicken DT40 cells (Sarkies et al., 2012); therefore, deletion
of Rev1 would lead to the cell using other specialized DNA polymerases like POLN in order
to replicate G4 sites in DNA. If so, then a severe replicative stress phenotype might be seen
in mice that lack both Rev1 and Poln.
While a role for POLN in the repair of ionizing radiation-induced DNA damage has
yet to be substantiated, one clearly exists for POLQ. As discussed in Chapters 2 and 4,
POLQ mediates the repair of DSBs through participation in an altEJ pathway and
overexpression of POLQ in breast cancer confers poorer outcomes (Lemée et al., 2010;
Yousefzadeh and Wood, 2013; Yousefzadeh et al., 2014). Preliminary evidence presented
in this chapter demonstrates that aberrantly high levels of POLQ confer DNA damage
resistance to cancer cells (Figure 24). This could mimic what is occurring in these breast
cancer patients with elevated POLQ levels, suggesting that chemoresistance may be the
mechanism that is conferring their poorer outcomes, but many other genes are also coupregulated in cancer. Further analysis is needed to understand the detailed mechanism of
how POLQ-dependent end joining promotes DSB repair and why elevated POLQ
expression has a negative impact on patient outcomes in breast cancer.
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Chapter 6. Generation and validation of human POLQ antibodies.
Note: This chapter discusses the generation of human POLQ antibodies that was discussed
in Chapter 2 and used in subsequent chapters, in addition to other antibodies that were
used in the laboratory.
6.1 Introduction
A valuable tool for studying the function of POLQ in cells is an antibody that
recognizes endogenous POLQ with great specificity. Until recently, an antibody that
recognizes endogenous POLQ in immunoblots or for immunoprecipitation studies, was
unavailable (Fernandez-Vidal et al., 2014). The Wood laboratory previously produced a pair
of rabbit polyclonal antibodies (NT and CEN) that were raised against fragments of
recombinant human POLQ (Seki et al., 2003), but the supply of these two antibodies was
exhausted. Our lab endeavored to generate a new series of antibodies against POLQ and
set upon making monoclonal antibodies in order to create a POLQ antibody that had great
specificity.
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6. 2 Material and Methods
Please note that this section is written as a protocol for persons that may be trying to repeat
these experimental procedures.

Note on centrifugation:
Cells were centrifuged in Thermo Sorvall Legend RT+ in Sorvall Heraeus swinging bucket
rotor at 1000 or 3000 rpm. At the bench top, lysates were centrifuged in an Eppendorf 5424
R centrifuge at 15000 rpm / 21,000xg.
Note on lysates:
All lysates were mixed 1:1 with 2X SDS loading buffer and heat denatured at 95°C for 5 min.

Western Blot Protocol
Use 4-20% TGX gels from Bio-Rad
-Run gel at 150 V for 1-1.5 h.
-Transfer to PVDF Immobilon at 20 V overnight or 30 V for 3 h in transfer buffer (1X TrisGlycine + 10% methanol) at 4° C.
-Block 1 h in 10% milk TBST.
-Incubate in primary antibody overnight (in TBST, no milk) at the indicated concentration at
4° C. Antibodies are also stored in 1X TBST with 1:400 dilution of 5% sodium azide.
-Wash three times in 1X TBST for 5 min.
-Incubate in secondary anti-mouse (A0168) or anti-rabbit (A0545) antibody (Sigma-Aldrich)
(1:10,000 dilution in 5% milk TBST) for 1.5-2 h at room temperature.
-Wash three times in 1X TBST for 5 min.
-Visualize with ECL.
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Nuclear Extract Preparation
Cells are trypsinized and neutralized with media.
-Pellet cells in Sorvall, 1000 rpm, 5 min, 4°C.
-Wash pellet with PBS. Count cell number, need at least 2 x108 cells for extracts, but can
make larger extract preps.
-Pellet cells in Sorvall, 1000 rpm, 5 min, 4°C.
-Wash pellet with Hypotonic Buffer.
-Pack cells in Sorvall, 3000 rpm, 5 min, 4°C.
-Add 2 packed cell volumes of Hypotonic Buffer and resuspend cells.
-Homogenize 10X slowly in 7 mL Wheaton Dounce Homogenizer (Tight). Check lysis by
trypan blue staining.
-Centrifuge in Sorvall 13000 rpm, 15 min, 4°C.
-Collect supernatant as cytosolic fraction.

___________ mg/mL

-Wash pellet in 5-10 volumes of Hypotonic Buffer.
-Pellet cells in Sorvall 13000rpm, 5 min, 4°C.
-Resuspend in 2 volumes of Nuclear Extract Buffer.
-Homogenize 10X slowly in 7 mL Wheaton Dounce Homogenizer.
-Incubate on rotation for 30”.
-Spin 13000 rpm, 15 min, 4°C.
-Collect supernatant as NE1.

___________ mg/mL

-Store extract in minus 80 freezer.
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Hypotonic Buffer

Nuclear Extract Buffer

10 mM HEPES, pH 7.9

10 mM HEPES, pH 7.9

10 mM KCl

0.42 M NaCl

1.5 mM MgCl2

1.5 mM MgCl2

0.5 mM PMSF

0.5 mM PMSF

1 mM DTT

1 mM DTT
10% Glycerol

Roche Protease Inhibitor Cocktail Tablet

Roche Protease Inhibitor Cocktail Tablet

Notes:
Roche Protease Inhibitor Cocktail Tablet (Catalog # 11 836 170 001)
Adapted from (Dignam et al., 1983; Lee et al., 1988).
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Whole Cell Extract Preparation
-Resuspend 5 x106 cells in 40 µL of Lysis buffers and incubate on ice in the cold room for 30
minutes.
-Centrifuge 13,000 rpm, 15 min, 4°C
-Collect supernatant as whole cell extract.

Whole Cell Extract Buffer
50 mM Tris-HCl pH 7.5
0.25 M NaCl
1 mM EDTA
0.5 mM PMSF
0.1% Triton X-100
Roche Protease Inhibitor Cocktail Tablet
Protocol adapted from (Welsh et al., 2004).

Transfection of 293T cells and Crude SDS Lysate Preparation
-1.5 x105 293T cells were plated into each well of a 6-well dish.
-The following day, cells were transfected with 2 µg of either pCDH/empty vector control or
pCDH/POLQ.
-48 h post-transfection cells from one well of a 6 well plate were resuspended in 200 µL of
2X SDS Loading Buffer.
-Heat denature at 95°C for 5 min.
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Immunoprecipitation Protocol
-Plate 1.5 x106 293T cells into four 10 cm dishes with 10 mL of complete media (DMEM).
-The following day, cells were transfected with 10 µg of either pCDH/empty vector control or
pCDH/POLQ.
-48 h post-transfection, scrape cells in 1X PBS. Centrifuge 3,000 rpm, 5 min, 4°C.
-Resuspend cells in 200 µL per dish in IP Lysis Buffer. Vortex for 30 seconds and agitate in
the cold room for 15 minutes. Centrifuge 13,000 rpm, 15 min, 4°C.
-Collect supernatant. Determine concentration.

___________ mg/mL

-Collect 25 µL and add 1:1 volume of 2X SDS Lysis Buffer. Heat denature at 95°C for 5 m.
-Wash 50 µL (per sample) FLAG-Dynabeads three times in IP Buffer.
-Use 5 mg of protein in 2 mL total volume for IP. Incubate overnight on rotation in cold room.
-Wash 3X in IP Wash Buffer.
-Add 50 µL of 2X SDS Lysis Buffer to beads and heat denature at 95°C for 5 m.
-Transfer liquid to new tube and freeze.
-For immunoblot: Load 10 µL of input (30 g total protein) and 25 µL IP product.
IP Lysis Buffer

IP Buffer

IP Wash Buffer

50 mM Tris-HCl pH 7.5

50 mM Tris-HCl pH 7.5

50 mM Tris-HCl pH 7.5

0.15 M NaCl

0.15 M NaCl

0.15 M NaCl

1 mM EDTA

1 mM EDTA

1 mM EDTA

0.5 mM PMSF

0.5 mM PMSF

0.5 mM PMSF

1% Triton X-100

0.2% NP-40

0.2% NP-40

Please add a Roche Protease Inhibitor Cocktail Tablet to each buffer before use.

Adapted from protocol of Arijit Dutta of Sankar Mitra’s Lab (Houston Methodist Research
Institute).
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Immunofluorescence
-1.5 x104 293T cells were plated into 4-well chamber slides (LabTek).
-The following day, cells were fixed in 2% p-formaldehyde for 10 min at room temperature.
-Rinse slides with 1X PBS.
-Permeabilize cells in 1X PBS + 0.2% Triton X-100 for 2 min at room temperature.
-Block for 30 m in 1X PBS + 0.2% Triton X-100 + 5% BSA at room temperature.
-Dilute primary antibody to 1:100 in 1X PBS + 0.2% Triton X-100 + 5% BSA and incubate
overnight at 4°C.
- Wash slides in 1X PBS + 0.2% Triton X-100 for 5 min at room temperature.
- Dilute secondary antibody (Molecular Probes Anti-mouse AlexaFluor-488) to 1:1,000 in 1X
PBS + 0.2% Triton X-100 + 5% BSA and incubate 1 h at room temperature.
- Wash slides in 1X PBS + 0.2% Triton X-100 for 5 min at room temperature.
-Mount with Vectashield + DAPI (Vector Labs) [Note dilute Vectashield + DAPI 1:5 in
Vectashield without DAPI. Or better yet, just DAPI stain and wash to clear up heavy DAPI
background.].
-Paint edges of slides with nail polish.
Adapted from (Bhagwat et al., 2009).

2X SDS Loading Buffer
20% Glycerol
4% SDS
0.2% Bromophenol Blue
12% 2-Mercaptoethanol
100 mM Tris-HCl pH 6.8
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6.3 Results
Matthew Hogg of Sylvie Doublié’s laboratory (Univ. of Vermont) graciously provided
us with a fragment of recombinant POLQ (Figure 25A) that possessed polymerase activity
(Hogg et al., 2011). This recombinant fragment was expressed in E. coli and was used to
generate antibodies against POLQ. The MDACC antibody core and Epitomics respectively
generated the mouse and rabbit monoclonal antibodies, respectively. A SUMO3 fusion tag
protein made from the same vector (Life Sensors) as the recombinant fragment was sent to
both sites as a control protein for ELISA screening. Over 80 mouse hybridoma clones that
were positive by ELISA were provided to me for further screening (Figure 25B). I
immunoblotted the recombinant protein fragment used to immunize the mice with the
supernatants from the hybridoma clones (Figure 25B) and narrowed the selection down to
13 different mouse monoclonal antibodies that underwent further purification and analysis
(Table 8). The rabbit monoclonal antibodies were screened in a similar fashion (Figure
25C). The purified mouse monoclonal antibodies were then screened against whole cell
and nuclear extracts from various cell lines (Figure 25D-F) as well as recombinant fulllength POLQ (Figure 25G).
Each monoclonal antibody recognizes a band larger than 250 kDa that might
represent full-length POLQ. Attempts to determine whether any of these bands are
endogenous POLQ by siRNA suppression have yielded variable results (Figure 25H). Each
of the monoclonal antibodies was epitope mapped by Shelley Reh using peptide arrays from
JPT (Figure 26, Table 8). The POLQ20 antibody was predominantly used for
immunoblotting in the laboratory because it maps near motif 1 and insert 1 of the
polymerase domain of POLQ (Figure 26, Table 8), and provides high sensitivity and low
background on immunoblots. It may be useful for immunoprecipitation experiments (Figure
25F-I). The POLQ20 antibody is able to recognize recombinant human POLQ, high
molecular weight bands (>250 kDa) in whole cell extracts that could be consistent with
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endogenous POLQ. POLQ20 recognizes no bands that correspond to full-length POLQ
when immunoblotted against extracts made from MEFs (Figure 27). All mouse monoclonal
hybridoma cell lines are stored at the MDACC monoclonal antibody core facility in Houston
and purified POLQ monoclonal antibodies are stored in my -80° C storage. A monoclonal
antibody against POLQ (pol θ 1B1) provided by Jean-Sebastién Hoffman was screened with
various extracts and recognizes a band very similar to the POLQ20 (Figure 28) (FernandezVidal et al., 2014). This antibody is able to recognize recombinant POLQ but recognizes
higher molecular weight bands sporadically upon very high levels of exposure, making it a
less than ideal antibody for use.
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Figure 25. Screening of human POLQ antibodies. (A) Schematic of the QLH fragment of
POLQ that was used to immunize rabbits and mice to generate monoclonal antibodies. (B)
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Primary screening of raw mouse monoclonal supernatants by immunoblotting against 150
ng of purified QLH fragment. + symbols below immunoblots represents the initial ELISA
analysis of monoclonal antibodies (++++ being the highest score and + being the lowest
score. (C) Rabbit monoclonal supernatants from Epitomics were similarly screened. (D)
Purified monoclonals, including one from Jean-Sebastién Hoffman are immunoblotted
against 75 µg of RKO whole cell extracts (WCE). POLQ83 and POLQ20 mouse monoclonal
antibodies were screened against (E) 100 µg WCE from HeLa and 293T cells, (F) 35 µg
nuclear extract 1 and 100 µg WCE from 293T cells, and (G) 10 µL of recombinant POLQ
preps purified from baculovirus-infected insect cells. (H) RKO cells were transfected with
non-targeting siRNA (siCTRL), a pool of 4 siRNAs (siPOLQ), or a single siRNA (siQ6)
against POLQ. WCE were made 48 h post transfection and 100 µg were immunoblotted with
the POLQ20 mouse monoclonal antibody. The band below just above the 250 kDa marker
is putatively thought to be POLQ. (I) Immunoblot of FLAG-IP experiment with 293T cells
transiently transfected with either pCDH/POLQ or empty vector control. Arrow denotes fulllength POLQ. All gels are 4-20% polyacrylamide gels (E is a 5% polyacrylamide gel).

Antibodies
Epitope
MOUSE MONOCLONAL ANTIBODIES1
POLQ20*
POLQ5
POLQ12
POLQ16**
POLQ35
POLQ46
POLQ58
POLQ78
POLQ81
POLQ83**
POLQ88

Amino Acid #
(MDACC ANTIBODY CORE)

(REMKN)
(QPGESYLFGS)
(QPGESYLFGS)
(PRDFEIKMP)
(LNTGADVFRS)
(VNPWK)
(TSASK)
(QPGESYLFGS)
(VNPWK)
(VNPWK)
(VNPWK)
(PRDFEIKMP)
(LNTGADVFRS)
(VNPWK)

2147:2151
1767:1776
1767:1776
2246:2254
2345:2354
1757:1761
1742:1746
1767:1776
1757:1761
1757:1761
1757:1761
2246:2254
2345:2354
1757:1761
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Hoffman antibody from 2014 Nature Communications
Antigen
pol θ 1B1
(CSIFRARKRASLDINKEKPG)
RABBIT MONOCLONAL ANTIBODIES2
MDA7-8-4
MDA7-8-8
MDA7-8-12
MDA7-14-6
MDA7-14-7
MDA7-14-8
MDA7-15-2
MDA7-15-7
MDA7-15-8
MDA7-16-2
MDA7-16-6
MDA7-16-8
MDA7-36-2
MDA7-36-7
MDA7-36-8
MDA7-37-7
MDA7-37-8
MDA7-37-10

(EPITOMICS)

(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(IGFSTAECESQKHIM)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)
(N/A)

RABBIT POLYCLONAL ANTIBODIES3

983:1002

2092:2106

(CELL SIGNALING TECHNOLOGIES)

CST PP3***
CST PP16****
CST PP27***
CST PP28***
CST PP36*****
RABBIT POLYCLONAL ANTIBODIES4

(BETHYL LABORATORIES)

BL18474
BL18475
BL18476
BL18477******
1

I typically use the mouse monoclonal antibodies at a dilution between 1:250-1:500 for
western blotting and the pol θ 1B1 mouse monoclonal antibody and the rabbit polyclonal
antibodies are recommended for use at 1:10,000 and 1:1000 dilutions. Epitopes to human
POLQ are listed above, amino acid in red denote deviations from homology between human
and mouse POLQ.
*Best antibody for western blotting, it is the most sensitive of the panel and has the least
background.
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**Both POLQ 16 and POLQ83 epitope map to where the secondary antibody control binds
on the QLH fragment but with much greater affinity.
2

Rabbit monoclonal hybridoma lines that were raised against the QL fragment by Epitomics
are currently stored in liquid nitrogen storage on site and with Cryogene. All of the
hybridomas recognize a high molecular weight band in 293T cells that could be consistent
with full length POLQ. Of these antibodies MDA7-15-8 was selected and sent to the
MDACC antibody core for ascites production and purification and epitope mapping. The
rest of the rabbit monoclonal antibodies still need to be epitope mapped for future use.
Epitomics clones are described by Project #-Original hybridoma clone #-Subclone #.
Therefore for MDA7-15-8, it is the 8th subclone of original clone 15 for the MDA7 project.
These hybridomas were generated from a single rabbit.
3

Rabbit polyclonal antibodies were generated by Cell Signaling Technologies using multiple
unknown peptide sequences of POLQ. Purportedly PP36’s epitope is conserved between
human and mouse. PP36 recognizes recombinant POLQ but with a lower affinity when
compared to the POLQ20 mouse monoclonal antibody. All of the antibodies recognize
recombinant POLQ seen in lysates from 293T cells transfected with either empty pCDH
vector or pCDH/POLQ by MJY. As of July 2014 the rabbits producing the PP16 and PP36
were moved into the monoclonal antibody production pipeline.
***PP3, PP27, and PP28 appear to be unsuitable as they fail to recognize bands above
~250 kDa in 293T and HeLa extracts.
**** PP16 antibody has a high background.
*****PP36 recognized a high molecular weight band that may be endogenous POLQ in 293T
cells but not in HeLa cells.
4

Rabbit polyclonal antibodies were generated by Bethyl Laboratories using multiple
unknown peptide sequences of POLQ. Purified antibody was sent to us and used at a
1:5,000 dilution for immunoblotting.
******BL18477 did not recognize recombinant POLQ in lysates from 293T cells transfected
with pCDH/POLQ. I would not recommend using this antibody.
Table 8: Human POLQ antibodies. Epitope sequences and amino acid numbers are
shown for each antibody. Amino acid residues in red are those that differ between human
and mouse.
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A

C
1740

POLQ46/77
(1742:1746)

~Central Domain
Chaos1

POLQ35/58/78/81/88
(1757:1761)

POLQ5/12/46
(1767:1776)

Hoffman polθ-1
(983:1002)
immunoblotting

Hoffman polθ-2
(1714:1733)
immunoprecipitation

B

MDA7-15-8
(2092:2106)

Motif 1
Insert 1

POLQ20
(2147:2151)

Motif 2

POLQ16/83
(2345:2354)

Motif 3

Motif 4

Polymerase Domain
Insert 2

POLQ16/83
(2246:2254)

Motif 6

Insert 3

Motif 5

2590
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Figure 26. Epitope mapping of human POLQ antibodies. JPT epitope mapping
microarray containing peptides that correspond to the antigen sequence is diagramed (A)
where 11 amino acid peptides are covalently attached to slide. (B) These peptides overlap
by 7 amino acids (shown in red) with the preceding peptide in order to specifically determine
the epitope site for each of the antibodies that were mapped. (C) Schematic of the QLH
fragment of POLQ showing the location of where each monoclonal antibody maps. Amino
acid numbers of epitope sites are shown in parentheses with the corresponding antibody.
Epitope mapping was performed and analyzed by Shelley Reh and MJY.
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Figure 27. Screening of human POLQ rabbit polyclonal antibodies from Cell Signaling
Technologies. POLQ20 mouse monoclonal antibody and three rabbit polyclonal antibodies
raised against POLQ peptides (CST3, CST16, CST36) were immunoblotted with: 10 µL of
crude SDS lysates from 293T cells transfected with either pCDH/empty vector control or
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pCDH/POLQ; 100 µg WCE from 293T, RKO, Polq-proficient (+/+) and deficient (-/-) mouse
embryonic fibroblasts.

Recently we have collaborated with Cell Signaling Technologies (CST) on human
POLQ antibodies (Table 8). We received multiple rabbit polyclonal antibodies raised
against different POLQ peptides for validation (CST PP 3, 16, 36). Each of the three
antibodies recognized recombinant POLQ, as did the control mouse monoclonal POLQ20
antibody (Figure 27). The antibodies also recognized bands above 250 kDa in whole cell
extracts but were unable to recognize a band specific to endogenous mouse POLQ. As of
September 2014, CST was utilizing our data to move the antibodies into their monoclonal
antibody production pipeline.
Human POLQ rabbit polyclonal antibodies from Bethyl Laboratories were also
screened in the laboratory (Table 8). Three of the four antibodies provided by Bethyl
Laboratories recognized recombinant POLQ (Figure 28), as did the mouse monoclonal
antibody controls (POLQ20, pol θ 1B1). The Bethyl antibodies yield a high amount of
background using the specified conditions and would need further purification (affinity
purification with recombinant POLQ) or dilution before further use.
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Figure 28. Screening of human POLQ rabbit polyclonal antibodies from Bethyl
Laboratories. POLQ20 and pol θ 1B1 mouse monoclonal antibodies and four rabbit
polyclonal antibodies (BL18474-7) raised against POLQ peptides by Bethyl Laboratories
were immunoblotted with 3 µL of crude SDS lysates from 293T cells transfected with either
pCDH/empty vector control or pCDH/POLQ.
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Figure 29. Cell staining and immunofluorescence with human POLQ antibodies. 293T
cells were fixed and stained with the indicated mouse monoclonal antibodies and AlexaFluor
488 conjugated secondary before stained with DAPI and imaged.
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6.4 Conclusion and future directions
Moving forward, there are many applications for which these antibodies against
POLQ could be of great use. These antibodies would be useful for immunofluorescence
(Figure 29), immunoprecipitation (Figure 25I), and potentially immunohistochemical staining
of human tissues. However, further validation of these antibodies is needed and proper
POLQ human knockout cell line would be vital to confirm specificity of these antibodies. Dr.
Kei-ichi Takata and Mrs. Shelley Reh (Wood laboratory) are currently generating POLQ
human knockout cell lines. These cell lines could be the key reagent to screening the POLQ
antibodies to find an antibody clone that recognizes POLQ with great sensitivity and
specificity. Then a validated antibody could be used to further determine subcellular
localization of POLQ, its interaction partners, and potentially any relevant post-translational
modifications that modulate its activity.
As it stands, the POLQ20 mouse monoclonal antibody appears to be the most
suitable for detecting human POLQ. This is based upon the high degree of sensitivity and
modest background levels observed when immunoblotting with this antibody as well as its
ability to recognize recombinant human POLQ and high molecular weight bands in an
extract (Figure 25, Figure 27). Only POLQ20 and POLQ83 mouse monoclonal antibodies
have been used in the immunoblotting of extracts made from MEFs. While both antibodies
recognize high molecular weight bands, they do not appear to be specific to POLQ. The
possibility that one of other mouse monoclonal antibodies against POLQ that were
generated by the MD Anderson Monoclonal Antibody Core recognizes endogenous mouse
POLQ is possible as they have not been immunoblotted with extracts from the MEFs. My
frank suggestion is avoid using the pol θ 1B1 mouse monoclonal antibody. It does not
reliably recognize high molecular weight bands in whole cell extracts of Polq MEFs or
HCT116 cells. Until a POLQ antibody has been properly vetted we must maintain a healthy
dose of skepticism with regard to immunoblotting results with antibodies against POLQ
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Chapter 7. Future directions.
7.1 POLQ maintains genomic integrity through its altEJ activity
Genetic screens have shown that POLQ and its homologs in C. elegans and
Drosophila are key components of an alternative end joining pathway that facilitates the
repair of DNA double strand breaks (DSBs) (Figure 5, Figure 12) (Koole et al., 2014;
Yousefzadeh et al., 2014; Yu and McVey, 2010). This repair pathway, termed synthesisdependent end joining (SD-EJ) or synthesis-dependent microhomology-mediated end
joining (SD-MMEJ), relies upon POLQ-dependent DNA polymerization to extend
enzymatically-processed 3’ DNA ends to create a novel microhomology. This homologous
region can then anneal to the other 3’ end from the DSB (Yousefzadeh et al., 2014). This
complex nucleotide insertion relies upon the presence of a free 3’ end (whether it be from
the other end of the break or from another free DNA end) to provide a suitable template for
creating the “insertion” (Chan et al., 2010; Yousefzadeh et al., 2014; Yu and McVey, 2010).
This alternative end joining pathway appears to be suppress to the formation of large
deletions and chromosomal translocations (Roerink et al., 2014; Yousefzadeh et al., 2014).
Consistent with this idea, we observed a four-fold increase in the frequency of Myc/IgH
translocations murine B cells deficient for Polq (Yousefzadeh et al., 2014).
This finding call into question the current paradigm that alternative end joining in toto
is responsible for the formation of potentially oncogenic translocations. Many oncogenic
translocations found in patients contain microhomologies in their breakpoint junctions
(Bunting and Nussenzweig, 2013; Weinstock et al., 2006). The subset of broken DNA ends
that ultimately give rise to chromosomal translocations are hypothesized to be formed
primarily through the microhomology-mediated end joining pathway (MMEJ) subpathway
(Bunting and Nussenzweig, 2013). MMEJ relies upon the broken DNA ends annealing at
existing microhomologies with only minimal end processing (flap trimming, gap filling,
ligation) (Decottignies, 2013). The POLQ-dependent altEJ pathway, which prevents
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translocations, is distinct from the MMEJ repair pathway that promotes chromosomal
translocations. While no definitive data have been presented to suggest that POLQ has a
role in MMEJ, we cannot exclude this possibility. We observed a ten-fold decrease in the
repair of substrates with 3’ DNA ends containing 4-nucleotide terminal microhomologies in
when Polq was absent (Figure 12) (Yousefzadeh et al., 2014). This finding still allows for a
role for POLQ in MMEJ in addition to SD-EJ which is supported by recent biochemical
evidence showing that POLQ can perform MMEJ with substrates that contain 3’ singlestranded overhangs with at least two nucleotides of homology (Kent et al., 2015).
Why chromosomal translocations form in the absence of POLQ is still unclear.
Translocations could form because in the absence of POLQ: (1) DNA breaks persist and
eventually free 3’ DNA ends find each other and anneal at a microhomology to create a
translocation or (2) there is a class of DNA ends that is preferentially handled by POLQdependent SD-EJ and are those that form translocations in the absence of POLQ. Further
analysis of translocations as proposed in Chapter 3 of this thesis will help clarify how these
translocations are formed. A recent study, reported a decrease in insertions at an artificial
translocation generated by CRISPR/Cas9 in Polq-null MEFs, however the overall frequency
of translocations was decreased in the absence of Polq (Mateos-Gomez et al., 2015). It
would be interesting to know how POLQ status affects translocations at naturally occurring
breaks versus those that are generated through site-specific nucleases.
NGS studies of translocations that occur in mice lacking Tp53 and Polq may
demonstrate preferential genomic sites, secondary structures, and sequence specificity that
facilitates Myc/IgH translocations. Human knockout cell lines, currently being developed by
Kei-ichi Takata, could provide insight into the apparent dichotomy that altEJ drives for in vivo
translocations in mice, whereas, cNHEJ drives translocations in human cell lines (Ghezraoui
et al., 2014).

138

By understanding which proteins POLQ interacts with, we may gain a better
understanding as to how POLQ operates in SD-EJ and the repair of DSBs. So far POLQ
has only been shown to interact with the replication origin proteins ORC2 and ORC4
(Ramiro et al., 2007). Preliminary data from our collaborator, Dr. Sankar Mitra (Houston
Methodist Research Institute), suggests that POLQ interacts with the DNA repair protein
XRCC1. XRCC1 is known to interact with DNA Ligase III and DNA polymerase β (Rice,
1999), and the XRCC1-pol β interaction is regulated by HSP90 (Fang et al., 2014).
Therefore further investigation of the putative POLQ-XRCC1 interaction may also lead to
discovery that HSP90 also interact interacts with POLQ. A proteomics approach to
understand the role of POLQ in altEJ is well warranted. Many of the other key proteins
involved in altEJ (MRN complex, PARP, XRCC1, DNA Ligases I and III) are also involved in
other DNA repair pathways and thus make genetic analysis more difficult to tease out the
effects on altEJ (Decottignies, 2013). Phenotypes of certain genetic crosses with Polq (ex.
XRCC6) could be problematic as loss of both Atm and Polq causes synthetic lethality in
mice. Understanding the detailed mechanism of alternative end joining pathways will give
better clarification to how these pathways act and the regulation of alternative end joining
with respect to classical non-homologous end joining and HR repair of DNA double-strand
breaks.
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7.2 POLQ diversifies the immunological portfolio
DNA polymerases play a vital role in adaptive immunity in order to help mammals
cope with a multitude of pathogenic insults. Following VDJ recombination, the variable
regions of immunoglobulin genes are further diversified through the somatic hypermutation
pathway (SHM). SHM relies upon AID-catalyzed deamination of cytosine to generate uracils
in the variable region that are processed by UNG to yield abasic sites that are further
enzymatically processed. These nucleotide gaps are then filled in by specialized DNA
polymerases (Weill and Reynaud, 2008). POLQ was thought to generate most of the A/T
mutations found in the variable region of murine B cells, but upon later examination, this
class of mutations was largely pol η-dependent (Martomo et al., 2008; Seki et al., 2005). A
role for POLQ in SHM may exist whereby POLQ is required to generate SHM-associated
indels, as discussed below.
Class switch recombination (CSR) is a programmed break rejoining in the constant
region of the immunoglobulin locus. This mechanism allows isotype switching enabling
antibodies to interact with different effector molecules without modifying antibody specificity
(Bunting and Nussenzweig, 2013; Weill and Reynaud, 2008). Investigation of POLQ function
in CSR showed that although cells lacking POLQ continue to switch at a normal frequency
compared to their wild-type counterparts, the junctions are different (Martomo et al., 2008;
Yousefzadeh et al., 2014). Sequencing of the Sµ-Sγ1 junctions showed that up to 10% of
CSR junctions in wild-type mice contained insertions longer than a single nucleotide, and
these insertions were dependent upon POLQ (Figure 11) (Yousefzadeh et al., 2014). Such
insertions form in an altEJ dependent manner (Callen et al., 2009). Our findings support that
these insertions arise from POLQ-dependent SD-EJ (Yousefzadeh et al., 2014). Consistent
with prior findings, we identified also homologies to nearby sequences around the break in
these longer insertions (Table 4) (Callen et al., 2009; Yousefzadeh et al., 2014). At least for
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CSR junctions, POLQ is responsible for creating the inserted sequences but it may be
creating insertions elsewhere in immunoglobulin genes.
Insertions and deletions (indels) that form as a result of SHM, termed SHMassociated (SHA-) indels, represent an understudied but important mechanism of
immunological diversity. While most of the purposeful mutations that arise in SHM are point
mutations, indels are observed in variable regions at a low frequency (2-6%) (Briney et al.,
2012; Wilson et al., 1998). These indels, which are created through AID-mediated breaks,
are thought to be a radical new way in which to further evolve our antibody repertoire
(Bowers et al., 2014). Currently, it is unknown which polymerase(s) induce these indels in
the V regions. However, given that long insertions found in CSR junctions are POLQdependent (Yousefzadeh et al., 2014) given evidence that POLQ can cause frameshifts in
vitro (Arana et al., 2008), we hypothesize that POLQ is the DNA polymerase responsible for
the creation these SHA-indels.
SHA-indels are commonly found in the complementarity determining region of
antibodies. This is the region where the antibody interacts with the antigen. On rare
occasions these SHA-indels are found in the antibody framework regions, which act as the
structural scaffold for the antibody (Klein et al., 2013). Indels in the framework regions are
generally poorly tolerated, but in rare instances they give rise to unique antibody abilities.
One such unique ability is the creation of broadly neutralizing antibodies. Broadly
neutralizing antibodies that feature nucleotide insertions in their framework regions are
responsible for highly effective responses to pathogens like influenza, HIV-1, and S.
pneumonia (Krause et al., 2011; Reason and Zhou, 2006; Yu et al., 2008). These
framework indels are thought to create new and unconventional ways for antibodies to
interact with antigens and notably, deletion of these indels ablates their broadly neutralizing
capacity (Klein et al., 2013). Whether POLQ is involved in this rare but distinct mechanism of
increasing immunological diversity remains to be seen. The NGS experiments proposed in
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Chapter 3 will investigate the whether POLQ regulates the formation of SHA-indels,
including those that occur in the framework region in B cells proficient. If POLQ does
contribute to the creation of these indels in either the CDR or framework regions, then the
regulation of POLQ’s activity will be of great interest in developing new immunotherapeutics.
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7.3 The impact of POLQ on breast cancer and chemotherapeutics
Reports that depletion or loss of POLQ in murine and human cancer cell lines
caused radiosensitivity, stimulated the idea of POLQ as a potential drug target (Begg, 2010;
Goff et al., 2009; Higgins et al., 2010b). Upon investigation of replicative stress in breast
cancer, our lab and collaborators reported that POLQ is the only DNA polymerase that is
significantly overexpressed in breast cancer. Further, POLQ overexpression is correlated
with poorer patient outcomes (Lemée et al., 2010). Subsequent reports also show that
overexpression of POLQ is associated poorer survival rates in early breast cancers. In
addition they identified specific POLQ SNPs that were associated with hereditary breast
cancer (Brandalize et al., 2014; Higgins et al., 2010a). Two questions float in the ether
unanswered right now: (1) If elevated POLQ expression leads to poorer outcomes in breast
cancer patients, what is the underlying mechanism and (2) if POLQ is of therapeutic value,
are there particular breast cancer subtypes that would display a greater therapeutic
response when POLQ is inhibited?
I sought to answer the first question of how POLQ causes poorer outcomes by in
vitro analysis. Preliminary evidence that I present in Chapter 4 demonstrates that ectopic
expression of POLQ in 293T cells increases resistance to the DNA damaging agent
bleomycin (Figure 24). This thesis presents evidence to demonstrate a role for mammalian
POLQ in an altEJ repair pathway that is involved in DSB restitution (Yousefzadeh et al.,
2014). I hypothesize that this bleomycin resistance seen in 293T cells expressing
recombinant POLQ is through its SD-EJ activity. This is supported by the fact that no DNA
damage resistance was seen in cells transfected with a polymerase-dead version of POLQ
and I have shown that the polymerase activity of POLQ is necessary for its DNA damage
resistance activities (Yousefzadeh et al., 2014). Further analysis is needed to see if this
DNA damage resistance effect upon ectopic expression of POLQ extends to breast cancer
cell lines and if increased SD-EJ is occurring in these cells. If ectopic POLQ expression
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leads to an increase in DNA damage resistance in cell culture models of breast cancer, then
further analysis using in vivo transgenic mouse models of POLQ would be warranted. I
would recommend the use of a conditional transgenic (such as STOP-floxed POLQ and
MMTV-Cre) to combat potential issues that may arise from constitutive gain of function of
POLQ.
With regard to the second question of whether particular breast cancer subtypes are
more responsive to POLQ inhibition, the Wood Laboratory (with the help of C. Marcelo
Aldaz) performed a meta-analysis of breast cancer microarray expression data. We found
POLQ to be highly expressed in triple negative breast cancers (TNBC), which are refractive
to common therapies (unpublished data, C. Marcelo Aldaz and Richard Wood). We
hypothesize that by suppressing POLQ by shRNA in TNBC lines we would be able to
achieve a significant increase in radiosensitivity in these cells. We are also surveying breast
cancer cell lines with a variety of different cancer genotypes (ER, PR, Her2/neu, p53 status)
to see if suppression of POLQ would induce hypersensitivity to ionizing radiation (IR). In the
mean time, we are investigating small molecule inhibitors of POLQ in the hope that if POLQsuppression mediates hypersensitivity to IR, that a POLQ-specific inhibitor will cause a
similar outcome.
If inhibition of POLQ induces further radiosensitization of breast cancer cells this
creates a fantastic therapeutic opportunity. Suppression of POLQ had no effect on a normal
human cell line (Higgins et al., 2010b), suggesting only limited off target effects in healthy
tissue. Thus delivery (oral or intravenous) of a POLQ-specific inhibitor to patients would
make radiotherapy more effective and allow for use of lower doses of radiation. POLQ was
shown to have as much predictive value for survival outcome for breast patients as CyclinE
(Lemée et al., 2010), which is currently being used for clinical prognoses (Keyomarsi et al.,
2002). Use of a POLQ antibody (like those presented in Chapter 6) could be useful to
determine which patient prognosis and which tumor types would be more responsive to
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POLQ inhibition. To date no POLQ antibody exists to serve that role but we have many
candidate antibodies that require further validation. While much work remains to investigate
the role of POLQ in breast cancer outcomes, POLQ presents a novel biomarker that is of
diagnostic and therapeutic interest.
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7.4 An “origin”al role for POLQ in DNA replication
A recent report demonstrated a role for POLQ in general DNA replication and that
loss of POLQ altered the firing of replication origin in cells (Fernandez-Vidal et al., 2014).
This finding, coupled with the data that POLQ interacts with the replication origin proteins
ORC2 and ORC4, serve as the first suggestions that POLQ operates at the replication fork
(Fernandez-Vidal et al., 2014). Expression of POLQ correlates with the expression of other
genes involved in DNA replication and in regulation of the cell cycle (Pillaire et al., 2009).
Ectopic expression of POLQ induces DNA damage signaling, increased chromosomal
aberrations, and defective progression of the replication fork (Lemée et al., 2010). In
Arabidopsis, mutants of the POLQ homolog, TEBICHI, exhibit impairments in meristem cell
division and differentiation (Inagaki et al., 2009; Inagaki et al., 2006). Furthermore, a recent
study suggested that in human cells POLQ promotes translesion DNA synthesis through
thymine glycol adduct (Yoon et al., 2014). These finding add further complexity to the
function of POLQ in the cell and now when working with POLQ, we must consider its
activities in replication, repair, and damage tolerance. While these in vitro findings give
pause for thought, these effects do not appear to have a large-scale effect at the organismal
level in mice lacking Polq. These mice only display a subtle phenotype of increased
spontaneous micronuclei (Shima et al., 2004). Therefore, more work is needed to fully
understand the biological relevance of POLQ’s activities during general DNA replication.
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7.5 Conclusion
DNA polymerase θ (POLQ) is a specialized DNA polymerase for which we are only
beginning to understand. Studies so far give insight into how this unique enzyme functions
in cells, but a considerable amount of information about this enzyme is still unknown.
Further exploration of how and with what other proteins POLQ functions with in alternative
end joining is required. How the synthesis-dependent end joining pathway, which is
predicated upon the polymerase activities of POLQ, functions in relation to other DNA
double-strand break pathways is still unclear. How DNA breaks are channeled into this
specific pathway in lieu of others is still a mystery. Is the nucleotide insertion activity of
POLQ salvaging genomic integrity and preventing Myc/IgH translocation formation at the
cost of creating indels? This is our current hypothesis but additional evidence is needed to
substantiate this notion.
The function of POLQ in other activities besides DNA double-strand break repair is
intriguing but requires more validation. If POLQ regulates origin firing and replication
dynamics, it would be valuable to know to what extent and the biological consequences of
misregulation. Also does POLQ share responsibility for these actions with any of the other
specialized DNA polymerases remains to be seen. Based on the published literature and
preliminary data generated in the lab, there are many unanswered questions about POLQ.
POLQ aids in maintaining a healthy genomic relationship through rejoining broken DNA
ends by inserting some common ground. We have only a limited knowledge of how it does
this, temporospatial nature of this activity, and how to exploit POLQ for better therapies. But
there is much to learn about POLQ and the sky is the limit.
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Appendix 1. Analysis of REV7 in breast cancer and DNA damage sensitivity.
DNA polymerase ζ, another specialized DNA polymerase that is studied by the lab, is
includes REV3L and REV7 that form the catalytic and accessory subunits of pol ζ,
respectively. Pol ζ is required for viability and defends cells against chromosomal instability,
as well as suppresses spontaneous tumor formation in vivo (Lange et al., 2011). However,
how human REV7 interacts with REV3L and the biological consequences of this interaction
on the human pol ζ complex remains to be clarified. Dr. Junya Tomida of our lab discovered
that in addition to a previously identified binging site, REV3L also contains a second REV7
binding motif (Tomida et al., 2015). Further work demonstrated that both REV7 binding sites
must be present for pol ζ to confer resistance to DNA damage (unpublished data, Junya
Tomida and Richard Wood). Dr. Tomida also found that reduced REV7 protein levels
increased the abundance of REV3L and that ectopic expression of REV7 in HeLa cells
induced mitomycin c (MMC) hypersensitivity compared to the empty vector control
(unpublished data, Junya Tomida) (Tomida et al., 2015).
Previously, I had surveyed expression of a number of DNA repair genes in breast
cancer cell lines (Figure 19) and found an elevated level of REV7 expression in HCC1806
cells (Figure 19E, Figure 30A), which is a triple negative breast cancer line that lacks
functional p53 (Neve et al., 2006). Following this, I surveyed the HCC1806 (REV7 high) and
MCF7 cell (REV7 low) lines for MMC sensitivity at different time points (Figure 30B).
Compared to MCF7 cells, HCC1806 cells display greater sensitivity to MMC, however this
may not be dependent upon REV7 levels alone (Figure 30B). To test the hypothesis that
elevated levels of REV7 confer DNA damage sensitivity, MCF7 (REV7 low) cells were
transiently transfected with a recombinant human REV7 expression vector or an empty
vector control (Figure 30C and D). MCF7 cells that expressed recombinant human REV7
were much more hypersensitive to MMC than cells containing the empty vector control
plasmid (Figure 30C).
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Figure 30. Ectopic expression of REV7 can induce DNA damage hypersensitivity in
breast cancer cells. (A) Expression of the indicated genes was quantified by qPCR in
multiple breast cancer cells. Relative quantification of gene expression was examined using
Taqman probes. Data was analyzed using the ∆∆Ct method and GAPDH expression was
used as an internal control. (B) MCF7 and HCC1806 breast cancer cells were treated with
mitomycin c and surveyed for ATP levels as a surrogate marker of survival at 48 and 72 h
after damage. (C) Similarly MC7 cells were transiently transfected with either pOZN/empty
or pOZN/REV7. Transfected cells were replated and treated with the indicated
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concentrations of mitomycin c and ATP levels were similarly measured 48 h after damage.
Data reflects three independent experiments. (D) Representative immunoblot of pooled
crude SDS lysates from the three independent experiments. The asterisk denotes
endogenous REV7, while the arrow indicates the recombinant N-terminal FLAG-HA-tagged
REV7. Cell lines were cultured and maintained by MJY. MJY isolated RNA and analyzed
qPCR expression data that was gathered by the Molecular Biology Core.

Further analysis of these preliminary findings is warranted. Analysis of breast cancer
outcomes and disease-free survival correlated to REV3L and REV7 levels or analysis of
tumor samples by REV7 immunohistochemistry is needed. The finding that ectopic
expression of REV7 increases DNA damage sensitivity in cultured cells should be further
evaluated by examining increased and decreased levels of REV7 protein in REV7 high
expressing cell lines, like HCC1806 (Figure 30). If elevated REV7 abundance is found in
these cells then ectopic expression of recombinant REV7 should have minimal effect protein
levels are already at a level that is saturating. However, once protein levels reach a certain
point, it is plausible that protein could become cytotoxic. Also REV7 levels are tightly
regulated and shRNA suppression of REV7 could rescue the MMC sensitivity phenotype,
but only up until a point as REV7-deficient chicken DT40 cells are hypersensitive to MMC
and cisplatin (Okada et al., 2005). Thus there is a fine balance required in regard to the
regulation of REV7 levels as too much or too little could pose grave consequences to the
cell.

150

Material and methods
Please note that this section is written as a protocol for persons that may be trying to repeat
these experimental procedures.

Cell lines
The following cell lines were purchased from American Type Culture Collection: MCF7,
MCF10, HCC1569, HCC1599, HCC1806, BT-474, MDA-MB-361, and MDA-MB-436. Cells
were STR fingerprinted, checked for mycoplasma contamination, and cultured in their
appropriate media (Neve et al., 2006).

RNA isolation and qPCR analysis
Total RNA was isolated from the each of the breast cancer cell lines were analyzed for
quality and purity using RNA 6000 Nano kit (Agilent Technologies, Santa Clara, CA). 1 µg of
total RNA was used to generate cDNA using the High Capacity cDNA RT kit (Life
Technologies). qPCR analysis was performed in triplicate using the ABI Prism 7900 HT
thermocycler and the following Taqman Probe set (Bio-Rad, Hercules, CA): REV3L
(Hs01076848_m1); REV7 (Hs01057448_m1). Data were analyzed using the ∆∆Ct method.
GAPDH was used as an internal control in all experiments and relative quantification
analysis was performed with MCF10 cells serving as the non-tumorigenic control.

Transfection of 293T cells and Crude SDS Lysate Preparation
1.5 x105 293T cells were plated into each well of a 6-well dish. The following day, cells were
transfected with 2 µg of either pOZN/empty vector control or pOZN/REV7 that was provided
by Dr. Junya Tomida. 48 h post-transfection cells from one well of a 6 well plate were
resuspended in 200 µL of 2X SDS Loading Buffer. Lysates were heat denatured at 95°C for
5 min.
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2X SDS Loading Buffer
20% Glycerol
4% SDS
0.2% Bromophenol Blue
12% 2-Mercaptoethanol
100 mM Tris-HCl pH 6.8
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Appendix 2. Analysis of Fam35a expression in murine tissues.
FAM35A was identified by co-immunoprecipitation/mass spectrometry analysis as an
interaction partner of human REV7, the catalytic subunit of DNA polymerase ζ (unpublished
data, Junya Tomida and Richard Wood). Little is known about the protein, but suppression
of FAM35A in human cancer cell lines induces hypersensitivity to the interstrandcrosslinking agent mitomycin c and causes elevated levels of DNA damage based on
enumeration of RAD51 and γH2AX foci (unpublished data, Junya Tomida and Richard
Wood). To get a better understanding of FAM35A and its role in cells, I surveyed Fam35a
transcript levels in murine tissues from C57BL/6J mice by qPCR using absolute
quantification method (Figure 31).
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Figure 31. Absolute quantification of transcript number shows that Fam35a is broadly
expressed in tissues. Total RNA was isolated from necropsied C57BL/6J mice by Trizol
(Life Technologies). Transcript abundance for Fam35a was determined by absolute
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quantification method as described in the material and methods section. Gapdh was used
as an internal control to normalize samples. Animal tissue was harvested and isolated for
RNA by MJY. MJY analyzed qPCR expression data generated by the Science Park
Molecular Biology Core.

Fam35a is broadly expressed in a number of tissues from mice, with the highest
expression in the liver. Further analysis (genetic, proteomic, etc.) of this gene in mammals
will reveal its cellular function and which DNA repair pathways that FAM35A could
participate in.

Material and methods
Quantitative real-time PCR analysis of mouse tissues. RNA was isolated from tissues of
C57BL/6J mice by Trizol and was analyzed for quality and purity using a RNA 6000 Nano kit
(Agilent Technologies, Santa Clara, CA). 1 µg of total RNA was used to generate cDNA
using the High Capacity cDNA RT kit (Life Technologies). qPCR analysis was performed in
triplicate using the ABI Prism 7900 HT thermocycler and the Fam35a (Mm01209709_m1)
Taqman Probe and primer set with iTAQ SYBR Green Supermix with ROX (Bio-Rad,
Hercules, CA). Data were analyzed using the absolute quantification method, where titration
of pT7T3D-PacI-Fam35a-AA242674 plasmid was used to generate standard curves for
expression. Transcript abundance was determined by extrapolation from linear regression
analysis of best-fit lines from titration experiments. Gapdh was used as an internal control
for normalization.
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